0000887921-21-000018 | 10-Q | XBRL Viewer

$ 521.1

$ 477.1

$ 1,463.5

$ 1,277.7

221.2

234.3

608.7

600.7

299.9

242.8

854.8

677.0

256.1

253.4

796.0

739.1

0.6

0.9

1.8

4.2

9.0

(0.7)

22.8

44.8

0.0

144.1

0.1

(1.1)

(1.7)

(0.5)

34.1

(9.7)

35.9

(254.7)

Other expenses:

Interest expense, net

63.1

68.7

183.9

178.0

8.7

7.8

30.7

17.8

0.0

(31.2)

0.0

(43.1)

9.9

(9.8)

11.5

9.1

0.1

(2.6)

2.8

13.9

81.8

32.9

228.9

175.7

Provision for (benefit from) income taxes

(47.7)

(42.6)

(193.0)

(430.4)

5.4

1.9

23.8

(45.2)

Foreign currency translation adjustments

(53.1)

(44.5)

(216.8)

(385.2)

Other comprehensive income (loss):

(0.6)

2.2

(6.0)

7.3

^[1],[2]

3.5

2.8

10.5

9.3

2.9

^[3]

5.0

^[3]

4.5

16.6

Basic (loss) earnings per common share (in dollars per share)

$ (50.2)

$ (39.5)

$ (212.3)

$ (368.6)

$ (0.98)

$ (0.83)

$ (4.02)

$ (7.22)

Diluted (loss) earnings per common share (in dollars per share)

$ (0.98)

$ (0.83)

$ (4.02)

$ (7.22)

Weighted average number of common shares outstanding:

Basic (in shares)

54,025,861

53,476,354

53,899,732

53,371,986

Diluted (in shares)

54,025,861

53,476,354

53,899,732

53,371,986

$ 521.1

$ 477.1

$ 1,463.5

$ 1,277.7

221.2

234.3

608.7

600.7

299.9

242.8

854.8

677.0

254.5

251.4

791.7

733.2

0.6

0.9

1.8

4.2

9.0

(0.7)

22.8

44.8

0.0

144.1

0.1

(1.1)

(1.7)

(0.5)

35.7

(7.7)

40.2

(248.8)

Other expenses:

Interest expense, net

63.1

68.7

183.9

178.0

8.7

7.8

30.7

17.8

0.0

(31.2)

0.0

(43.1)

9.9

(9.8)

11.5

9.1

0.1

(2.6)

2.8

13.9

81.8

32.9

228.9

175.7

Provision for (benefit from) income taxes

(46.1)

(40.6)

(188.7)

(424.5)

5.5

2.3

23.9

(44.2)

Foreign currency translation adjustments

(51.6)

(42.9)

(212.6)

(380.3)

Other comprehensive income (loss):

(0.6)

2.2

(6.0)

7.3

^[4],[5]

3.5

2.8

10.5

9.3

2.9

^[6]

5.0

^[6]

4.5

16.6

Increase (Decrease) in Stockholders' Equity [Roll Forward]

$ (48.7)

$ (37.9)

$ (208.1)

$ (363.7)

[1]	Net of tax expense of nil and $0.5 million for the three months ended September 30, 2021 and 2020, respectively, and net of tax benefit of nil and $0.7 million for the nine months ended September 30, 2021 and 2020, respectively.
[2]	This amount is included in the computation of net periodic benefit costs (income). See Note 10, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).
[3]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the nine months ended September 30, 2021 and 2020, respectively.
[4]	Net of tax expense of nil and $0.5 million for the three months ended September 30, 2021 and 2020, respectively, and net of tax benefit of nil and $0.7 million for the nine months ended September 30, 2021 and 2020, respectively.
[5]	This amount is included in the computation of net periodic benefit costs (income). See Note 10, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).
[6]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the nine months ended September 30, 2021 and 2020, respectively.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Amortization of pension related costs, tax expense (benefit)	$ 0	$ 500,000	$ 0	$ (700,000)
Revlon Consumer Products Corporation
Amortization of pension related costs, tax expense (benefit)	$ 0	$ 500,000	$ 0	$ (700,000)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Jun. 30, 2021

Mar. 31, 2021

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Sep. 30, 2021

Sep. 30, 2020

Treasury stock acquired, at cost

$ (2,020.0)

$ (1,958.7)

$ (1,862.0)

$ (1,548.5)

$ (1,435.8)

$ (1,221.2)

$ (1,862.0)

$ (1,221.2)

^[1]

(2.4)

(1.3)

(0.4)

3.9

3.4

3.1

5.1

1.1

2.4

(53.1)

(67.7)

(96.0)

(44.5)

(126.8)

(213.9)

(216.8)

(385.2)

2.9

^[2]

3.0

^[2]

(1.4)

^[2]

5.0

^[2]

14.3

^[2]

(2.7)

^[2]

4.5

16.6

Increase (Decrease) in Stockholders' Equity [Roll Forward]

(2,066.3)

(2,020.0)

(1,958.7)

(1,582.9)

(1,548.5)

(1,435.8)

(2,066.3)

(1,582.9)

Common Stock

0.5

Additional Paid-In Capital

0.5

Increase (Decrease) in Stockholders' Equity [Roll Forward]

1,088.8

1,085.4

1,082.3

1,075.4

1,074.3

1,071.9

1,082.3

1,071.9

3.9

3.4

3.1

5.1

1.1

2.4

Increase (Decrease) in Stockholders' Equity [Roll Forward]

1,092.7

1,088.8

1,085.4

1,080.5

1,075.4

1,074.3

1,092.7

1,080.5

Treasury Stock

Treasury stock acquired, at cost

(37.6)

(35.2)

(33.9)

(33.5)

(35.2)

(33.5)

^[1]

(2.4)

(1.3)

(0.4)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

(37.6)

(35.2)

(33.9)

(37.6)

(35.2)

Accumulated Deficit

(2,795.4)

(2,727.7)

(2,631.7)

(2,353.4)

(2,226.6)

(2,012.7)

(2,631.7)

(2,012.7)

(53.1)

(67.7)

(96.0)

(44.5)

(126.8)

(213.9)

Accumulated Other Comprehensive (Loss) Income

(2,848.5)

(2,795.4)

(2,727.7)

(2,397.9)

(2,353.4)

(2,226.6)

(2,848.5)

(2,397.9)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

(276.3)

(279.3)

(277.9)

(235.8)

(250.1)

(247.4)

(277.9)

(247.4)

^[2]

2.9

3.0

(1.4)

5.0

14.3

(2.7)

(273.4)

(276.3)

(279.3)

(230.8)

(235.8)

(250.1)

(273.4)

(230.8)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

(1,855.9)

(1,796.2)

(1,703.0)

(1,411.7)

(1,301.9)

(1,089.4)

(1,703.0)

(1,089.4)

3.9

3.4

3.1

5.1

1.1

2.4

(51.6)

(66.1)

(94.9)

(42.9)

(125.2)

(212.2)

(212.6)

(380.3)

2.9

^[3]

3.0

^[3]

(1.4)

^[3]

5.0

^[3]

14.3

^[3]

(2.7)

^[3]

4.5

16.6

Revlon Consumer Products Corporation | Preferred Stock

(1,900.7)

(1,855.9)

(1,796.2)

(1,444.5)

(1,411.7)

(1,301.9)

(1,900.7)

(1,444.5)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

54.6

Revlon Consumer Products Corporation | Additional Paid-In Capital

54.6

Increase (Decrease) in Stockholders' Equity [Roll Forward]

1,013.4

1,010.0

1,006.9

1,000.0

998.9

996.5

1,006.9

996.5

3.9

3.4

3.1

5.1

1.1

2.4

Revlon Consumer Products Corporation | Accumulated Deficit

1,017.3

1,013.4

1,010.0

1,005.1

1,000.0

998.9

1,017.3

1,005.1

Increase (Decrease) in Stockholders' Equity [Roll Forward]

(2,647.6)

(2,581.5)

(2,486.6)

(2,230.5)

(2,105.3)

(1,893.1)

(2,486.6)

(1,893.1)

(51.6)

(66.1)

(94.9)

(42.9)

(125.2)

(212.2)

Revlon Consumer Products Corporation | Accumulated Other Comprehensive (Loss) Income

(2,699.2)

(2,647.6)

(2,581.5)

(2,273.4)

(2,230.5)

(2,105.3)

(2,699.2)

(2,273.4)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

(276.3)

(279.3)

(277.9)

(235.8)

(250.1)

(247.4)

(277.9)

(247.4)

^[3]

2.9

3.0

(1.4)

5.0

14.3

(2.7)

$ (273.4)

$ (276.3)

$ (279.3)

$ (230.8)

$ (235.8)

$ (250.1)

$ (273.4)

$ (230.8)

[1]	Pursuant to the share withholding provisions of the Fourth Amended and Restated Revlon, Inc. Stock Plan (as amended, the "Stock Plan"), the Company withheld an aggregate of 763 and 756 shares of Revlon Class A Common Stock during the three months ended September 30, 2021 and 2020, respectively, and 163,259 and 127,725 shares of Revlon Class A Common Stock during the nine months ended September 30, 2021 and 2020, respectively, to satisfy certain minimum statutory tax withholding requirements related to the vesting of restricted shares and restricted stock units ("RSUs") for certain senior executives and employees. These withheld shares were recorded as treasury stock using the cost method, at a weighted-average price per share of $12.84 and $8.50 during the three months ended September 30, 2021 and 2020, respectively, and $14.94 and $12.99 during the nine months ended September 30, 2021 and 2020, respectively, based on the closing price of Revlon Class A Common Stock as reported on the New York Stock Exchange (the "NYSE") consolidated tape on each respective vesting date, for a total of approximately $9,700 and $6,400 during the three months ended September 30, 2021 and 2020, respectively, and $2.4 million and $1.6 million during the nine months ended September 30, 2021 and 2020. See Note 11, "Stock Compensation Plan," for details regarding restricted stock awards and RSUs under the Stock Plan.
[2]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the nine months ended September 30, 2021 and 2020, respectively.
[3]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the nine months ended September 30, 2021 and 2020, respectively.

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY (Parenthetical) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Tax withholdings related to net share settlements of restricted stock units and awards	$ 9,700	$ 6,400	$ 2,400,000	$ 1,600,000
Treasury Stock
Shares withheld for withholding taxes (in shares)	763	756	163,259	127,725
Treasury Stock \| Restricted Stock and Restricted Stock Units \| Class A Common Stock
Share repurchase price (in dollars per share)	$ 12.84	$ 8.50	$ 14.94	$ 12.99

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Adjustments to reconcile net loss to net cash used in operating activities:

$ (216,800,000)

$ (385,200,000)

Depreciation and amortization

96,800,000

108,300,000

Foreign currency losses from re-measurement

11,500,000

9,100,000

Amortization of debt discount

700,000

1,300,000

10,400,000

8,600,000

Provision for (benefit from) deferred income taxes

144,100,000

3,900,000

(54,400,000)

(43,100,000)

Pension and other post-retirement cost

30,700,000

17,800,000

Gain on divested assets

(1,700,000)

(500,000)

3,600,000

4,200,000

Paid-in-kind interest expense on the 2020 BrandCo Facilities

14,100,000

6,200,000

Change in assets and liabilities:

(Increase) decrease in trade receivables

(44,400,000)

78,000,000.0

Increase in inventories

(8,100,000)

(79,400,000)

Decrease (increase) in prepaid expenses and other current assets

200,000

(1,700,000)

Increase (decrease) in accounts payable

56,100,000

(27,800,000)

Decrease in accrued expenses and other current liabilities

(25,200,000)

Decrease in deferred revenue

(2,000,000.0)

Pension and other post-retirement plan contributions

(20,500,000)

(7,500,000)

Purchases of permanent displays

(15,000,000.0)

(16,500,000)

Other, net

19,000,000.0

6,800,000

Net cash used in operating activities

(86,700,000)

(256,900,000)

Proceeds from the sale of certain assets

Capital expenditures

(6,300,000)

(7,400,000)

2,100,000

Net cash used in investing activities

(4,200,000)

(7,400,000)

Net decrease in short-term borrowings and overdraft

(12,500,000)

(700,000)

305,000,000.0

880,000,000.0

^[1]

(186,700,000)

(354,700,000)

(2,700,000)

19,500,000

Tax withholdings related to net share settlements of restricted stock and RSUs

(17,900,000)

(108,300,000)

(2,400,000)

(1,600,000)

Net cash provided by (used in) financing activities

(300,000)

82,500,000

433,900,000

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(2,400,000)

(400,000)

Net increase (decrease) in cash, cash equivalents and restricted cash

(10,800,000)

169,200,000

Cash, cash equivalents and restricted cash at beginning of period

^[2]

102,500,000

104,500,000

Cash, cash equivalents and restricted cash at end of period

^[2]

91,700,000

273,700,000

Cash paid during the period for:

Interest

186,400,000

182,200,000

Income taxes, net of refunds

7,300,000

12,600,000

Supplemental schedule of non-cash investing and financing activities:

Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities

846,000,000.0

Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities

29,100,000

Paid-in-kind interest capitalized to the 2020 BrandCo Facilities

14,100,000

Adjustments to reconcile net loss to net cash used in operating activities:

(212,600,000)

(380,300,000)

Depreciation and amortization

96,800,000

108,300,000

Foreign currency losses from re-measurement

11,500,000

9,100,000

Amortization of debt discount

700,000

1,300,000

10,400,000

8,600,000

Provision for (benefit from) deferred income taxes

144,100,000

4,400,000

(53,100,000)

(43,100,000)

Pension and other post-retirement cost

30,700,000

17,800,000

Gain on divested assets

(1,700,000)

(500,000)

3,600,000

4,200,000

Paid-in-kind interest expense on the 2020 BrandCo Facilities

14,100,000

6,200,000

Change in assets and liabilities:

(Increase) decrease in trade receivables

(44,400,000)

78,000,000.0

Increase in inventories

(8,100,000)

(79,400,000)

Decrease (increase) in prepaid expenses and other current assets

(6,600,000)

(9,300,000)

Increase (decrease) in accounts payable

56,100,000

(27,800,000)

Decrease in accrued expenses and other current liabilities

(25,100,000)

(24,300,000)

Decrease in deferred revenue

(2,000,000.0)

Pension and other post-retirement plan contributions

(20,500,000)

(7,500,000)

Purchases of permanent displays

(15,000,000.0)

(16,500,000)

Other, net

21,000,000.0

7,300,000

Net cash used in operating activities

(86,700,000)

(256,900,000)

Proceeds from the sale of certain assets

Capital expenditures

(6,300,000)

(7,400,000)

2,100,000

Net cash used in investing activities

(4,200,000)

(7,400,000)

Net decrease in short-term borrowings and overdraft

(12,500,000)

(700,000)

305,000,000.0

880,000,000.0

^[3]

(186,700,000)

(354,700,000)

(2,700,000)

19,500,000

Tax withholdings related to net share settlements of restricted stock and RSUs

(17,900,000)

(108,300,000)

(2,400,000)

(1,600,000)

Net cash provided by (used in) financing activities

(300,000)

82,500,000

433,900,000

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(2,400,000)

(400,000)

Net increase (decrease) in cash, cash equivalents and restricted cash

(10,800,000)

169,200,000

Cash, cash equivalents and restricted cash at beginning of period

^[4]

102,500,000

104,500,000

Cash, cash equivalents and restricted cash at end of period

^[4]

91,700,000

273,700,000

Cash paid during the period for:

Interest

186,400,000

182,200,000

Income taxes, net of refunds

7,300,000

12,600,000

Supplemental schedule of non-cash investing and financing activities:

Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities

846,000,000.0

Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities

29,100,000

Paid-in-kind interest capitalized to the 2020 BrandCo Facilities

$ 14,100,000

$ 0

[1]	Repayments on term loans for the nine months ended September 30, 2020 includes the repayment of the 2019 Term Loan Facility, repayment under the 2018 Foreign Asset-Based Term Loan and repayments under the 2016 Term Loan Facility of $200.0 million, $31.4 million and $9.2 million, respectively, as well as repurchases of the 5.75% Senior Notes of $114.1 million. During 2020, the Company used a portion of the proceeds from the 2020 BrandCo Facility to repurchase and subsequently cancel a portion of its 5.75% Senior Notes. See Note 8, "Debt" in the Company's 2020 Form 10-K for additional information.
[2]	These amounts include restricted cash of $18.4 million and $5.4 million as of September 30, 2021 and 2020, respectively. The balance as of September 30, 2021 represents: (i) cash on deposit in lieu of a mandatory prepayment and loan proceeds held in escrow until certain collateral perfection requirements are satisfied under the 2021 Foreign Asset-Based Term Agreement; and (ii) cash on deposit to support outstanding undrawn letters of credit. The balance as of September 30, 2020 represents: (i) cash on deposit in lieu of a mandatory prepayment under the 2018 Foreign Asset-Based Term Facility; and (ii) cash on deposit to support outstanding undrawn letters of credit. These balances were included within prepaid expenses and other current assets and other assets in the Company's Consolidated Balance Sheets as of September 30, 2021 and September 30, 2020, respectively.
[3]	Repayments on term loans for the nine months ended September 30, 2020 includes the repayment of the 2019 Term Loan Facility, repayment under the 2018 Foreign Asset-Based Term Loan and repayments under the 2016 Term Loan Facility of $200.0 million, $31.4 million and $9.2 million, respectively, as well as repurchases of the 5.75% Senior Notes of $114.1 million. During 2020, the Company used a portion of the proceeds from the 2020 BrandCo Facility to repurchase and subsequently cancel a portion of its 5.75% Senior Notes. See Note 8, "Debt" in the Company's 2020 Form 10-K for additional information.
[4]	These amounts include restricted cash of $18.4 million and $5.4 million as of September 30, 2021 and 2020, respectively. The balance as of September 30, 2021 represents: (i) cash on deposit in lieu of a mandatory prepayment and loan proceeds held in escrow until certain collateral perfection requirements are satisfied under the 2021 Foreign Asset-Based Term Agreement; and (ii) cash on deposit to support outstanding undrawn letters of credit. The balance as of September 30, 2020 represents: (i) cash on deposit in lieu of a mandatory prepayment under the 2018 Foreign Asset-Based Term Facility; and (ii) cash on deposit to support outstanding undrawn letters of credit. These balances were included within prepaid expenses and other current assets and other assets in the Company's Consolidated Balance Sheets as of September 30, 2021 and September 30, 2020, respectively

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)
$ in Millions

9 Months Ended

Sep. 30, 2020

USD ($)

$ 354.7

^[1]

Restricted cash

5.4

2019 Term Loan Facility

2018 Foreign Asset-Based Term Facility

200.0

31.4

2016 Term Loan Facility

9.2

5.75% Senior Notes

114.1

Revlon Consumer Products Corporation | 2019 Term Loan Facility

354.7

^[2]

Restricted cash

5.4

Revlon Consumer Products Corporation | 2018 Foreign Asset-Based Term Facility

200.0

Revlon Consumer Products Corporation | 2016 Term Loan Facility

31.4

Revlon Consumer Products Corporation | 5.75% Senior Notes

9.2

Restructuring and Related Activities [Abstract]

$ 114.1

[1]

Repayments on term loans for the nine months ended September 30, 2020 includes the repayment of the 2019 Term Loan Facility, repayment under the 2018 Foreign Asset-Based Term Loan and repayments under the 2016 Term Loan Facility of $200.0 million, $31.4 million and $9.2 million, respectively, as well as repurchases of the 5.75% Senior Notes of $114.1 million. During 2020, the Company used a portion of the proceeds from the 2020 BrandCo Facility to repurchase and subsequently cancel a portion of its 5.75% Senior Notes. See Note 8, "Debt" in the Company's 2020 Form 10-K for additional information.

[2]

DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Revlon, Inc. ("Revlon" and together with its subsidiaries, the "Company") conducts its business exclusively through its direct wholly-owned operating subsidiary, Revlon Consumer Products Corporation ("Products Corporation") and its subsidiaries. Revlon is an indirect majority-owned subsidiary of MacAndrews & Forbes Incorporated (together with certain of its affiliates other than the Company, "MacAndrews & Forbes"), a corporation beneficially owned by Ronald O. Perelman. Mr. Perelman is Chairman of Revlon's and Products Corporation's Board of Directors. The Company is a leading global beauty company with an iconic portfolio of brands that develops, manufactures, markets, distributes and sells an extensive array of color cosmetics; hair color, hair care and hair treatments; fragrances; skin care; beauty tools; men’s grooming products; anti-perspirant deodorants; and other beauty care products across a variety of distribution channels. The accompanying Consolidated Financial Statements are unaudited. In management's opinion, all adjustments necessary for a fair presentation of the Company's financial information have been made. The Unaudited Consolidated Financial Statements include the Company's accounts after the elimination of all material intercompany balances and transactions. Certain prior year amounts have been reclassified to conform to the current year presentation. The preparation of the Company's Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the Consolidated Financial Statements in the period they are determined to be necessary. Significant estimates made in the accompanying Consolidated Financial Statements include, but are not limited to: expected sales returns; certain assumptions related to the valuation of acquired intangible and long-lived assets and the recoverability of goodwill, intangible and long-lived assets; income taxes, including deferred tax valuation allowances and reserves for estimated tax liabilities; and certain estimates and assumptions used in the calculation of the net periodic benefit (income) costs and the projected benefit obligations for the Company’s pension and other post-retirement plans, including the expected long-term return on pension plan assets and the discount rate used to value the Company’s pension benefit obligations. The Unaudited Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and related notes contained in Revlon's Annual Report on Form 10-K for the fiscal year ended December 31, 2020 ("2020 Form 10-K"). The Company's results of operations and financial position for the interim periods are not indicative of those to be expected for the full year. Liquidity and Ability to Continue as a Going Concern The ongoing COVID-19 pandemic has continued to adversely impact the Company’s business in 2021. The COVID-19 pandemic’s adverse impact has resulted in significant and extended quarantines, stay-at-home orders and other social distancing measures; closures and bankruptcies of retailers, beauty salons, spas, offices and manufacturing facilities; increased levels of unemployment; travel and transportation restrictions leading to declines in consumer traffic in key shopping and tourist areas around the globe; and import and export restrictions. These adverse conditions have resulted in the general slowdown of the global economy, in turn contributing to declines in net sales within some of the Company’s reporting segments and regions. However, as COVID-19 restrictions are lifted, the Company is seeing a resumption in consumer spending and consumption. The Company continues to closely monitor the associated impacts and take appropriate actions in an effort to mitigate the COVID-19 pandemic’s negative effects on the Company’s operations and financial results. Each reporting period, the Company assesses its ability to continue as a going concern for one year from the date the financial statements are issued. At September 30, 2021, the Company had a liquidity position of $121.9 million, consisting of: (i) $73.3 million of unrestricted cash and cash equivalents (with approximately $67.1 million held outside the U.S.); (ii) $53.2 million in available borrowing capacity under the Amendment No.8 to the Amended 2016 Revolving Credit Facility (which had $316.2 million drawn at such date); and less (iii) approximately $4.6 million of outstanding checks. The Company's evaluation includes its ability to meet its future contractual obligations and other conditions and events that may impact its liquidity. The Company continues to focus on cost reduction and risk mitigation actions to address the ongoing impact from the COVID-19 pandemic as well as other risks in the business environment. It expects to generate additional liquidity through continued cost control initiatives as well as funds provided by selling certain assets or other strategic transactions in connection with the Company's ongoing Strategic Review. If sales continue to decline, the Company’s cost control initiatives may include reductions in discretionary spend and reductions in investments in capital and permanent displays. Management believes that the debt transactions completed during the nine months ended September 30, 2021, along with existing cash and cash equivalents and cost control initiatives provides the Company with sufficient liquidity to meet its obligations and maintain business operations for the next twelve months. However, there can be no assurance that available funds will be sufficient to meet the Company’s cash requirements on a consolidated basis, as, among other things, the Company’s liquidity can be impacted by a number of factors, including its level of sales, costs and expenditures, as well as accounts receivable and inventory, which serve as the principal variables impacting the amount of liquidity available under the Amended 2016 Revolving Credit Facility and the 2021 Foreign Asset-Based Term Facility. For example, subject to certain exceptions, revolving loans under the Amended 2016 Revolving Credit Facility and term loans under the 2021 Foreign Asset-Based Term Facility must be prepaid to the extent that such outstanding loans exceed the applicable borrowing base, consisting of certain accounts receivable, inventory and real estate. Recently Evaluated and/or Adopted Accounting Pronouncements In December 2019, the Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocations, calculating income taxes in interim periods and how a company accounts for future events. This ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. The Company adopted this guidance as of January 1, 2021. The adoption of this new guidance did not have any significant impacts on the Company’s results of operations, financial condition and/or financial statement disclosures. Recently Issued Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The new guidance under ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is in the process of assessing the impact, if any, that ASU No. 2020-04 is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures. In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which was subsequently amended in November 2018 through ASU No. 2018-19, "Codification Improvements to Topic 326, Financial Instruments - Credit Losses." ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. In November 2019, the FASB issued ASU No. 2019-10, which, among other things, deferred the application of the new guidance on credit losses for smaller reporting companies ("SRC") to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. This guidance will be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (i.e., a modified-retrospective approach). Under the above-mentioned deferral, the Company expects to adopt ASU No. 2016-03, and the related ASU No. 2018-19 amendments, beginning as of January 1, 2023 and is in the process of assessing the impact, if any, that this new guidance is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures.

RESTRUCTURING CHARGES

9 Months Ended

Sep. 30, 2021

RESTRUCTURING CHARGES

Revlon Global Growth Accelerator Program

On May 10, 2021, the Company announced that it was expanding the existing Revlon 2020 Restructuring Program through 2023. The Company renamed the revised program the Revlon Global Growth Accelerator (“RGGA”). RGGA includes a reinvestment strategy to strengthen our brands and drive long-term profitable margin and revenue growth through realized incremental productivity initiatives and enhanced capabilities.

The major initiatives underlying RGGA include:

•Strategic Growth: Boost organic sales growth behind our strategic pillars – brands, markets, and channels – to deliver an approximate mid-single digit compound average annual growth rate through 2023;

•Operating Efficiencies: Drive additional operational efficiencies and cost savings to fuel investments in revenue growth; and

•Build Capabilities: Enhance capabilities and up-skill employees in order to evolve our culture to promote agility and deliver transformational change.

Since inception and through September 30, 2021, the Company recorded pre-tax restructuring and related charges of $96.8 million in connection with RGGA, consisting primarily of (i) $73.3 million of employee severance, other personnel benefits and other costs; and (ii) $23.5 million of lease and other restructuring-related charges that were recorded within Selling, general & administrative expenses ("SG&A") and Cost of sales.

A summary of the RGGA charges incurred since its inception in March 2020 and through September 30, 2021 is presented in the following table:



	Restructuring Charges and Other, Net
	Employee Severance and Other Personnel Benefits		Other Costs		Total Restructuring Charges		Leases (a)		Other Related Charges (b)		Total Restructuring and Related Charges
Charges incurred through December 31, 2020	$	48.6	$	1.9	$	50.5	$	12.6	$	5.7	$	68.8
Charges incurred during the nine months ended September 30, 2021	3.5		19.3		22.8		3.9		1.3		28.0
Cumulative charges incurred through September 30, 2021	$	52.1	$	21.2	$	73.3	$	16.5	$	7.0	$	96.8

(a) Lease-related charges are recorded within SG&A in the Company’s Consolidated Statement of Operations and Comprehensive Loss.

(b) Other related charges are recorded within SG&A and cost of sales in the Company’s Consolidated Statement of Operations and Comprehensive Loss.

A summary of the RGGA restructuring charges incurred since its inception in March 2020 and through September 30, 2021 by reportable segment is presented in the following table:



	Charges incurred in the nine months ended September 30, 2021		Cumulative charges incurred through September 30, 2021
Revlon	$	6.5	$	27.2
Elizabeth Arden	8.0		17.4
Portfolio	3.9		17.5
Fragrances	4.4		11.2
Total	$	22.8	$	73.3

Restructuring Reserve

The liability balance and related activity for each of the Company's restructuring programs are presented in the following table:



					Utilized, Net
	Liability Balance at January 1, 2021		Expense, Net		Cash		Liability Balance at September 30, 2021
RGGA:
Employee severance and other personnel benefits	$	12.6	$	3.5	$	(13.5)	$	2.6
Other	—		19.3		(19.3)		—
Total RGGA	12.6		22.8		(32.8)		2.6






Other restructuring initiatives:
Employee severance and other personnel benefits	1.2		—		(0.3)		0.9

Total other restructuring initiatives	1.2		—		(0.3)		0.9
Total restructuring reserve	$	13.8	$	22.8	$	(33.1)	$	3.5

All of the restructuring reserve balances were included within accrued expenses and other current liabilities in the Company's Consolidated Balance Sheets.

INVENTORIES

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

INVENTORIES

The Company's net inventory balances consisted of the following:


	September 30,		December 31,
	2021		2020
Finished goods	329.0		$	356.7
Raw materials and supplies	116.3		97.1
Work-in-process	16.2		8.8
	$	461.5	$	462.6

PROPERTY, PLANT AND EQUIPMENT

9 Months Ended

Sep. 30, 2021

Property, Plant and Equipment [Abstract]

PROPERTY, PLANT AND EQUIPMENT

The Company's property, plant and equipment, net balances consisted of the following:



	September 30,		December 31,
	2021		2020
Land and improvements	$	10.9	$	11.4
Building and improvements	44.7		48.3
Machinery and equipment	86.8		98.7
Office furniture, fixtures and capitalized software	63.6		76.2
Leasehold improvements	18.7		21.3
Construction-in-progress	5.6		9.1
Right-of-Use assets	75.6		87.0
Property, plant and equipment and Right-of-Use assets, net	$	305.9	$	352.0

Depreciation and amortization expense on property, plant and equipment and right-of-use assets for the three months ended September 30, 2021 and September 30, 2020 was $16.5 million and $18.3 million, respectively. Depreciation and amortization expense on property, plant and equipment and right-of-use assets for the nine months ended September 30, 2021 and September 30, 2020 was $50.7 million and $59.3 million, respectively. Accumulated depreciation and amortization was $559.9 million and $528.9 million as of September 30, 2021 and December 31, 2020, respectively.

GOODWILL AND INTANGIBLE ASSETS, NET

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS, NET

In accordance with ASC Topic 350, “Intangibles – Goodwill and Other,” the Company performs its annual impairment test during the fourth quarter of each year. The Company also reviews goodwill for impairment whenever events or changes in circumstances indicate that the carrying value of its goodwill may not be recoverable. After the close of each interim quarter, management assesses whether there exists any indicators of impairment requiring the Company to perform an interim goodwill impairment analysis.

As of September 30, 2021, the Company assessed that no indicators of impairment existed requiring the performance of a goodwill interim impairment analysis. No goodwill impairment charges were recorded during the three and nine months ended September 30, 2021.

The following table presents the changes in goodwill by segment for the nine months ended September 30, 2021:



	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total




Balance at January 1, 2021	$	265.4	$	87.9	$	89.5	$	120.9	$	563.7
Foreign currency translation adjustment	(0.2)		(0.2)		(0.1)		(0.1)		(0.6)


Balance at September 30, 2021	$	265.2	$	87.7	$	89.4	$	120.8	$	563.1

Cumulative goodwill impairment charges(a)									$	(166.2)

(a) Amount refers to cumulative goodwill impairment charges related to impairments recognized in 2015, 2017, 2018 and 2020.

For the three and nine months ended September 30, 2020, the Company recorded goodwill impairment charges of nil and $111.0 million, respectively.

Intangible Assets, Net

Finite-Lived Intangibles

In accordance with ASC Topic 360, the Company makes judgments about the recoverability of its purchased finite-lived intangible assets whenever events or changes in circumstances indicate that an impairment to its finite-lived intangible assets may exist. The Company also considers several indicators of impairment, including, among other factors, the following: (i) whether there exists any significant adverse change in the extent or manner in which a long-lived asset and/or asset group is being used; (ii) whether there exists any projection or forecast demonstrating losses associated with the use of a long-lived asset and/or asset group; and (iii) whether there exists a current expectation that, more likely than not, a long-lived asset and/or asset group will be sold or otherwise disposed of significantly before the end of its previously-estimated useful life. The carrying amount of a finite-lived intangible asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the finite-lived intangible asset and/or asset group and the impairment loss is measured as the amount by which the carrying amount of the finite-lived intangible asset exceeds its fair value.

As of September 30, 2021, the Company assessed that no indicators of impairment existed requiring the performance of a finite-lived intangibles interim impairment analysis.

As a result, no impairment charges were recognized related to the carrying value of any of the Company's finite-lived intangible assets for the three and nine months ended September 30, 2021 and 2020, respectively.

Indefinite-Lived Intangibles

As of September 30, 2021, the Company assessed that no indicators of impairment existed requiring the performance of an indefinite-lived intangibles interim impairment analysis. No intangibles impairment charges were recorded during the three and nine months ended September 30, 2021.

For the three and nine months ended September 30, 2020, the Company recorded indefinite-lived intangible assets impairment charges of nil and $33.1 million, respectively.

The following tables present details of the Company's total intangible assets as of September 30, 2021 and December 31, 2020:


	September 30, 2021
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	271.1	$	(139.2)	$	—	$	131.9	12
Customer relationships	247.4		(119.5)		—		127.9		10
Patents and internally-developed intellectual property	23.7		(16.9)		—		6.8		4
Distribution rights	31.0		(8.8)		—		22.2		13
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	574.5	$	(285.7)	$	—	$	288.8

Indefinite-lived intangible assets:
Trade names	$	145.8	N/A		$	(33.1)	$	112.7
Total indefinite-lived intangible assets	$	145.8	N/A		$	(33.1)	$	112.7

Total intangible assets	$	720.3	$	(285.7)	$	(33.1)	$	401.5

	December 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	272.8	$	(128.6)	$	—	$	144.2	12
Customer relationships	249.9		(110.7)		—		139.2		11
Patents and internally-developed intellectual property	23.6		(15.6)		—		8.0		5
Distribution rights	31.0		(7.5)		—		23.5		14
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	578.6	$	(263.7)	$	—	$	314.9

Indefinite-lived intangible assets:
Trade names	$	149.0	N/A		$	(33.1)	$	115.9
Total indefinite-lived intangible assets	$	149.0	N/A		$	(33.1)	$	115.9

Total intangible assets	$	727.6	$	(263.7)	$	(33.1)	$	430.8

Amortization expense for finite-lived intangible assets was $9.1 million and $8.3 million for the three months ended September 30, 2021 and 2020, respectively, and $26.1 million and $25.0 million for the nine months ended September 30, 2021 and 2020, respectively.

The following table reflects the estimated future amortization expense for each period presented, a portion of which is subject to exchange rate fluctuations, for the Company's finite-lived intangible assets as of September 30, 2021:



	Estimated Amortization Expense
2021	$	8.3
2022	32.6
2023	30.8
2024	27.5
2025	26.3
Thereafter	163.3
Total	$	288.8

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

9 Months Ended

Sep. 30, 2021

Payables and Accruals [Abstract]

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIESThe Company's accrued expenses and other current liabilities consisted of the following:


	September 30,		December 31,
	2021		2020
Advertising, marketing and promotional costs	$	99.0	$	96.3
Sales returns and allowances	74.9		95.5
Taxes (a)	54.2		41.8
Compensation and related benefits	44.4		50.1
Interest	24.0		29.6
Freight and distribution costs	17.6		9.5
Professional services and insurance	14.7		18.6
Short-term lease liability	14.3		16.6
Restructuring reserve	3.5		13.8
Software	2.2		3.1
Other	51.7		46.0
Total	$	400.5	$	420.9

(a) Accrued Taxes for Products Corporation as of September 30, 2021 and December 31, 2020 were $57.3 million and $44.8 million,

DEBT

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

DEBT

The table below details the Company's debt balances, net of discounts and debt issuance costs.


	September 30,		December 31,
	2021		2020
Amended 2016 Revolving Credit Facility (Tranche A) due 2024	$	134.5	$	136.7
SISO Term Loan Facility due 2024	125.8		—
2021 Foreign Asset-Based Term Facility due 2024	70.7		—

2020 ABL FILO Term Loans due 2023	50.0		50.0
2020 Troubled-debt-restructuring: future interest	46.2		57.8
2020 BrandCo Term Loan Facility due 2025	1,742.9		1,719.8
2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025	869.2		874.8
2018 Foreign Asset-Based Term Facility due 2021	—		57.7

6.25% Senior Notes due 2024	426.5		425.4
Spanish Government Loan due 2025	0.3		0.3


Debt	$	3,466.1	$	3,322.5
Less current portion	(163.8)		(217.5)
Long-term debt	$	3,302.3	$	3,105.0

Short-term borrowings (*)	$	0.6	$	2.5

(*)The weighted average interest rate on these short-term borrowings outstanding at September 30, 2021 and December 31, 2020 was 11.4% and 11.7%, respectively.

Amendment No. 8 to the Amended 2016 Revolving Credit Agreement: Tranche A - Revolving Credit Facility and Second-In, Second-Out ("SISO") Term Loan Facility

On May 7, 2021, Products Corporation entered into Amendment No. 8 to the Amended 2016 Revolving Credit Agreement (“Amendment No. 8”). Amendment No. 8, among other things, made certain amendments pursuant to which: (i) the maturity date applicable to the “Tranche A” revolving loans and SISO facility (as defined further below in this section within "Amendment No. 7 to the Amended 2016 Revolving Credit Agreement: Tranche A - Revolving Credit Facility and SISO Term Loan Facility") is extended from June 8, 2023 to May 7, 2024, subject to a springing maturity to the earlier of: (x) 91 days prior to the maturity of the Company’s term loan facility due September 7, 2023, to the extent such term loans are then outstanding, and (y) to the extent the Company’s first-in, last-out term loans (the “2020 ABL FILO Term Loans”) are then outstanding, the earliest stated maturity of the 2020 ABL FILO Term Loans; (ii) the commitments under the “Tranche A” revolving facility are reduced from $300 million to $270 million and under the SISO Facility are upsized from $100 million to $130 million, (iii) the financial covenant is changed from (A)(x) a minimum excess availability requirement of $20 million when the fixed charge coverage ratio is greater than 1.00x or (y) a minimum excess availability requirement of $30 million when the fixed charge coverage ratio is less than 1.00x to (B) a springing minimum fixed charge coverage ratio of 1.00x when excess availability is less than $27.5 million, (iv) certain advance rates in respect of the borrowing base under the credit agreement are increased, and (v) the perpetual cash dominion requirement is replaced with a springing cash dominion requirement triggered only when excess availability is less than $45 million. In addition, Amendment No. 8 increased the interest rate margin applicable to the “Tranche A” revolving loans to 3.75% from a range of 2.50-3.00% and decreased the LIBOR “floor” applicable thereto from 1.75% to 0.50%.

On May 7, 2021, the Company also entered into a successor agent appointment and agency transfer agreement pursuant to which MidCap Funding IV Trust ("MidCap") succeeded Citibank, N.A. as the collateral agent and administrative agent for the Amended 2016 Revolving Credit Agreement. Products Corporation has paid certain customary fees to MidCap and the lenders under the Amended 2016 Revolving Credit Facility in connection with Amendment No. 8.

Amendment No. 8 included an extinguishment, as defined by ASC 470, Debt, with the prior lenders under the Company's Tranche A Revolving Credit facility and the substitution of such lenders under the revolving credit facility with a new lender, MidCap, with which the Company had no prior loans outstanding. In connection with this transaction:

•Fees of $0.8 million paid to the old lenders that were extinguished under the Tranche A Revolving Credit facility were expensed within SG&A on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the nine months ended September 30, 2021;

•Deferred financing costs associated with the extinguished, old lenders prior to the effective date of Amendment No. 8, amounting to approximately $4.7 million, were expensed within "Amortization of debt issuance costs” on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the nine months ended September 30, 2021; and

•Fees of approximately $2.1 million paid to the new lender and third parties were recorded as deferred financing costs and are amortized in accordance with the straight-line method over the revised term of Tranche A through May 7, 2024.

The above-mentioned Amendment No. 8 also included an extinguishment and a modification of a term loan in connection with the existing SISO facility. More specifically, in accordance with ASC 470, Debt:

•Extinguishment accounting was applied to one existing prior lender, which is no longer involved with the SISO facility after Amendment No. 8. In connection with such extinguishment, deferred financing costs of approximately $1.4 million were expensed within "Amortization of debt issuance costs” on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the nine months ended September 30, 2021; and

•Modification accounting was applied to those exiting lenders for which the cash flow effect between the amount owed to them before and after the consummation of Amendment No. 8, on a present value basis, was less than 10% and, thus, the debt instruments were not considered to be substantially different. In connection with such modification, fees of approximately $0.9 million paid to the lenders were recorded as deferred financing costs and are amortized within "Amortization of debt issuance costs” (together with previously exiting deferred financing costs associated with these lenders of approximately $4.0 million), in accordance with the new effective interest rate computed over the revised term of the SISO facility. Additionally, approximately $0.4 million of fees paid to third parties were expensed within SG&A on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the nine months ended September 30, 2021.

Amendment No. 7 to the Amended 2016 Revolving Credit Agreement: Tranche A - Revolving Credit Facility and SISO Term Loan Facility

On March 8, 2021, Products Corporation entered into Amendment No. 7 to the Amended 2016 Revolving Credit Agreement (“Amendment No. 7”). Amendment No. 7, among other things, made certain amendments pursuant to which: (i) the maturity date applicable to the “Tranche A” revolving loans under the Amended 2016 Revolving Credit Agreement was extended from September 7, 2021 to June 8, 2023; (ii) the commitments under the “Tranche A” revolving facility were reduced from $400 million to $300 million; and (iii) a new $100 million senior secured second-in, second-out term loan facility maturing June 8, 2023 (the “SISO Facility”) was established and Products Corporation borrowed $100 million of term loans thereunder. Except as to pricing, maturity, enforcement priority and certain voting rights, the terms of the SISO Facility are substantially consistent with the first-in, last-out “Tranche B” term loan facility under the Amended 2016 Revolving Credit Agreement, including as to guarantees and collateral.

Term loans under the SISO Facility accrue interest at the LIBOR rate, subject to a floor of 1.75%, plus a margin of 5.75%. In addition, Amendment No. 7 increased the interest rate margin applicable to the “Tranche A” revolving loans by 0.50% to a range of 2.50% to 3.0%, depending on average excess revolving availability. Products Corporation paid certain customary fees to Citibank, N.A. and the lenders under the Amended 2016 Revolving Credit Facility in connection with Amendment No. 7.

Amendment No. 7 represented an exchange of an existing revolving credit agreement with a new revolving credit agreement with the same lenders as defined by ASC 470, Debt, under the revolving credit facility. All pre-existing unamortized deferred financing costs associated with the old revolving credit agreement of approximately $0.8 million were added to the newly incurred deferred financing costs of approximately $4.2 million and their total of approximately $5.1 million started to be amortized in accordance with the straight-line method over the term of Tranche A through June 8, 2023. Additionally, approximately $4.3 million of new deferred financing costs were incurred in connection with the SISO Facility with the new lenders, which are amortized in accordance with the effective interest method over the term of the facility.

2021 Foreign Asset-Based Term Facility

On March 2, 2021 (the “2021 ABTL Closing Date”), Revlon Finance LLC (the “ABTL Borrower”), a wholly owned indirect subsidiary of Products Corporation, certain foreign subsidiaries of Products Corporation party thereto as guarantors, the lenders party thereto and Blue Torch Finance LLC, as administrative agent and collateral agent (the “ABTL Agent”), entered into an Asset-Based Term Loan Credit Agreement (the “2021 Foreign Asset-Based Term Agreement”, and the term loan facility thereunder, the “2021 Foreign Asset-Based Term Facility”).

Principal and Maturity: The 2021 Foreign Asset-Based Term Facility provides for a U.S. dollar-denominated senior secured asset-based term loan facility in an aggregate principal amount of $75 million, the full amount of which was funded on the closing of the facility. On the 2021 ABTL Closing Date, approximately $7.5 million of the proceeds of the 2021 Foreign Asset-Based Term Facility were deposited in an escrow account by the ABTL Agent pending completion of certain post-closing perfection actions with respect to certain foreign real property of the guarantors constituting collateral securing the 2021 Foreign Asset-Based Term Facility. The 2021 Foreign Asset-Based Term Facility has an uncommitted incremental facility pursuant to which it may be increased from time to time by up to the amount of the borrowing base in effect at the time such incremental facility is incurred, subject to certain conditions and the agreement of the lenders providing such increase. The proceeds of the loans under the 2021 Foreign Asset-Based Term Facility were used: (i) to repay in full the obligations under the Asset-Based Term Loan Credit Agreement, dated as of July 9, 2018, as amended, among the ABTL Borrower, the other subsidiaries of Products Corporation party thereto, the lenders party thereto and Citibank, N.A., as administrative agent and collateral agent (the “ABTL Refinancing”); (ii) to pay fees and expenses in connection with the 2021 Foreign Asset-Based Term Facility and the ABTL Refinancing; and (iii) for working capital and other general corporate purposes. The 2021 Foreign Asset-Based Term Facility matures on March 2, 2024, subject to a springing maturity date of August 1, 2023 if, on such date, any principal amount of loans under the 2016 Term Loan Agreement due September 7, 2023 remain outstanding.

The 2021 Foreign Asset-Based Term Agreement requires the maintenance of a borrowing base supporting the borrowing thereunder, to be evidenced with the delivery of biweekly borrowing base certificates customary for facilities of this type, with more frequent reporting required upon the triggering of certain events. The borrowing base calculation under the 2021 Foreign Asset-Based Term Facility is based on the sum of: (i) 80% of eligible accounts receivable; (ii) 65% of the net orderly liquidation value of eligible finished goods inventory; and (iii) 45% of the mortgage value of eligible real property, in each case with respect to certain of Products Corporation’s subsidiaries organized in Australia, Bermuda, Germany, Italy, Spain and Switzerland (the “ABTL Borrowing Base Guarantors”). The borrowing bases in each jurisdiction are subject to certain customary availability reserves set by the ABTL Agent.

Guarantees and Security: The 2021 Foreign Asset-Based Term Facility is guaranteed by the Borrowing Base Guarantors, as well as by the direct parent entities of each ABTL Borrowing Base Guarantor (not including Revlon, Inc. or Products Corporation) on a limited recourse basis (the “ABTL Parent Guarantors”) and by certain subsidiaries of Products Corporation organized in Mexico (the “ABTL Other Guarantors” and, together with the ABTL Borrower and the ABTL Borrowing Base Guarantors, the “ABTL Loan Parties”). The obligations of the ABTL Loan Parties and the ABTL Parent Guarantors under the 2021 Foreign Asset-Based Term Facility are secured by first-ranking pledges of the equity of each ABTL Loan Party (other than the Other Guarantors), the inventory and accounts receivable of the ABTL Borrowing Base Guarantors, the material bank accounts of each Loan Party, the material intercompany indebtedness owing to any Loan Party (including any intercompany loans made with the proceeds of the 2021 Foreign Asset-Based Term Facility) and certain other material assets of the ABTL Borrowing Base Guarantors, subject to customary exceptions and exclusions. The 2021 Foreign Asset-Based Term Facility includes a cash dominion feature customary for transactions of this type.

Interest and Fees: Interest is payable on each interest payment date as set forth in the 2021 Foreign Asset-Based Term Agreement, and in any event at least quarterly, and accrues on borrowings under the 2021 Foreign Asset-Based Term Facility at a rate per annum equal to the LIBOR rate, with a floor of 1.50%, plus an applicable margin equal to 8.50%. The ABTL Borrower is obligated to pay certain fees and expenses in connection with the 2021 Foreign Asset-Based Term Facility, including a fee payable to Blue Torch Finance LLC for its services as Agent. Loans under the 2021 Foreign Asset-Based Term Facility may be prepaid without premium or penalty, subject to a prepayment premium equal to 3.0% of the aggregate principal amount of loans prepaid or repaid during the first year after the 2021 ABTL Closing Date, 2.0% of the aggregate principal amount of loans prepaid or repaid during the second year after the 2021 ABTL Closing Date and 1.0% of the aggregate principal amount of loans prepaid or repaid thereafter.

Affirmative and Negative Covenants: The 2021 Foreign Asset-Based Term Agreement contains certain affirmative and negative covenants that, among other things, limit the ABTL Loan Parties’ ability to, subject to various exceptions and

qualifications: (i) incur additional debt; (ii) incur liens; (iii) sell, transfer or dispose of assets; (iv) make investments; (v) make dividends and distributions on, or repurchases of, equity; (vi) make prepayments of contractually subordinated or junior lien debt; (vii) enter into certain transactions with their affiliates, including amending certain material intercompany agreements or trade terms; (viii) enter into sale-leaseback transactions; (ix) change their lines of business; (x) restrict dividends from their subsidiaries or restrict liens; (xi) change their fiscal year; and (xii) modify the terms of certain debt. The ABTL Parent Guarantors are subject to certain customary holding company covenants. The ability of the Loan Parties to make certain intercompany asset sales, investments, restricted payments and prepayments of intercompany debt is contingent on certain "cash movement conditions" or "payment conditions" being met, which among other things, require a certain level of liquidity for the applicable Loan Party to effect such type of transactions. The 2021 Foreign Asset-Based Term Agreement also contains a financial covenant requiring the ABTL Loan Parties to maintain a minimum average balance of cash and cash equivalents of $3.5 million, tested monthly, based on the last 10 business days of each month, subject to certain cure rights. The 2021 Foreign Asset-Based Term Agreement also contains certain customary representations, warranties and events of default.

Prepayments: The ABTL Borrower must prepay loans under the 2021 Foreign Asset-Based Term Facility to the extent that outstanding loans exceed the borrowing base. In lieu of a mandatory prepayment, the Loan Parties may deposit cash into a designated U.S. bank account with the ABTL Agent that is subject to a control agreement (such cash, the “Qualified Cash”). If an event of default occurs and is continuing, the Qualified Cash may be applied, at the ABTL Agent’s option, to prepay the loans under the 2021 Foreign Asset-Based Term Facility. If the borrowing base subsequently exceeds the outstanding loans, the ABTL Borrower can withdraw Qualified Cash from such bank account to the extent of such excess. In addition, the 2021 Foreign Asset-Based Term Facility is subject to mandatory prepayments from the net proceeds from the incurrence by the Loan Parties of debt not permitted thereunder.

As a result of the ABTL Refinancing and the closing of the 2021 Foreign Asset-Based Term Facility without the participation of MacAndrews & Forbes as a lender, MacAndrews & Forbes’ commitment in respect of the New European ABL FILO Facility under the 2020 Restated Line of Credit Facility terminated on the ABTL Closing Date in accordance with its terms.

The proceeds from the 2021 Foreign Asset-Based Term Facility were used to extinguish the entire amount outstanding under the 2018 Foreign Asset-Based Term Facility as of the closing date, which was due on July 9, 2021. In connection with such extinguishment, approximately nil and $1.0 million of pre-existing unamortized deferred financing costs were expensed within "Amortization of Debt Issuance Costs" on the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and nine month periods ended September 30, 2021. In accordance with the terms of the 2021 Foreign Asset-Based Term Agreement, approximately $13.8 million of the proceeds from the transaction are held in escrow and are recorded within "Prepaid expenses and other assets" on the Company's Unaudited Consolidated Balance Sheet as of September 30, 2021.

The Company incurred approximately $3.2 million of new debt issuance costs in connection with the closing of the 2021 Foreign Asset-Based Term Facility, which are amortized within "Amortization of debt issuance costs" in accordance with the effective interest method over the term of the facility.

2020 Troubled Debt Restructuring

As a result of the 5.75% Senior Notes Exchange Offer, and following the applicability of the Troubled Debt Restructuring guidance in ASC 470, Debt, the Company recorded $57.8 million of future interest payments. During the three and nine months ended September 30, 2021, the Company recorded $3.7 million and $11.6 million, respectively, of amortization of such future interest as an offset within "Interest expense, net" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss.

Covenants

Products Corporation was in compliance with all applicable covenants under the 2020 BrandCo Credit Agreement, 2016 Credit Agreements, the 2021 Foreign Asset-Based Term Facility, as well as with all applicable covenants under its 6.25% Senior Notes Indenture, in each case as of September 30, 2021. At September 30, 2021, the aggregate principal amounts outstanding and availability under Products Corporation’s various revolving credit facilities were as follows:



	Commitment		Borrowing Base		Aggregate principal amount outstanding at September 30, 2021		Availability at September 30, 2021 (a)
Tranche A Revolving Credit Facility	$	270.0	$	189.4	$	136.2	$	53.2
SISO Term Loan Facility	130.0		130.0		130.0		—

2020 ABL FILO Term Loans	50.0		40.6		$	50.0	$	—

(a) Availability as of September 30, 2021 is based upon the Tranche A Revolving borrowing base then in effect under Amendment No.8 to the Amended 2016 Revolving Credit Facility of $189.4 million (which includes a $9.4 million reserve for the shortfall of the borrowing base that supports the 2020 ABL FILO Term Loans compared to the corresponding aggregate principal amount outstanding of $50 million), less $136.2 million then drawn.

The Company’s foreign subsidiaries held $67.1 million out of the Company's total $73.3 million in cash and cash equivalents as of September 30, 2021. While the cash held by the Company’s foreign subsidiaries is primarily used to fund their operations, the Company regularly assesses its global cash needs and the available sources of cash to fund these needs, which regularly includes repatriating foreign-held cash to settle historical intercompany loans and other intercompany payables.

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

FAIR VALUE MEASUREMENTS

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

Assets and liabilities are required to be categorized into three levels of fair value based upon the assumptions used to value the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, generally would require significant management judgment. The three levels for categorizing the fair value measurement of assets and liabilities are as follows:

•Level 1: Fair valuing the asset or liability using observable inputs, such as quoted prices in active markets for identical assets or liabilities;

•Level 2: Fair valuing the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and

•Level 3: Fair valuing the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.

As of both September 30, 2021 and December 31, 2020, the Company did not have any financial assets and liabilities that were required to be measured at fair value.

As of September 30, 2021, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


	September 30, 2021
	Fair Value
	Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:
Long-term debt, including current portion(a)	$	—	$	2,531.2	$	—	$	2,531.2	$	3,466.1

As of December 31, 2020, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


	December 31, 2020
	Fair Value
	Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:
Long-term debt, including current portion(a)	$	—	$	2,168.9	$	—	$	2,168.9	$	3,322.5

(a) The fair value of the Company's long-term debt, including the current portion of long-term debt, is based on quoted market prices for similar issuances and maturities.

The carrying amounts of the Company's cash and cash equivalents, trade receivables, notes receivable, accounts payable and short-term borrowings approximate their respective fair values.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

PENSION AND POST-RETIREMENT BENEFITS

FINANCIAL INSTRUMENTS	9 Months Ended
FINANCIAL INSTRUMENTS	Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
FINANCIAL INSTRUMENTS	FINANCIAL INSTRUMENTS Letters of Credit Products Corporation maintains standby and trade letters of credit for various corporate purposes under which Products Corporation is obligated, of which $9.1 million and $7.8 million (including amounts available under credit agreements in effect at that time) were maintained as of September 30, 2021 and December 31, 2020, respectively. Included in these amounts are approximately $6.6 million and $5.3 million in standby letters of credit that primarily support Products Corporation’s workers compensation, general liability and automobile insurance programs, in each case as outstanding as of September 30, 2021 and December 31, 2020, respectively. At September 30, 2021 and December 31, 2020, respectively, all of the outstanding letters of credit were collateralized with a deposit of cash at the issuing financial institution. The estimated liability under such programs is accrued by Products Corporation.

PENSION AND POST-RETIREMENT BENEFITS

9 Months Ended

Sep. 30, 2021

Retirement Benefits [Abstract]

Net Periodic Benefit Cost

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the three months ended September 30, 2021 and 2020, respectively, were as follows:


	Pension Plans				Other Post-Retirement Benefit Plans
	Three Months Ended September 30,
	2021		2020		2021		2020
Net periodic benefit costs:
Service cost	$	0.4	$	0.5	$	—	$	—
Interest cost	2.3		3.8		—		0.1
Expected return on plan assets	(4.9)		(5.7)		$	—	—
Amortization of actuarial loss	3.3		2.7		0.2		0.1

Total net periodic benefit costs prior to allocation	$	1.1	$	1.3	$	0.2	$	0.2
Portion allocated to Revlon Holdings	—		—		—		—
Total net periodic benefit costs	$	1.1	$	1.3	$	0.2	$	0.2

In the three months ended September 30, 2021, the Company recognized net periodic benefit cost of $1.3 million, compared to net periodic benefit cost of $1.5 million in the three months ended September 30, 2020.

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the nine months ended September 30, 2021 and 2020, respectively, were as follows:


	Pension Plans				Other Post-Retirement Benefit Plans
	Nine Months Ended September 30,
	2021		2020		2021		2020
Net periodic benefit costs:
Service cost	$	1.1	$	1.3	$	—	$	—
Interest cost	6.9		11.2		0.1		0.3
Expected return on plan assets	(14.8)		(17.1)		—		—
Amortization of actuarial loss	9.9		8.3		0.5		0.3

Total net periodic benefit costs prior to allocation	$	3.1	$	3.7	$	0.6	$	0.6
Portion allocated to Revlon Holdings	(0.1)		(0.1)		—		—
Total net periodic benefit costs	$	3.0	$	3.6	$	0.6	$	0.6

In the nine months ended September 30, 2021, the Company recognized net periodic benefit cost of $3.6 million, compared to net periodic benefit cost of $4.2 million in the nine months ended September 30, 2020.

Net periodic benefit costs are reflected in the Company's Consolidated Financial Statements as follows for the periods presented:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net periodic benefit costs:

Selling, general and administrative expense	$	0.4	$	0.5	$	1.1	$	1.3
Miscellaneous, net	0.9		1.0		2.5		2.9
Total net periodic benefit costs	$	1.3	$	1.5	$	3.6	$	4.2

The Company expects that it will have net periodic benefit cost of approximately $5 million for its pension and other post-retirement benefit plans for all of 2021, compared with net periodic benefit cost of $4.0 million in 2020.

Contributions:

The Company’s intent is to fund at least the minimum contributions required to meet applicable federal employee benefit laws and local laws, or to directly pay benefit payments where appropriate. During the three months ended September 30, 2021, $3.1 million and $0.2 million were contributed to the Company’s pension plans and other post-retirement benefit plans, respectively. During the nine months ended September 30, 2021, $19.9 million and $0.6 million were contributed to the Company's pension plans and other post-retirement benefit plans, respectively. During 2021, the Company expects to contribute approximately $21 million to $24 million in the aggregate to its pension and other post-retirement benefit plans once given effect to the provision of the American Rescue Plan signed into law by President Biden on March 11, 2021. The American Rescue Plan includes pension funding relief for both single employer and multiemployer plans. The single employer provisions provide for higher interest rates and a longer shortfall amortization period to be used for funding valuation and benefit restriction purposes. By default, the interest rate changes will take effect for the 2020 plan year (for both minimum contribution and benefit restriction purposes) and the change in the shortfall amortization period will take effect for the 2022 plan year. However, plan sponsors can elect to defer the interest rate changes to as late as 2022 or accelerate the change in shortfall amortization period to as early as 2019. As a result, each plan sponsor will need to assess the optimal effective date(s) for the relief and make any appropriate elections.

As a result of the CARES Act passed by the U.S. Congress in March 2020 to address the economic environment resulting from COVID-19, and in accordance with the Limited Relief for Pension Funding and Retirement Plan Distributions provision of such act, the Company deferred to 2021 approximately $11.8 million of contributions that were otherwise scheduled to be paid to its two qualified pension plans at different earlier dates during 2020. The deferral was in effect only for 2020 and under the CARES relief provisions the Company was required to pay the contributions by no later than January 4, 2021, including interest at the plans’ 2020 effective interest rate from the original due date to the actual payment date. The Company paid the contributions by the due date.

The entire disclosure for retirement benefits.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Share-based Payment Arrangement [Abstract]

STOCK COMPENSATION PLAN

9 Months Ended

Sep. 30, 2021

STOCK COMPENSATION PLAN

Revlon's amended Stock Plan provides for awards of stock options, stock appreciation rights, restricted or unrestricted stock and restricted stock units ("RSUs") to eligible employees and directors of Revlon and its affiliates, including Products Corporation. On June 3, 2021 Revlon’s stockholders approved an amendment to the Stock Plan to reserve an additional 2,000,000 shares and extend the term until August 2030. As a result, an aggregate of 8,565,000 shares were reserved for issuance as Awards under the Stock Plan, of which there remained approximately 2.7 million shares available for grant as of September 30, 2021.

2019 Transaction Incentive Program

As of September 30, 2021, a total of 121,891 time-based RSUs under Tier 1 of the Revlon 2019 Transaction Incentive Program (the "2019 TIP") had been granted and are outstanding under the Stock Plan.

The 2019 TIP also provided for the following cash-based awards payable to certain employees, subject to continued employment through the respective vesting dates: (i) Tier 1 - $6.8 million payable in two equal installments as of December 31, 2020 and December 31, 2021; and (ii) Tier 2 - $2.5 million payable in one installment as of December 31, 2020. Such RSUs and cash-based awards are eligible for vesting following a termination without cause or due to death or disability or if not assumed upon a change in control (the “Special Vesting Rules”). Since inception and through September 30, 2021, the Company granted $1.4 million cash-based awards, net of forfeitures, under Tier 1, which are being amortized over the period from the grant dates to December 31, 2021. The total amount amortized for this Tier 1 cash-based awards since the program's inception and through September 30, 2021 is approximately $4.5 million, of which $0.4 million and $1.5 million were recorded during the three and nine months ended September 30, 2021, respectively. The amortization of such awards is recorded within "Acquisition, integration and divestiture costs" in the Company's Consolidated Statements of Operations and Comprehensive Loss.

Long-Term Incentive Program

During the first quarter of 2021, the Company granted approximately 1.5 million time-based RSU awards under the Stock Plan (the "2021 LTIP RSUs") to certain employees. During the second quarter of 2021, the Company granted approximately 35,000 time-based RSU awards under the 2021 LTIP RSUs. During the third quarter of 2021 there were approximately 15,000 grants of time-based RSUs. The 2021 LTIP RSUs are 100% time-based and vests as follows: 50% in March 2022; 25% in March 2023; 25% in March 2024.

During the first quarter of 2020, the Company granted approximately 1.3 million time-based and performance-based RSU awards under the Stock Plan (the "2020 LTIP RSUs") to certain employees. During the second and third quarter of 2020, there were no grants of 2020 LTIP RSUs.

During the second quarter of 2021, the Company granted approximately 78,000 TIP awards with both a cash component and RSU component, all pursuant to the Stock Plan. These TIP awards are 100% time-based and vests as follows: 50% in June 2022; 50% in June 2023. The awards are subject to continued employment through the respective vesting dates.

Time-Based LTIP and TIP RSUs

The Company recognized $3.4 million and $9.0 million of net compensation expense related to the time-based LTIP and TIP RSUs for the three and nine months ended September 30, 2021, respectively. As of September 30, 2021, the Company had $15.0 million of total deferred compensation expense related to non-vested, time-based LTIP and TIP RSUs. The cost is recognized over the vesting period of the awards, as described above.

Performance-based LTIP RSUs

The Company recognized $0.5 million and $1.0 million of net compensation expense related to the performance-based LTIP RSUs for the three and nine months ended September 30, 2021, respectively. As of September 30, 2021, the Company had $11.3 million of total deferred compensation expense related to non-vested, performance-based LTIP RSUs. The cost is recognized over the service period of the awards, as described above.

Acceleration of Vesting

Under the aforementioned provisions for acceleration of vesting, as of September 30, 2021 and since the time these provisions became effective in September 2019, 57,763 LTIP RSUs and 47,743 2019 TIP Tier 1 RSUs were vested on an accelerated basis due to involuntary terminations, resulting in accelerated amortization of approximately $2.0 million. In addition, for the nine months ended September 30, 2021 and under the same accelerated vesting provisions, the Company also recorded approximately $1.8 million of accelerated amortization in connection with the cash portion of the 2019 TIP Tier 1 and Tier 2 awards that were vested on an accelerated basis due to involuntary terminations. Approximately nil and $0.2 million in accelerated amortization were recorded in connection with the cash portion of the 2019 TIP Tier 1 awards during the three and nine months ended September 30, 2021, respectively. See the roll-forward table in the following sections of this Note 11 for activity related to the nine months ended September 30, 2021.

During the nine months ended September 30, 2021, the activity related to time-based and performance-based RSUs previously granted to eligible employees and the grant date fair value per share related to these RSUs were as follows under the LTIP and 2019 TIP programs, respectively:


	Time-Based LTIP	Performance-Based LTIP
	RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU		RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU
Outstanding as of December 31, 2020
2019 TIP RSUs (a)	58.8	$	15.95	n/a	$	—
LTIP RSUs:
2020	496.5	14.96		462.9	14.96
2019	169.3	22.55		255.3	22.55
2018	66.4	19.40		215.9	19.42
Total LTIP RSUs	732.2			934.1
Total LTIP and TIP RSUs Outstanding as of December 31, 2020	791.0			934.1
Granted
2019 TIP RSUs Granted	80.1	13.11		n/a	—
LTIP RSUs:
2021	1,559.0	10.77		—	—
2020	—	—		—	—
2019	—	—		—	—
2018	—	—		—	—
Total LTIP RSUs Granted	1,559.0			—
Vested
2019 TIP RSUs Vested (b)	(8.9)	15.30		—	—
LTIP RSUs:
2020 (b)	(182.7)	14.96		—	—
2019 (b)	(91.4)	22.53		—	—
2018)(b)	(65.9)	19.42		(38.5)	19.44
Total LTIP RSUs Vested	(340.0)			(38.5)
Forfeited/Canceled
2019 TIP RSUs Forfeited/Canceled (a)	(8.1)	15.11		n/a	—
LTIP RSUs:
2021	(81.2)	10.75		—	—
2020	(52.1)	14.96		(73.5)	14.96
2019	(6.2)	22.55		(38.6)	22.55
2018	(0.5)	16.80		(177.4)	19.42
Total LTIP RSUs Forfeited/Canceled	(140.0)			(289.5)
Outstanding as of September 30, 2021
2019 TIP RSUs	121.9	14.09		n/a	—
LTIP RSUs:
2021	1,477.8	10.77		—	—
2020	261.7	14.96		389.4	14.96
2019	71.7	22.57		216.7	22.55
2018	—	—		—	—
Total LTIP RSUs	1,811.2			606.1
Total LTIP and TIP RSUs Outstanding as of September 30, 2021	1,933.1			606.1

((a) The 2019 TIP provides for RSU awards that are only time-based.

(b) Includes acceleration of vesting upon involuntary terminations for the three and nine months ended September 30, 2021 of 887 and 8,121 RSUs, respectively, under the 2019 and 2018 LTIPs as well as 355 and 6,540 RSUs, respectively, under the 2019 TIP Tier I awards.

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company's provision for income taxes represents federal, foreign, state and local income taxes. The Company's effective tax rate differs from the applicable federal statutory rate due to the effect of state and local income taxes, tax rates and income in foreign jurisdictions. The Company’s tax provision changes quarterly based on various factors including, but not limited to, the geographical level and mix of earnings; enacted tax legislation; foreign, state and local income taxes; changes in valuation allowances; tax audit settlements; and the interaction of various global tax strategies. The Company recorded a provision for income taxes of $5.4 million (Products Corporation - provision for income taxes of $5.5 million) for the three months ended September 30, 2021 and a provision for income taxes of $1.9 million (Products Corporation - provision for income taxes of $2.3 million) for the three months ended September 30, 2020, respectively. The $3.5 million increase (Products Corporation $3.2 million in the provision for income taxes in the three months ended September 30, 2021, compared to the three months ended September 30, 2020, was primarily due to an increase in losses for which no tax benefit can be recognized. The Company recorded a provision for income taxes of $23.8 million (Products Corporation - provision for income taxes of $23.9 million) for the nine months ended September 30, 2021 and a benefit from income taxes of $45.2 million (Products Corporation - benefit from income taxes of $44.2 million) for the nine months ended September 30, 2020, respectively. The $69.0 million increase (Products Corporation - $68.1 million) in the provision for income taxes in the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, was primarily due to an increase in losses for which no tax benefit can be recognized. For the three and nine month periods ended September 30, 2020, the Company concluded that the use of the cut-off tax rate method was more appropriate than the annual effective tax rate method, because the annual effective tax rate method would have not been reliable due to its sensitivity to minimal changes in forecasted annual pre-tax earnings. The Company's effective tax rate for the three and nine month periods ended September 30, 2021 was lower than the federal statutory rate of 21% primarily due to losses for which no tax benefit can be recognized. On March 11, 2021, President Biden signed into law the “American Rescue Plan Act of 2021” (the "ARPA") which expands the Employee Retention Credit and the roster of ‘covered employees’ under §162(m) deduction limits. The ARPA did not have a significant impact on the Company’s financial results. The Company's effective tax rate for the three months ended September 30, 2020 was lower than the federal statutory rate of 21% primarily due to the mix and level of earnings and the change in valuation allowance related to the limitation on the deductibility of interest. The Company's effective tax rate for the nine months ended September 30, 2020 was lower than the federal statutory rate of 21% primarily due to the impact of non-deductible impairment charges and the valuation allowance related to the limitation on the deductibility of interest, partially offset by the impact of the "Coronavirus Aid, Relief and Economic Security Act" (the "CARES Act"), signed into law on March 27, 2020 by President Trump, which resulted in a partial release of a valuation allowance on the Company's 2019 federal tax attributes associated with the limitation on the deductibility of interest. The CARES Act, among other things, includes provisions providing for refundable payroll tax credits, the deferral of employer social security tax payments, acceleration of alternative minimum tax credit refunds and the increase of the net interest deduction limitation from 30% to 50%. The Company adopted the net interest deduction limitation of 50% for the taxable period ending December 31, 2020 as outlined in the CARES Act. In assessing the recoverability of its deferred tax assets, the Company continually evaluates all available positive and negative evidence to assess the amount of deferred tax assets which are more likely than not to be realized. Deferred tax assets are reduced by a valuation allowance if some portion or all of the deferred tax assets will not be realized. A valuation allowance is a non-cash charge, and it in no way limits the Company's ability to utilize its deferred tax assets, including its ability to utilize tax loss and credit carryforward amounts. For further information, see Note 13, "Income Taxes," to the Consolidated Financial Statements in the Company's 2020 Form 10-K and Item 1A. “Risk Factors - Uncertainties in the interpretation and application of the income tax provisions could have a material impact on the Company's financial condition, results of operations and/or cash flows” in the Company's 2020 Form 10-K.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

9 Months Ended

Sep. 30, 2021

ACCUMULATED OTHER COMPREHENSIVE LOSS

A roll-forward of the Company's accumulated other comprehensive loss as of September 30, 2021 is as follows:


	Foreign Currency Translation		Actuarial (Loss) Gain on Post-retirement Benefits		Other		Accumulated Other Comprehensive Loss







Balance at January 1, 2021	$	(17.1)	$	(260.5)	$	(0.3)	$	(277.9)
Foreign currency translation adjustment, net of tax (b)	(6.0)		—		—		(6.0)
Amortization of pension related costs, net of tax (a) (b)	—		10.5		—		10.5




Other comprehensive (loss) gain	$	(6.0)	$	10.5	$	—	$	4.5
Balance at September 30, 2021	$	(23.1)	$	(250.0)	$	(0.3)	$	(273.4)

(a) Amounts represent the change in accumulated other comprehensive loss as a result of the amortization of actuarial losses (gains) arising during each year related to the Company’s pension and other post-retirement plans. See Note 10, "Pension and Post-retirement Benefits," for further information on the Company’s pension and other post-retirement plans.

(b) Amounts presented are net of tax expense of nil for the nine months ended September 30, 2021.

For the nine months ended and September 30, 2021, the Company did not have any activity related to derivative instruments.

SEGMENT DATA AND RELATED INFORMATION

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

SEGMENT DATA AND RELATED INFORMATION

Operating Segments

Operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the Company's "Chief Executive Officer") in deciding how to allocate resources and in assessing the Company's performance. As a result of the similarities in the procurement, manufacturing and distribution processes for the Company’s products, much of the information provided in the Consolidated Financial Statements and provided in the segment table below is similar to, or the same as, that reviewed on a regular basis by the Company's Chief Executive Officer. The Company operates in four brand-centric reporting units that are aligned with its organizational structure based on four global brand teams: Revlon; Elizabeth Arden; Portfolio; and Fragrances, which represent the Company's four reporting segments.

The Company's management evaluates segment profit for each of the Company's reportable segments. The Company allocates corporate expenses to each reportable segment to arrive at segment profit, and these expenses are included in the internal measure of segment operating performance. The Company defines segment profit as income from continuing operations before interest, taxes, depreciation, amortization, stock-based compensation expense, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt and miscellaneous expenses. Segment profit also excludes the impact of certain items that are not directly attributable to the reportable segments' underlying operating performance. Such items are shown below in the table reconciling segment profit to consolidated income from continuing operations before income taxes. The Company does not have any material inter-segment sales.

The accounting policies for each of the reportable segments are the same as those described in the Company's 2020 Form 10-K, in Note 1, "Description of Business and Summary of Significant Accounting Policies." The Company's assets and liabilities are managed centrally and are reported internally in the same manner as the Consolidated Financial Statements; thus, no additional information regarding assets and liabilities of the Company’s reportable segments is produced for the Company's Chief Executive Officer or included in these Consolidated Financial Statements.

The following table is a comparative summary of the Company’s net sales and segment profit for Revlon and Products Corporation by reportable segment for the periods presented.

Revlon, Inc.




	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Segment Net Sales:
Revlon	$	173.0	$	166.0	$	521.8	$	482.8
Elizabeth Arden	122.8		106.3		359.7		282.4
Portfolio	112.7		99.6		307.4		298.1
Fragrances	112.6		105.2		274.6		214.4
Total	$	521.1	$	477.1	$	1,463.5	$	1,277.7

Segment Profit:
Revlon	$	16.1	$	13.5	$	45.3	$	41.4
Elizabeth Arden	21.3		3.4		42.1		18.4
Portfolio	22.1		12.2		46.3		33.9
Fragrances	22.9		25.4		50.8		34.6
Total	$	82.4	$	54.5	$	184.5	$	128.3

Reconciliation:
Total Segment Profit	$	82.4	$	54.5	$	184.5	$	128.3
Less:

Depreciation and amortization	31.2		35.1		96.8		108.3
Non-cash stock compensation expense	3.9		5.1		10.4		8.6
Non-Operating items:
Restructuring and related charges	10.8		4.5		28.0		61.2
Acquisition, integration and divestiture costs	0.6		0.9		1.8		4.2
Loss (gain) on divested assets	0.1		(1.1)		(1.7)		(0.5)
Financial control remediation and sustainability actions and related charges	—		0.7		0.4		8.5
Excessive coupon redemptions	—		—		—		4.2
COVID-19 charges	(0.1)		9.7		6.1		35.1


Capital structure and related charges	1.8		9.3		6.8		9.3
Impairment charges	—		—		—		144.1



Operating income (loss)	34.1		(9.7)		35.9		(254.7)
Less:
Interest Expense	63.1		68.7		183.9		178.0

Amortization of debt issuance costs	8.7		7.8		30.7		17.8

Gain on early extinguishment of debt	—		(31.2)		—		(43.1)
Foreign currency losses (gains), net	9.9		(9.8)		11.5		9.1
Miscellaneous, net	0.1		(2.6)		2.8		13.9
Loss from operations before income taxes	$	(47.7)	$	(42.6)	$	(193.0)	$	(430.4)

Products Corporation



	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Segment Net Sales:
Revlon	$	173.0	$	166.0	$	521.8	$	482.8
Elizabeth Arden	122.8		106.3		359.7		282.4
Portfolio	112.7		99.6		307.4		298.1
Fragrances	112.6		105.2		274.6		214.4
Total	$	521.1	$	477.1	$	1,463.5	$	1,277.7

Segment Profit:
Revlon	$	16.6	$	14.2	$	46.8	$	43.6
Elizabeth Arden	21.7		3.8		43.1		19.7
Portfolio	22.5		12.6		47.3		35.3
Fragrances	23.2		25.9		51.6		35.6
Total	$	84.0	$	56.5	$	188.8	$	134.2

Reconciliation:
Total Segment Profit	$	84.0	$	56.5	$	188.8	$	134.2
Less:

Depreciation and amortization	31.2		35.1		96.8		108.3
Non-cash stock compensation expense	3.9		5.1		10.4		8.6
Non-Operating items:
Restructuring and related charges	10.8		4.5		28.0		61.2
Acquisition, integration and divestiture costs	0.6		0.9		1.8		4.2
Loss (gain) on divested assets	0.1		(1.1)		(1.7)		(0.5)
Financial control remediation and sustainability actions and related charges	—		0.7		0.4		8.5


Excessive coupon redemptions	—		—		—		4.2
COVID-19 charges	(0.1)		9.7		6.1		35.1
Capital structure and related charges	1.8		9.3		6.8		9.3
Impairment charge	—		—		—		144.1

Operating income (loss)	35.7		(7.7)		40.2		(248.8)
Less:
Interest Expense	63.1		68.7		183.9		178.0

Amortization of debt issuance costs	8.7		7.8		30.7		17.8

Gain on early extinguishment of debt	—		(31.2)		—		(43.1)
Foreign currency losses (gains), net	9.9		(9.8)		11.5		9.1
Miscellaneous, net	0.1		(2.6)		2.8		13.9
Loss from operations before income taxes	$	(46.1)	$	(40.6)	$	(188.7)	$	(424.5)

As of September 30, 2021, the Company had operations established in approximately 25 countries outside of the U.S. and its products are sold throughout the world. Generally, net sales by geographic area are presented by attributing revenues from external customers on the basis of where the products are sold.

The following tables present the Company's segment net sales by geography and total net sales by classes of similar products for the periods presented:


	Three Months Ended September 30, 2021										Nine Months Ended September 30, 2021
	Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio		Fragrances		Total
Geographic Area:
Net Sales
North America	$	88.4	$	32.3	$	75.2	$	81.5	$	277.4	$	270.9	$	80.9	$	201.9	$	193.8	$	747.5
EMEA*	43.8		30.4		28.7		20.5		123.4		125.4		85.9		80.6		54.0		345.9
Asia	9.1		52.0		0.4		3.5		65.0		31.7		171.8		2.3		10.4		216.2
Latin America*	14.2		2.5		4.8		3.4		24.9		40.7		5.8		12.2		7.9		66.6
Pacific*	17.5		5.6		3.6		3.7		30.4		53.1		15.3		10.4		8.5		87.3
	$	173.0	$	122.8	$	112.7	$	112.6	$	521.1	$	521.8	$	359.7	$	307.4	$	274.6	$	1,463.5


			Three Months Ended September 30, 2020											Nine Months Ended September 30, 2020
	Revlon			Elizabeth Arden		Portfolio		Fragrances		Total		Revlon			Elizabeth Arden		Portfolio		Fragrances		Total
Geographic Area:
Net Sales
North America	$	86.4		$	30.5	$	59.9	$	79.2	$	256.0	$	265.6		$	66.9	$	182.8	$	151.1	$	666.4
EMEA*	41.4			25.3		32.8		18.8		118.3		105.2			64.9		93.6		44.4		308.1
Asia	12.1			43.3		0.4		2.7		58.5		33.6			135.5		1.6		8.1		178.8
Latin America*	11.3			2.5		3.3		1.5		18.6		35.3			3.5		11.6		2.6		53.0
Pacific*	14.8			4.7		3.2		3.0		25.7		43.1			11.6		8.5		8.2		71.4
	$	166.0		$	106.3	$	99.6	$	105.2	$	477.1	$	482.8		$	282.4	$	298.1	$	214.4	$	1,277.7

* The EMEA region includes Europe, the Middle East and Africa; the Latin America region includes Mexico, Central America and South America; and the Pacific region includes Australia and New Zealand.



	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Classes of similar products:
Net sales:
Color cosmetics	$	124.8	24%	$	104.7	22%	$	368.5	25%	$	305.3	24%
Fragrance	160.1		31%	141.6		30%	395.4		27%	300.5		24%
Hair care	124.2		24%	115.9		24%	351.6		24%	338.0		26%
Beauty care	45.6		9%	50.4		11%	124.8		9%	141.9		11%
Skin care	66.4		12%	64.5		13%	223.2		15%	192.0		15%
	$	521.1		$	477.1		$	1,463.5		$	1,277.7

The following table presents the Company's long-lived assets by geographic area:


	September 30, 2021			December 31, 2020
Long-lived assets, net:
United States	$	1,137.7	83%	$	1,194.9	82%
International	228.0		17%	260.7		18%
	$	1,365.7		$	1,455.6

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

Earnings Per Share, Basic and Diluted [Abstract]

REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE

9 Months Ended

Sep. 30, 2021

REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE

Following are the components of Revlon's basic and diluted loss per common share for the periods presented:


	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Numerator:


Net loss	$	(53.1)	$	(44.5)	$	(216.8)	$	(385.2)
Denominator:
Weighted-average common shares outstanding – Basic	54,025,861		53,476,354		53,899,732		53,371,986
Effect of dilutive restricted stock and RSUs	—		—		—		—
Weighted-average common shares outstanding – Diluted	54,025,861		53,476,354		53,899,732		53,371,986
Basic and Diluted (loss) earnings per common share:


Net loss per common share	$	(0.98)	$	(0.83)	$	(4.02)	$	(7.22)





Unvested restricted stock and RSUs under the Stock Plan(a)	759,994		—		581,856		—

(a) These are outstanding common stock equivalents that were not included in the computation of Revlon's diluted earnings per common share because their inclusion would have had an anti-dilutive effect.

CONTINGENCIES	9 Months Ended
CONTINGENCIES	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES Citibank Litigation In the matter captioned In re Citibank August 11, 2020 Wire Transfers, No. 20-cv-06539-JMF (S.D.N.Y. Feb. 16, 2021) (the “Citi Decision”), the United States District Court for the Southern District of New York held that certain wire transfers mistakenly paid by Citibank, N.A. (“Citi”) from its own funds on August 11, 2020 to holders of term loans issued to Revlon under a Term Credit Agreement dated as of September 7, 2016 (as amended, the “2016 Facility”) were final and complete transactions not subject to revocation. The wire payments at issue were made to all lenders under the 2016 Facility in amounts equaling the principal and interest outstanding on the loans at that time. Certain lenders that received the payments returned the funds soon after the mistaken transfer, but holders of approximately $504 million did not, and as a result of the Citi Decision those lenders are entitled to keep the funds in discharge of their debt. Citi has appealed the Citi Decision. Citi has also asserted subrogation rights, but, as yet, there has been no determination of those rights (if any) under the 2016 Facility and Revlon has not taken a position on this issue. In these circumstances, it is the current intention of the Company to continue to make the scheduled payments under the 2016 Facility as if the full amount of the 2016 Facility remains outstanding. The Company is involved in various routine legal proceedings incidental to the ordinary course of its business. The Company believes that the outcome of all pending legal proceedings in the aggregate is not reasonably likely to have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows. However, in light of the uncertainties involved in legal proceedings generally, the ultimate outcome of a particular matter could be material to the Company’s operating results for a particular period depending on, among other things, the size of the loss or the nature of the liability imposed and the level of the Company’s income for that particular period.

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Sep. 30, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Transfer and Reimbursement Agreements Revlon, Products Corporation and MacAndrews & Forbes have entered into reimbursement agreements (the "Reimbursement Agreements") pursuant to which: (i) MacAndrews & Forbes is obligated to provide (directly or through its affiliates) certain professional and administrative services, including, without limitation, employees, to the Company, and to purchase services from third-party providers, such as insurance, legal, accounting and air transportation services, on behalf of the Company, to the extent requested by Products Corporation; and (ii) Products Corporation is obligated to provide certain professional and administrative services, including, without limitation, employees, to MacAndrews & Forbes and to purchase services from third-party providers, such as insurance, legal and accounting services, on behalf of MacAndrews & Forbes, to the extent requested by MacAndrews & Forbes, provided that in each case the performance of such services does not cause an unreasonable burden to MacAndrews & Forbes or Products Corporation, as the case may be. The Company reimburses MacAndrews & Forbes for the allocable costs of the services that MacAndrews & Forbes purchases for or provides to the Company and for the reasonable out-of-pocket expenses that MacAndrews & Forbes incurs in connection with the provision of such services. MacAndrews & Forbes reimburses Products Corporation for the allocable costs of the services that Products Corporation purchases for or provides to MacAndrews & Forbes and for the reasonable out-of-pocket expenses incurred by Products Corporation in connection with the purchase or provision of such services. Each of the Company, on the one hand, and MacAndrews & Forbes, on the other, has agreed to indemnify the other party for losses arising out of the services provided by it under the Reimbursement Agreements, other than losses resulting from its willful misconduct or gross negligence. The Reimbursement Agreements may be terminated by either party on 90 days' notice. The Company does not intend to request services under the Reimbursement Agreements unless their costs would be at least as favorable to the Company as could be obtained from unaffiliated third parties. The Company participates in MacAndrews & Forbes' directors and officers liability insurance program (the "D&O Insurance Program"), as well as its other insurance coverages, such as property damage, business interruption, liability and other coverages, which cover the Company, as well as MacAndrews & Forbes and its subsidiaries. The limits of coverage for certain of the policies are available on an aggregate basis for losses to any or all of the participating companies and their respective directors and officers. The Company reimburses MacAndrews & Forbes from time-to-time for their allocable portion of the premiums for such coverage or the Company pays the insurers directly, which premiums the Company believes are more favorable than the premiums that the Company would pay were it to secure stand-alone coverage. Any amounts paid by the Company directly to MacAndrews & Forbes in respect of premiums are included in the amounts paid under the Reimbursement Agreements. To ensure the availability of directors and officers liability insurance coverage through January 2023, the Company and MacAndrews & Forbes agreed to collectively make payments under MacAndrews & Forbes’ D&O Insurance Program. In furtherance of such arrangement, during 2020, the Company made a payment of approximately $5.3 million to MacAndrews & Forbes under the Reimbursement Agreements. The Company made a payment of approximately $1.3 million during the third quarter of 2021 in respect of its participation in the D&O Insurance Program. The net activity related to services purchased under the Transfer and Reimbursement Agreements during the nine months ended September 30, 2021 and 2020 was approximately $0.2 million and $0.6 million income, respectively. As of both September 30, 2021 and December 31, 2020, a receivable balance of $0.1 million from MacAndrews & Forbes was included in the Company's Unaudited Consolidated Balance Sheet for transactions subject to the Transfer and Reimbursement Agreements. Tax Sharing Agreements As a result of a debt-for-equity exchange transaction completed in March 2004 (the "2004 Revlon Exchange Transactions"), as of March 25, 2004, Revlon, Products Corporation and their U.S. subsidiaries were no longer included in the MacAndrews & Forbes Group for U.S. federal income tax purposes. Registration Rights Agreement Prior to the consummation of Revlon's initial public equity offering in February 1996, Revlon and Revlon Worldwide Corporation (which subsequently merged into REV Holdings LLC, a Delaware limited liability company and a wholly-owned subsidiary of MacAndrews & Forbes ("REV Holdings")), the then direct parent of Revlon entered into a registration rights agreement (the "Registration Rights Agreement"). In February 2003, MacAndrews & Forbes executed a joinder agreement to the Registration Rights Agreement, pursuant to which REV Holdings, MacAndrews & Forbes and certain transferees of Revlon's Common Stock held by REV Holdings (the "Holders") have the right to require Revlon to register under the Securities Act all or part of the Class A Common Stock owned by such Holders, including, without limitation, the shares of Class A Common Stock purchased by MacAndrews & Forbes in connection with Revlon's 2003 $50.0 million equity rights offering and the shares of Class A Common Stock which were issued to REV Holdings upon its conversion of all 3,125,000 shares of its Class B Common Stock in October 2013 (a "Demand Registration"). In connection with closing the 2004 Revlon Exchange Transactions and pursuant to the 2004 Investment Agreement, MacAndrews & Forbes executed a joinder agreement that provided that MacAndrews & Forbes would also be a Holder under the Registration Rights Agreement and that all shares acquired by MacAndrews & Forbes pursuant to the 2004 Investment Agreement are deemed to be registrable securities under the Registration Rights Agreement. This included all of the shares of Class A Common Stock acquired by MacAndrews & Forbes in connection with Revlon’s March 2006 $110 million rights offering of shares of its Class A Common Stock and related private placement to MacAndrews & Forbes, and Revlon’s January 2007 $100 million rights offering of shares of its Class A Common Stock and related private placement to MacAndrews & Forbes. Pursuant to the Registration Rights Agreement, in 2009 Revlon registered under the Securities Act all 9,336,905 shares of Class A Common Stock issued to MacAndrews & Forbes in the 2009 Exchange Offer, in which, among other things, Revlon issued to MacAndrews & Forbes shares of Class A Common Stock at a ratio of one share of Class A Common Stock for each $5.21 of outstanding principal amount of the then-outstanding Senior Subordinated Term Loan that MacAndrews & Forbes contributed to Revlon Revlon may postpone giving effect to a Demand Registration for a period of up to 30 days if Revlon believes such registration might have a material adverse effect on any plan or proposal by Revlon with respect to any financing, acquisition, recapitalization, reorganization or other material transaction, or if Revlon is in possession of material non-public information that, if publicly disclosed, could result in a material disruption of a major corporate development or transaction then pending or in progress or could result in other material adverse consequences to Revlon. In addition, the Holders have the right to participate in registrations by Revlon of its Class A Common Stock (a "Piggyback Registration"). The Holders will pay all out-of-pocket expenses incurred in connection with any Demand Registration. Revlon will pay any expenses incurred in connection with a Piggyback Registration, except for underwriting discounts, commissions and expenses attributable to the shares of Class A Common Stock sold by such Holders. As of September 30, 2021, MacAndrews & Forbes beneficially owned approximately 86.1% of Revlon's Class A Common Stock, which at such date was Revlon's only class of capital stock outstanding. As a result, MacAndrews & Forbes is able to elect Revlon’s entire Board of Directors and control the vote on all matters submitted to a vote of Revlon's stockholders. MacAndrews & Forbes is beneficially owned by Ronald O. Perelman. Mr. Perelman is Chairman of Revlon’s and Products Corporation's Board of Directors. Other Certain of Products Corporation’s debt obligations, including the 2016 Credit Agreements and Products Corporation's Senior Notes, have been, and may in the future be, supported by, among other things, guarantees from all of Products Corporation's domestic subsidiaries (subject to certain limited exceptions) and, for the 2016 Credit Agreements, guarantees from Revlon. The obligations under such guarantees are secured by, among other things, all of the capital stock of Products Corporation and, its domestic subsidiaries (subject to certain limited exceptions) and 66% of the capital stock of Products Corporation's and its domestic subsidiaries' first-tier foreign subsidiaries. During the nine months ended September 30, 2021 and 2020, the Company engaged several companies in which MacAndrews & Forbes had a controlling interest to provide the Company with various ordinary course business services. These services included processing approximately $8.7 million and $28.2 million of coupon redemptions for the Company's retail customers for the nine months ended September 30, 2021 and 2020, respectively, for which the Company incurred fees of approximately $0.2 million and $0.8 million for the nine months ended September 30, 2021 and 2020, respectively, and other similar advertising, coupon redemption and raw material supply services, for which the Company had net payables aggregating to approximately $0.3 million as of both September 30, 2021 and December 31, 2020. As of September 30, 2021 and December 31, 2020, payable balances of $1.6 million and approximately $0.6 million, respectively, were included in the Company's Consolidated Balance Sheet for the aforementioned coupon redemption services. The Company believes that its engagement of each of these affiliates was on arm's length terms, taking into account each firm's expertise in its respective field, and that the fees paid or received were at least as favorable as those available from unaffiliated parties.

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION

9 Months Ended

Sep. 30, 2021

Condensed Financial Information Disclosure [Abstract]

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION

Products Corporation's 6.25% Senior Notes are fully and unconditionally guaranteed on a senior basis by certain of Products Corporation’s direct and indirect wholly-owned domestic subsidiaries (the "Guarantors Subsidiaries").

The following Condensed Consolidating Financial Statements present the financial information as of September 30, 2021 and December 31, 2020, and for each of the nine months September 30, 2021 and 2020 for: (i) Products Corporation on a stand-alone basis; (ii) the Guarantor Subsidiaries on a stand-alone basis; (iii) the subsidiaries of Products Corporation that did not guarantee and do not guarantee Products Corporation's 6.25% Senior Notes (the "Non-Guarantor Subsidiaries") on a stand-alone basis; and; (iv) Products Corporation, the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries on a consolidated basis. The Condensed Consolidating Financial Statements are presented on the equity method, under which the investments in subsidiaries are recorded at cost and adjusted to the applicable share of the subsidiary's cumulative results of operations, capital contributions, distributions and other equity changes. The principal elimination entries eliminate investments in subsidiaries and intercompany balances and transactions.


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of September 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	5.6	$	3.2	$	64.5	$	—	$	73.3
Trade receivables, less allowances for doubtful accounts	88.0		119.3		184.0		—		391.3
Inventories, net	121.5		154.8		185.2		—		461.5
Prepaid expenses and other	215.4		26.2		63.8		—		305.4
Intercompany receivables	4,098.4		4,011.3		726.7		(8,836.4)		—
Investment in subsidiaries	1,231.7		(206.0)		—		(1,025.7)		—
Property, plant and equipment, net	159.8		62.8		83.3		—		305.9
Deferred income taxes	—		12.2		20.2		—		32.4
Goodwill	404.9		30.0		128.2		—		563.1
Intangible assets, net	9.4		174.6		217.5		—		401.5
Other assets	60.5		8.4		26.3		—		95.2
Total assets	$	6,395.2	$	4,396.8	$	1,699.7	$	(9,862.1)	$	2,629.6
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	—	$	—	$	0.6	$	—	$	0.6
Current portion of long-term debt	163.7		—		0.1		—		163.8
Accounts payable	95.1		55.3		95.2		—		245.6
Accrued expenses and other	149.4		75.3		179.0		—		403.7
Intercompany payables	4,390.2		3,552.4		893.6		(8,836.2)		—
Long-term debt	3,229.5		—		72.8		—		3,302.3
Other long-term liabilities	272.5		109.5		32.3		—		414.3
Total liabilities	8,300.4		3,792.5		1,273.6		(8,836.2)		4,530.3
Stockholder’s (deficiency) equity	(1,905.2)		604.3		426.1		(1,025.9)		(1,900.7)
Total liabilities and stockholder’s (deficiency) equity	$	6,395.2	$	4,396.8	$	1,699.7	$	(9,862.1)	$	2,629.6


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of December 31, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	5.5	$	2.5	$	89.1	$	—	$	97.1
Trade receivables, less allowances for doubtful accounts	86.0		95.7		170.6		—		352.3
Inventories, net	121.3		147.7		193.6		—		462.6
Prepaid expenses and other	220.6		24.6		55.3		—		300.5
Intercompany receivables	3,592.2		3,549.6		614.1		(7,755.9)		—
Investment in subsidiaries	1,653.6		2.3		—		(1,655.9)		—
Property, plant and equipment, net	178.5		72.1		101.4		—		352.0
Deferred income taxes	—		10.6		23.5		—		34.1
Goodwill	48.9		264.0		250.8		—		563.7
Intangible assets, net	10.0		187.8		233.0		—		430.8
Other assets	67.9		9.3		31.9		—		109.1
Total assets	$	5,984.5	$	4,366.2	$	1,763.3	$	(9,411.8)	$	2,702.2
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	—	$	—	$	2.5	$	—	$	2.5
Current portion of long-term debt	159.2		—		58.3		—		217.5
Accounts payable	72.5		48.0		82.8		—		203.3
Accrued expenses and other	144.1		61.7		217.4		—		423.2
Intercompany payables	3,897.1		3,162.0		696.6		(7,755.7)		—
Long-term debt	3,104.7		—		0.3		—		3,105.0
Other long-term liabilities	377.3		33.8		42.6		—		453.7
Total liabilities	7,754.9		3,305.5		1,100.5		(7,755.7)		4,405.2
Stockholder’s (deficiency) equity	(1,770.4)		1,060.7		662.8		(1,656.1)		(1,703.0)
Total liabilities and stockholder’s (deficiency) equity	$	5,984.5	$	4,366.2	$	1,763.3	$	(9,411.8)	$	2,702.2



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended September 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	103.1	$	162.2	$	255.8	$	—	$	521.1
Cost of sales	56.7		72.4		92.1		—		221.2
Gross profit	46.4		89.8		163.7		—		299.9
Selling, general and administrative expenses	74.0		65.9		114.6		—		254.5
Acquisition and integration costs	0.6		—		—		—		0.6
Restructuring charges and other, net	6.7		0.3		2.0		—		9.0
Impairment charges	—		—		—		—		—
Loss (gain) on divested assets	0.1		—		—		—		0.1
Operating (loss) income	(35.0)		23.6		47.1		—		35.7
Other (income) expense:
Intercompany interest, net	(3.1)		0.7		2.4		—		—
Interest expense	58.7		—		4.4		—		63.1
Amortization of debt issuance costs	8.7		—		—		—		8.7
Gain on early extinguishment of debt	—		—		—		—		—
Foreign currency losses (gains), net	—		0.6		9.3		—		9.9
Miscellaneous, net	194.4		(115.1)		(79.2)		—		0.1
Other expense (income), net	258.7		(113.8)		(63.1)		—		81.8
(Loss) income from continuing operations before income taxes	(293.7)		137.4		110.2		—		(46.1)
(Benefit from) provision for income taxes	—		3.2		2.3		—		5.5
(Loss) income from continuing operations, net of taxes	(293.7)		134.2		107.9		—		(51.6)

Equity in income (loss) of subsidiaries	243.9		92.5		—		(336.4)		—
Net (loss) income	$	(49.8)	$	226.7	$	107.9	$	(336.4)	$	(51.6)
Other comprehensive income (loss)	2.9		3.9		(2.5)		(1.4)		2.9
Total comprehensive (loss) income	$	(46.9)	$	230.6	$	105.4	$	(337.8)	$	(48.7)



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended September 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	95.7	$	148.9	$	232.4	$	0.1	$	477.1
Cost of sales	45.6		92.6		96.0		0.1		234.3
Gross profit	50.1		56.3		136.4		—		242.8
Selling, general and administrative expenses	84.4		47.7		119.3		—		251.4
Acquisition and integration costs	0.8		—		0.1		—		0.9
Restructuring charges and other, net	(8.4)		2.7		5.0		—		(0.7)
Impairment charges	(23.4)		22.0		1.4		—		—
Gain on divested assets	(1.1)		—		—		—		(1.1)
Operating (loss) income	(2.2)		(16.1)		10.6		—		(7.7)
Other (income) expense:
Intercompany interest, net	(0.5)		0.7		(0.2)		—		—
Interest expense	67.3		—		1.4		—		68.7
Amortization of debt issuance costs	7.8		—		—		—		7.8
Gain on early extinguishment of debt, net	(31.2)		—		—		—		(31.2)
Foreign currency losses (gains), net	1.0		(0.7)		(10.1)		—		(9.8)
Miscellaneous, net	(1.8)		(55.4)		54.6		—		(2.6)
Other expense (income), net	42.6		(55.4)		45.7		—		32.9
(Loss) income from continuing operations before income taxes	(44.8)		39.3		(35.1)		—		(40.6)
(Benefit from) provision for income taxes	(6.3)		17.8		(9.2)		—		2.3
Loss (income) from continuing operations, net of taxes	(38.5)		21.5		(25.9)		—		(42.9)

Equity in income (loss) of subsidiaries	30.0		(10.0)		—		(20.0)		—
Net (loss) income	$	(8.5)	$	11.5	$	(25.9)	$	(20.0)	$	(42.9)
Other comprehensive income (loss)	5.0		(7.1)		1.6		5.5		5.0
Total comprehensive (loss) income	$	(3.5)	$	4.4	$	(24.3)	$	(14.5)	$	(37.9)



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Nine Months Ended September 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	311.6	$	411.6	$	740.3	$	—	$	1,463.5
Cost of sales	155.4		182.8		270.5		—		608.7
Gross profit	156.2		228.8		469.8		—		854.8
Selling, general and administrative expenses	262.8		178.9		350.0		—		791.7
Acquisition, integration and divestiture costs	1.7		—		0.1		—		1.8
Restructuring charges and other, net	13.5		2.5		6.8		—		22.8

(Gain) loss on divested assets	(1.7)		—		—		—		(1.7)
Operating (loss) income	(120.1)		47.4		112.9		—		40.2
Other (income) expense:
Intercompany interest, net	(3.9)		1.9		2.0		—		—
Interest expense	178.4		—		5.5		—		183.9
Amortization of debt issuance costs	30.7		—		—		—		30.7

Foreign currency losses, net	(0.2)		(0.3)		12.0		—		11.5
Miscellaneous, net	231.1		(126.9)		(101.4)		—		2.8
Other expense (income), net	436.1		(125.3)		(81.9)		—		228.9
(Loss) income from operations before income taxes	(556.2)		172.7		194.8		—		(188.7)
Provision for (benefit from) for income taxes	—		4.6		19.3		—		23.9
(Loss) income from operations, net of taxes	(556.2)		168.1		175.5		—		(212.6)

Equity in income (loss) of subsidiaries	353.9		102.2		—		(456.1)		—
Net (loss) income	$	(202.3)	$	270.3	$	175.5	$	(456.1)	$	(212.6)
Other comprehensive (loss) income	4.5		8.1		—		(8.1)		4.5
Total comprehensive (loss) income	$	(197.8)	$	278.4	$	175.5	$	(464.2)	$	(208.1)


Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Nine Months Ended September 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	305.9	$	339.6	$	632.2	$	—	$	1,277.7
Cost of sales	158.5		190.5		251.7		—		600.7
Gross profit	147.4		149.1		380.5		—		677.0
Selling, general and administrative expenses	247.6		163.8		321.8		—		733.2
Acquisition, integration and divestiture costs	4.0		—		0.2		—		4.2
Restructuring charges and other, net	32.3		7.0		5.5		—		44.8
Impairment charges	120.7		22.0		1.4		—		144.1
Loss on divested assets	(0.5)		—		—		—		(0.5)
Operating (loss) income	(256.7)		(43.7)		51.6		—		(248.8)
Other (income) expenses:
Intercompany interest, net	(3.5)		1.8		1.7		—		—
Interest expense	173.0		—		5.0		—		178.0
Amortization of debt issuance costs	17.8		—		—		—		17.8
Gain on early extinguishment of debt, net	(43.1)		—		—		—		(43.1)
Foreign currency losses, net	1.6		1.7		5.8		—		9.1
Miscellaneous, net	(0.9)		(71.5)		86.3		—		13.9
Other expense (income), net	144.9		(68.0)		98.8		—		175.7
Loss from operations before income taxes	(401.6)		24.3		(47.2)		—		(424.5)
Benefit from income taxes	(58.4)		19.2		(5.0)		—		(44.2)
(Loss) income from operations, net of taxes	(343.2)		5.1		(42.2)		—		(380.3)

Equity in (loss) income of subsidiaries	0.7		(36.9)		—		36.2		—
Net (loss) income	$	(342.5)	$	(31.8)	$	(42.2)	$	36.2	$	(380.3)
Other comprehensive (loss) income	16.6		7.3		4.0		(11.3)		16.6
Total comprehensive (loss) income	$	(325.9)	$	(24.5)	$	(38.2)	$	24.9	$	(363.7)


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Nine Months Ended September 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash provided by (used in) operating activities	$	(418.6)	$	57.7	$	274.2	$	—	$	(86.7)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities	(1.9)		(0.8)		(1.5)		—		(4.2)



CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	(4.5)		(5.6)		(2.4)		—		(12.5)
Borrowings on term loans	305.0		—		—		—		305.0

Repayments on term loans	(186.7)		—		—		—		(186.7)
Net (repayments) borrowings under the revolving credit facilities	(2.7)		—		—		—		(2.7)


Payment of financing costs	(17.9)		—		—		—		(17.9)
Tax withholdings related to net share settlements of restricted stock and RSUs	(2.4)		—		—		—		(2.4)
Other financing activities	(0.2)		(0.1)		—		—		(0.3)
Net cash provided by (used in) financing activities	90.6		(5.7)		(2.4)		—		82.5
Effect of exchange rate changes on cash, cash equivalents and restricted cash	349.5		(57.8)		(294.1)		—		(2.4)
Net increase (decrease) in cash, cash equivalents and restricted cash	19.6		(6.6)		(23.8)		—		(10.8)
Cash, cash equivalents and restricted cash at beginning of period	$	6.5	$	7.8	$	88.2	$	—	$	102.5
Cash, cash equivalents and restricted cash at end of period	$	26.1	$	1.2	$	64.4	$	—	$	91.7


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Nine Months Ended September 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(260.0)	$	6.6	$	(3.5)	$	—	$	(256.9)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities	(6.0)		(0.5)		(0.9)		—		(7.4)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	2.5		(3.8)		0.6		—		(0.7)
Borrowings on term loans	880.0		—		—		—		880.0
Repayments on Term Loans	(354.7)		—		—		—		(354.7)
Net (repayments) borrowings under the revolving credit facilities	19.5		—		—		—		19.5
Payments of financing costs	(109.4)		—		1.1		—		(108.3)
Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		—		—		—		(1.6)
Other financing activities	(0.1)		(0.1)		(0.1)		—		(0.3)
Net cash provided by (used in) financing activities	436.2		(3.9)		1.6		—		433.9
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0.4		2.0		(2.8)		—		(0.4)
Net increase (decrease) in cash, cash equivalents and restricted cash	170.6		4.2		(5.6)		—		169.2
Cash, cash equivalents and restricted cash at beginning of period	$	1.0	$	6.4	97.2		$	—	104.5
Cash, cash equivalents and restricted cash at end of period	$	171.6	$	10.6	$	91.6	$	—	$	273.7

DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The preparation of the Company's Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the Consolidated Financial Statements in the period they are determined to be necessary. Significant estimates made in the accompanying Consolidated Financial Statements include, but are not limited to: expected sales returns; certain assumptions related to the valuation of acquired intangible and long-lived assets and the recoverability of goodwill, intangible and long-lived assets; income taxes, including deferred tax valuation allowances and reserves for estimated tax liabilities; and certain estimates and assumptions used in the calculation of the net periodic benefit (income) costs and the projected benefit obligations for the Company’s pension and other post-retirement plans, including the expected long-term return on pension plan assets and the discount rate used to value the Company’s pension benefit obligations. The Unaudited Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and related notes contained in Revlon's Annual Report on Form 10-K for the fiscal year ended December 31, 2020 ("2020 Form 10-K"). The Company's results of operations and financial position for the interim periods are not indicative of those to be expected for the full year.
Recently Evaluated and/or Adopted and Recently Issued Accounting Pronouncements	Recently Evaluated and/or Adopted Accounting Pronouncements In December 2019, the Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocations, calculating income taxes in interim periods and how a company accounts for future events. This ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. The Company adopted this guidance as of January 1, 2021. The adoption of this new guidance did not have any significant impacts on the Company’s results of operations, financial condition and/or financial statement disclosures. Recently Issued Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The new guidance under ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is in the process of assessing the impact, if any, that ASU No. 2020-04 is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures. In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which was subsequently amended in November 2018 through ASU No. 2018-19, "Codification Improvements to Topic 326, Financial Instruments - Credit Losses." ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. In November 2019, the FASB issued ASU No. 2019-10, which, among other things, deferred the application of the new guidance on credit losses for smaller reporting companies ("SRC") to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. This guidance will be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (i.e., a modified-retrospective approach). Under the above-mentioned deferral, the Company expects to adopt ASU No. 2016-03, and the related ASU No. 2018-19 amendments, beginning as of January 1, 2023 and is in the process of assessing the impact, if any, that this new guidance is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures.

RESTRUCTURING CHARGES (Tables)

9 Months Ended

Sep. 30, 2021

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Charges

A summary of the RGGA charges incurred since its inception in March 2020 and through September 30, 2021 is presented in the following table:



	Restructuring Charges and Other, Net
	Employee Severance and Other Personnel Benefits		Other Costs		Total Restructuring Charges		Leases (a)		Other Related Charges (b)		Total Restructuring and Related Charges
Charges incurred through December 31, 2020	$	48.6	$	1.9	$	50.5	$	12.6	$	5.7	$	68.8
Charges incurred during the nine months ended September 30, 2021	3.5		19.3		22.8		3.9		1.3		28.0
Cumulative charges incurred through September 30, 2021	$	52.1	$	21.2	$	73.3	$	16.5	$	7.0	$	96.8

(a) Lease-related charges are recorded within SG&A in the Company’s Consolidated Statement of Operations and Comprehensive Loss.

(b) Other related charges are recorded within SG&A and cost of sales in the Company’s Consolidated Statement of Operations and Comprehensive Loss.

A summary of the RGGA restructuring charges incurred since its inception in March 2020 and through September 30, 2021 by reportable segment is presented in the following table:



	Charges incurred in the nine months ended September 30, 2021		Cumulative charges incurred through September 30, 2021
Revlon	$	6.5	$	27.2
Elizabeth Arden	8.0		17.4
Portfolio	3.9		17.5
Fragrances	4.4		11.2
Total	$	22.8	$	73.3

Schedule of Liability Balance and Activity of Restructuring Programs

The liability balance and related activity for each of the Company's restructuring programs are presented in the following table:



					Utilized, Net
	Liability Balance at January 1, 2021		Expense, Net		Cash		Liability Balance at September 30, 2021
RGGA:
Employee severance and other personnel benefits	$	12.6	$	3.5	$	(13.5)	$	2.6
Other	—		19.3		(19.3)		—
Total RGGA	12.6		22.8		(32.8)		2.6






Other restructuring initiatives:
Employee severance and other personnel benefits	1.2		—		(0.3)		0.9

Total other restructuring initiatives	1.2		—		(0.3)		0.9
Total restructuring reserve	$	13.8	$	22.8	$	(33.1)	$	3.5

INVENTORIES (Tables)

9 Months Ended

Sep. 30, 2021

Inventory Disclosure [Abstract]

Components of Inventories

The Company's net inventory balances consisted of the following:


	September 30,		December 31,
	2021		2020
Finished goods	329.0		$	356.7
Raw materials and supplies	116.3		97.1
Work-in-process	16.2		8.8
	$	461.5	$	462.6

PROPERTY, PLANT AND EQUIPMENT (Tables)

9 Months Ended

Sep. 30, 2021

Property, Plant and Equipment [Abstract]

Components of Property, Plant and Equipment Balances

The Company's property, plant and equipment, net balances consisted of the following:



	September 30,		December 31,
	2021		2020
Land and improvements	$	10.9	$	11.4
Building and improvements	44.7		48.3
Machinery and equipment	86.8		98.7
Office furniture, fixtures and capitalized software	63.6		76.2
Leasehold improvements	18.7		21.3
Construction-in-progress	5.6		9.1
Right-of-Use assets	75.6		87.0
Property, plant and equipment and Right-of-Use assets, net	$	305.9	$	352.0

GOODWILL AND INTANGIBLE ASSETS, NET (Tables)

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in Goodwill by Segment

The following table presents the changes in goodwill by segment for the nine months ended September 30, 2021:



	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total




Balance at January 1, 2021	$	265.4	$	87.9	$	89.5	$	120.9	$	563.7
Foreign currency translation adjustment	(0.2)		(0.2)		(0.1)		(0.1)		(0.6)


Balance at September 30, 2021	$	265.2	$	87.7	$	89.4	$	120.8	$	563.1

Cumulative goodwill impairment charges(a)									$	(166.2)

(a) Amount refers to cumulative goodwill impairment charges related to impairments recognized in 2015, 2017, 2018 and 2020.

Summary of Finite-Lived Intangible Assets

The following tables present details of the Company's total intangible assets as of September 30, 2021 and December 31, 2020:


	September 30, 2021
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	271.1	$	(139.2)	$	—	$	131.9	12
Customer relationships	247.4		(119.5)		—		127.9		10
Patents and internally-developed intellectual property	23.7		(16.9)		—		6.8		4
Distribution rights	31.0		(8.8)		—		22.2		13
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	574.5	$	(285.7)	$	—	$	288.8

Indefinite-lived intangible assets:
Trade names	$	145.8	N/A		$	(33.1)	$	112.7
Total indefinite-lived intangible assets	$	145.8	N/A		$	(33.1)	$	112.7

Total intangible assets	$	720.3	$	(285.7)	$	(33.1)	$	401.5

	December 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	272.8	$	(128.6)	$	—	$	144.2	12
Customer relationships	249.9		(110.7)		—		139.2		11
Patents and internally-developed intellectual property	23.6		(15.6)		—		8.0		5
Distribution rights	31.0		(7.5)		—		23.5		14
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	578.6	$	(263.7)	$	—	$	314.9

Indefinite-lived intangible assets:
Trade names	$	149.0	N/A		$	(33.1)	$	115.9
Total indefinite-lived intangible assets	$	149.0	N/A		$	(33.1)	$	115.9

Total intangible assets	$	727.6	$	(263.7)	$	(33.1)	$	430.8

Summary of Indefinite-Lived Intangible Assets

The following tables present details of the Company's total intangible assets as of September 30, 2021 and December 31, 2020:


	September 30, 2021
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	271.1	$	(139.2)	$	—	$	131.9	12
Customer relationships	247.4		(119.5)		—		127.9		10
Patents and internally-developed intellectual property	23.7		(16.9)		—		6.8		4
Distribution rights	31.0		(8.8)		—		22.2		13
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	574.5	$	(285.7)	$	—	$	288.8

Indefinite-lived intangible assets:
Trade names	$	145.8	N/A		$	(33.1)	$	112.7
Total indefinite-lived intangible assets	$	145.8	N/A		$	(33.1)	$	112.7

Total intangible assets	$	720.3	$	(285.7)	$	(33.1)	$	401.5

	December 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	272.8	$	(128.6)	$	—	$	144.2	12
Customer relationships	249.9		(110.7)		—		139.2		11
Patents and internally-developed intellectual property	23.6		(15.6)		—		8.0		5
Distribution rights	31.0		(7.5)		—		23.5		14
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	578.6	$	(263.7)	$	—	$	314.9

Indefinite-lived intangible assets:
Trade names	$	149.0	N/A		$	(33.1)	$	115.9
Total indefinite-lived intangible assets	$	149.0	N/A		$	(33.1)	$	115.9

Total intangible assets	$	727.6	$	(263.7)	$	(33.1)	$	430.8

Estimated Future Amortization Expense



	Estimated Amortization Expense
2021	$	8.3
2022	32.6
2023	30.8
2024	27.5
2025	26.3
Thereafter	163.3
Total	$	288.8

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2021

Payables and Accruals [Abstract]

Components of Accrued Expenses and Other Current Liabilities

The Company's accrued expenses and other current liabilities consisted of the following:


	September 30,		December 31,
	2021		2020
Advertising, marketing and promotional costs	$	99.0	$	96.3
Sales returns and allowances	74.9		95.5
Taxes (a)	54.2		41.8
Compensation and related benefits	44.4		50.1
Interest	24.0		29.6
Freight and distribution costs	17.6		9.5
Professional services and insurance	14.7		18.6
Short-term lease liability	14.3		16.6
Restructuring reserve	3.5		13.8
Software	2.2		3.1
Other	51.7		46.0
Total	$	400.5	$	420.9

(a) Accrued Taxes for Products Corporation as of September 30, 2021 and December 31, 2020 were $57.3 million and $44.8 million,

DEBT (Tables)

9 Months Ended

Sep. 30, 2021

Debt Disclosure [Abstract]

Schedule of Components of Long-Term Debt

The table below details the Company's debt balances, net of discounts and debt issuance costs.


	September 30,		December 31,
	2021		2020
Amended 2016 Revolving Credit Facility (Tranche A) due 2024	$	134.5	$	136.7
SISO Term Loan Facility due 2024	125.8		—
2021 Foreign Asset-Based Term Facility due 2024	70.7		—

2020 ABL FILO Term Loans due 2023	50.0		50.0
2020 Troubled-debt-restructuring: future interest	46.2		57.8
2020 BrandCo Term Loan Facility due 2025	1,742.9		1,719.8
2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025	869.2		874.8
2018 Foreign Asset-Based Term Facility due 2021	—		57.7

6.25% Senior Notes due 2024	426.5		425.4
Spanish Government Loan due 2025	0.3		0.3


Debt	$	3,466.1	$	3,322.5
Less current portion	(163.8)		(217.5)
Long-term debt	$	3,302.3	$	3,105.0

Short-term borrowings (*)	$	0.6	$	2.5

(*)The weighted average interest rate on these short-term borrowings outstanding at September 30, 2021 and December 31, 2020 was 11.4% and 11.7%, respectively.

Schedule of Line of Credit Facilities

At September 30, 2021, the aggregate principal amounts outstanding and availability under Products Corporation’s various revolving credit facilities were as follows:



	Commitment		Borrowing Base		Aggregate principal amount outstanding at September 30, 2021		Availability at September 30, 2021 (a)
Tranche A Revolving Credit Facility	$	270.0	$	189.4	$	136.2	$	53.2
SISO Term Loan Facility	130.0		130.0		130.0		—

2020 ABL FILO Term Loans	50.0		40.6		$	50.0	$	—

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

Fair Value Disclosure of Asset and Liability Not Measured at Fair Value

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

As of September 30, 2021, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


	September 30, 2021
	Fair Value
	Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:
Long-term debt, including current portion(a)	$	—	$	2,531.2	$	—	$	2,531.2	$	3,466.1

As of December 31, 2020, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


	December 31, 2020
	Fair Value
	Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:
Long-term debt, including current portion(a)	$	—	$	2,168.9	$	—	$	2,168.9	$	3,322.5

(a) The fair value of the Company's long-term debt, including the current portion of long-term debt, is based on quoted market prices for similar issuances and maturities.

PENSION AND POST-RETIREMENT BENEFITS (Tables)

9 Months Ended

Sep. 30, 2021

Retirement Benefits [Abstract]

Schedule of Components of Net Periodic Benefit Costs


	Pension Plans				Other Post-Retirement Benefit Plans
	Three Months Ended September 30,
	2021		2020		2021		2020
Net periodic benefit costs:
Service cost	$	0.4	$	0.5	$	—	$	—
Interest cost	2.3		3.8		—		0.1
Expected return on plan assets	(4.9)		(5.7)		$	—	—
Amortization of actuarial loss	3.3		2.7		0.2		0.1

Total net periodic benefit costs prior to allocation	$	1.1	$	1.3	$	0.2	$	0.2
Portion allocated to Revlon Holdings	—		—		—		—
Total net periodic benefit costs	$	1.1	$	1.3	$	0.2	$	0.2


	Pension Plans				Other Post-Retirement Benefit Plans
	Nine Months Ended September 30,
	2021		2020		2021		2020
Net periodic benefit costs:
Service cost	$	1.1	$	1.3	$	—	$	—
Interest cost	6.9		11.2		0.1		0.3
Expected return on plan assets	(14.8)		(17.1)		—		—
Amortization of actuarial loss	9.9		8.3		0.5		0.3

Total net periodic benefit costs prior to allocation	$	3.1	$	3.7	$	0.6	$	0.6
Portion allocated to Revlon Holdings	(0.1)		(0.1)		—		—
Total net periodic benefit costs	$	3.0	$	3.6	$	0.6	$	0.6

Schedule of Classification of Net Periodic Benefit Costs

Net periodic benefit costs are reflected in the Company's Consolidated Financial Statements as follows for the periods presented:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net periodic benefit costs:

Selling, general and administrative expense	$	0.4	$	0.5	$	1.1	$	1.3
Miscellaneous, net	0.9		1.0		2.5		2.9
Total net periodic benefit costs	$	1.3	$	1.5	$	3.6	$	4.2

STOCK COMPENSATION PLAN (Tables)

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Restricted stock units award activity


	Time-Based LTIP	Performance-Based LTIP
	RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU		RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU
Outstanding as of December 31, 2020
2019 TIP RSUs (a)	58.8	$	15.95	n/a	$	—
LTIP RSUs:
2020	496.5	14.96		462.9	14.96
2019	169.3	22.55		255.3	22.55
2018	66.4	19.40		215.9	19.42
Total LTIP RSUs	732.2			934.1
Total LTIP and TIP RSUs Outstanding as of December 31, 2020	791.0			934.1
Granted
2019 TIP RSUs Granted	80.1	13.11		n/a	—
LTIP RSUs:
2021	1,559.0	10.77		—	—
2020	—	—		—	—
2019	—	—		—	—
2018	—	—		—	—
Total LTIP RSUs Granted	1,559.0			—
Vested
2019 TIP RSUs Vested (b)	(8.9)	15.30		—	—
LTIP RSUs:
2020 (b)	(182.7)	14.96		—	—
2019 (b)	(91.4)	22.53		—	—
2018)(b)	(65.9)	19.42		(38.5)	19.44
Total LTIP RSUs Vested	(340.0)			(38.5)
Forfeited/Canceled
2019 TIP RSUs Forfeited/Canceled (a)	(8.1)	15.11		n/a	—
LTIP RSUs:
2021	(81.2)	10.75		—	—
2020	(52.1)	14.96		(73.5)	14.96
2019	(6.2)	22.55		(38.6)	22.55
2018	(0.5)	16.80		(177.4)	19.42
Total LTIP RSUs Forfeited/Canceled	(140.0)			(289.5)
Outstanding as of September 30, 2021
2019 TIP RSUs	121.9	14.09		n/a	—
LTIP RSUs:
2021	1,477.8	10.77		—	—
2020	261.7	14.96		389.4	14.96
2019	71.7	22.57		216.7	22.55
2018	—	—		—	—
Total LTIP RSUs	1,811.2			606.1
Total LTIP and TIP RSUs Outstanding as of September 30, 2021	1,933.1			606.1

((a) The 2019 TIP provides for RSU awards that are only time-based.

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

9 Months Ended

Sep. 30, 2021

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Accumulated Other Comprehensive Loss

A roll-forward of the Company's accumulated other comprehensive loss as of September 30, 2021 is as follows:


	Foreign Currency Translation		Actuarial (Loss) Gain on Post-retirement Benefits		Other		Accumulated Other Comprehensive Loss







Balance at January 1, 2021	$	(17.1)	$	(260.5)	$	(0.3)	$	(277.9)
Foreign currency translation adjustment, net of tax (b)	(6.0)		—		—		(6.0)
Amortization of pension related costs, net of tax (a) (b)	—		10.5		—		10.5




Other comprehensive (loss) gain	$	(6.0)	$	10.5	$	—	$	4.5
Balance at September 30, 2021	$	(23.1)	$	(250.0)	$	(0.3)	$	(273.4)

(b) Amounts presented are net of tax expense of nil for the nine months ended September 30, 2021.

SEGMENT DATA AND RELATED INFORMATION (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table is a comparative summary of the Company’s net sales and segment profit for Revlon and Products Corporation by reportable segment for the periods presented. Revlon, Inc.




	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Segment Net Sales:
Revlon	$	173.0	$	166.0	$	521.8	$	482.8
Elizabeth Arden	122.8		106.3		359.7		282.4
Portfolio	112.7		99.6		307.4		298.1
Fragrances	112.6		105.2		274.6		214.4
Total	$	521.1	$	477.1	$	1,463.5	$	1,277.7

Segment Profit:
Revlon	$	16.1	$	13.5	$	45.3	$	41.4
Elizabeth Arden	21.3		3.4		42.1		18.4
Portfolio	22.1		12.2		46.3		33.9
Fragrances	22.9		25.4		50.8		34.6
Total	$	82.4	$	54.5	$	184.5	$	128.3

Reconciliation:
Total Segment Profit	$	82.4	$	54.5	$	184.5	$	128.3
Less:

Depreciation and amortization	31.2		35.1		96.8		108.3
Non-cash stock compensation expense	3.9		5.1		10.4		8.6
Non-Operating items:
Restructuring and related charges	10.8		4.5		28.0		61.2
Acquisition, integration and divestiture costs	0.6		0.9		1.8		4.2
Loss (gain) on divested assets	0.1		(1.1)		(1.7)		(0.5)
Financial control remediation and sustainability actions and related charges	—		0.7		0.4		8.5
Excessive coupon redemptions	—		—		—		4.2
COVID-19 charges	(0.1)		9.7		6.1		35.1


Capital structure and related charges	1.8		9.3		6.8		9.3
Impairment charges	—		—		—		144.1



Operating income (loss)	34.1		(9.7)		35.9		(254.7)
Less:
Interest Expense	63.1		68.7		183.9		178.0

Amortization of debt issuance costs	8.7		7.8		30.7		17.8

Gain on early extinguishment of debt	—		(31.2)		—		(43.1)
Foreign currency losses (gains), net	9.9		(9.8)		11.5		9.1
Miscellaneous, net	0.1		(2.6)		2.8		13.9
Loss from operations before income taxes	$	(47.7)	$	(42.6)	$	(193.0)	$	(430.4)

Products Corporation



	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Segment Net Sales:
Revlon	$	173.0	$	166.0	$	521.8	$	482.8
Elizabeth Arden	122.8		106.3		359.7		282.4
Portfolio	112.7		99.6		307.4		298.1
Fragrances	112.6		105.2		274.6		214.4
Total	$	521.1	$	477.1	$	1,463.5	$	1,277.7

Segment Profit:
Revlon	$	16.6	$	14.2	$	46.8	$	43.6
Elizabeth Arden	21.7		3.8		43.1		19.7
Portfolio	22.5		12.6		47.3		35.3
Fragrances	23.2		25.9		51.6		35.6
Total	$	84.0	$	56.5	$	188.8	$	134.2

Reconciliation:
Total Segment Profit	$	84.0	$	56.5	$	188.8	$	134.2
Less:

Depreciation and amortization	31.2		35.1		96.8		108.3
Non-cash stock compensation expense	3.9		5.1		10.4		8.6
Non-Operating items:
Restructuring and related charges	10.8		4.5		28.0		61.2
Acquisition, integration and divestiture costs	0.6		0.9		1.8		4.2
Loss (gain) on divested assets	0.1		(1.1)		(1.7)		(0.5)
Financial control remediation and sustainability actions and related charges	—		0.7		0.4		8.5


Excessive coupon redemptions	—		—		—		4.2
COVID-19 charges	(0.1)		9.7		6.1		35.1
Capital structure and related charges	1.8		9.3		6.8		9.3
Impairment charge	—		—		—		144.1

Operating income (loss)	35.7		(7.7)		40.2		(248.8)
Less:
Interest Expense	63.1		68.7		183.9		178.0

Amortization of debt issuance costs	8.7		7.8		30.7		17.8

Gain on early extinguishment of debt	—		(31.2)		—		(43.1)
Foreign currency losses (gains), net	9.9		(9.8)		11.5		9.1
Miscellaneous, net	0.1		(2.6)		2.8		13.9
Loss from operations before income taxes	$	(46.1)	$	(40.6)	$	(188.7)	$	(424.5)

Schedule of Net Sales and Long-Lived Assets by Geographic Area

The following tables present the Company's segment net sales by geography and total net sales by classes of similar products for the periods presented:


	Three Months Ended September 30, 2021										Nine Months Ended September 30, 2021
	Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio		Fragrances		Total
Geographic Area:
Net Sales
North America	$	88.4	$	32.3	$	75.2	$	81.5	$	277.4	$	270.9	$	80.9	$	201.9	$	193.8	$	747.5
EMEA*	43.8		30.4		28.7		20.5		123.4		125.4		85.9		80.6		54.0		345.9
Asia	9.1		52.0		0.4		3.5		65.0		31.7		171.8		2.3		10.4		216.2
Latin America*	14.2		2.5		4.8		3.4		24.9		40.7		5.8		12.2		7.9		66.6
Pacific*	17.5		5.6		3.6		3.7		30.4		53.1		15.3		10.4		8.5		87.3
	$	173.0	$	122.8	$	112.7	$	112.6	$	521.1	$	521.8	$	359.7	$	307.4	$	274.6	$	1,463.5


			Three Months Ended September 30, 2020											Nine Months Ended September 30, 2020
	Revlon			Elizabeth Arden		Portfolio		Fragrances		Total		Revlon			Elizabeth Arden		Portfolio		Fragrances		Total
Geographic Area:
Net Sales
North America	$	86.4		$	30.5	$	59.9	$	79.2	$	256.0	$	265.6		$	66.9	$	182.8	$	151.1	$	666.4
EMEA*	41.4			25.3		32.8		18.8		118.3		105.2			64.9		93.6		44.4		308.1
Asia	12.1			43.3		0.4		2.7		58.5		33.6			135.5		1.6		8.1		178.8
Latin America*	11.3			2.5		3.3		1.5		18.6		35.3			3.5		11.6		2.6		53.0
Pacific*	14.8			4.7		3.2		3.0		25.7		43.1			11.6		8.5		8.2		71.4
	$	166.0		$	106.3	$	99.6	$	105.2	$	477.1	$	482.8		$	282.4	$	298.1	$	214.4	$	1,277.7

* The EMEA region includes Europe, the Middle East and Africa; the Latin America region includes Mexico, Central America and South America; and the Pacific region includes Australia and New Zealand.

The following table presents the Company's long-lived assets by geographic area:


	September 30, 2021			December 31, 2020
Long-lived assets, net:
United States	$	1,137.7	83%	$	1,194.9	82%
International	228.0		17%	260.7		18%
	$	1,365.7		$	1,455.6

Schedule of Net Sales by Classes of Similar Products



	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Classes of similar products:
Net sales:
Color cosmetics	$	124.8	24%	$	104.7	22%	$	368.5	25%	$	305.3	24%
Fragrance	160.1		31%	141.6		30%	395.4		27%	300.5		24%
Hair care	124.2		24%	115.9		24%	351.6		24%	338.0		26%
Beauty care	45.6		9%	50.4		11%	124.8		9%	141.9		11%
Skin care	66.4		12%	64.5		13%	223.2		15%	192.0		15%
	$	521.1		$	477.1		$	1,463.5		$	1,277.7

REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE (Tables)

9 Months Ended

Sep. 30, 2021

Earnings Per Share, Basic and Diluted [Abstract]

Components of Basic and Diluted Loss Per Share

Following are the components of Revlon's basic and diluted loss per common share for the periods presented:


	Three months ended September 30,				Nine months ended September 30,
	2021		2020		2021		2020
Numerator:


Net loss	$	(53.1)	$	(44.5)	$	(216.8)	$	(385.2)
Denominator:
Weighted-average common shares outstanding – Basic	54,025,861		53,476,354		53,899,732		53,371,986
Effect of dilutive restricted stock and RSUs	—		—		—		—
Weighted-average common shares outstanding – Diluted	54,025,861		53,476,354		53,899,732		53,371,986
Basic and Diluted (loss) earnings per common share:


Net loss per common share	$	(0.98)	$	(0.83)	$	(4.02)	$	(7.22)





Unvested restricted stock and RSUs under the Stock Plan(a)	759,994		—		581,856		—

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION (Tables)

9 Months Ended

Sep. 30, 2021

Condensed Financial Information Disclosure [Abstract]

Condensed Consolidating Balance Sheets


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of September 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	5.6	$	3.2	$	64.5	$	—	$	73.3
Trade receivables, less allowances for doubtful accounts	88.0		119.3		184.0		—		391.3
Inventories, net	121.5		154.8		185.2		—		461.5
Prepaid expenses and other	215.4		26.2		63.8		—		305.4
Intercompany receivables	4,098.4		4,011.3		726.7		(8,836.4)		—
Investment in subsidiaries	1,231.7		(206.0)		—		(1,025.7)		—
Property, plant and equipment, net	159.8		62.8		83.3		—		305.9
Deferred income taxes	—		12.2		20.2		—		32.4
Goodwill	404.9		30.0		128.2		—		563.1
Intangible assets, net	9.4		174.6		217.5		—		401.5
Other assets	60.5		8.4		26.3		—		95.2
Total assets	$	6,395.2	$	4,396.8	$	1,699.7	$	(9,862.1)	$	2,629.6
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	—	$	—	$	0.6	$	—	$	0.6
Current portion of long-term debt	163.7		—		0.1		—		163.8
Accounts payable	95.1		55.3		95.2		—		245.6
Accrued expenses and other	149.4		75.3		179.0		—		403.7
Intercompany payables	4,390.2		3,552.4		893.6		(8,836.2)		—
Long-term debt	3,229.5		—		72.8		—		3,302.3
Other long-term liabilities	272.5		109.5		32.3		—		414.3
Total liabilities	8,300.4		3,792.5		1,273.6		(8,836.2)		4,530.3
Stockholder’s (deficiency) equity	(1,905.2)		604.3		426.1		(1,025.9)		(1,900.7)
Total liabilities and stockholder’s (deficiency) equity	$	6,395.2	$	4,396.8	$	1,699.7	$	(9,862.1)	$	2,629.6


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of December 31, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	5.5	$	2.5	$	89.1	$	—	$	97.1
Trade receivables, less allowances for doubtful accounts	86.0		95.7		170.6		—		352.3
Inventories, net	121.3		147.7		193.6		—		462.6
Prepaid expenses and other	220.6		24.6		55.3		—		300.5
Intercompany receivables	3,592.2		3,549.6		614.1		(7,755.9)		—
Investment in subsidiaries	1,653.6		2.3		—		(1,655.9)		—
Property, plant and equipment, net	178.5		72.1		101.4		—		352.0
Deferred income taxes	—		10.6		23.5		—		34.1
Goodwill	48.9		264.0		250.8		—		563.7
Intangible assets, net	10.0		187.8		233.0		—		430.8
Other assets	67.9		9.3		31.9		—		109.1
Total assets	$	5,984.5	$	4,366.2	$	1,763.3	$	(9,411.8)	$	2,702.2
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	—	$	—	$	2.5	$	—	$	2.5
Current portion of long-term debt	159.2		—		58.3		—		217.5
Accounts payable	72.5		48.0		82.8		—		203.3
Accrued expenses and other	144.1		61.7		217.4		—		423.2
Intercompany payables	3,897.1		3,162.0		696.6		(7,755.7)		—
Long-term debt	3,104.7		—		0.3		—		3,105.0
Other long-term liabilities	377.3		33.8		42.6		—		453.7
Total liabilities	7,754.9		3,305.5		1,100.5		(7,755.7)		4,405.2
Stockholder’s (deficiency) equity	(1,770.4)		1,060.7		662.8		(1,656.1)		(1,703.0)
Total liabilities and stockholder’s (deficiency) equity	$	5,984.5	$	4,366.2	$	1,763.3	$	(9,411.8)	$	2,702.2

Condensed Consolidating Statement of Operations and and Comprehensive (Loss) Income



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended September 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	103.1	$	162.2	$	255.8	$	—	$	521.1
Cost of sales	56.7		72.4		92.1		—		221.2
Gross profit	46.4		89.8		163.7		—		299.9
Selling, general and administrative expenses	74.0		65.9		114.6		—		254.5
Acquisition and integration costs	0.6		—		—		—		0.6
Restructuring charges and other, net	6.7		0.3		2.0		—		9.0
Impairment charges	—		—		—		—		—
Loss (gain) on divested assets	0.1		—		—		—		0.1
Operating (loss) income	(35.0)		23.6		47.1		—		35.7
Other (income) expense:
Intercompany interest, net	(3.1)		0.7		2.4		—		—
Interest expense	58.7		—		4.4		—		63.1
Amortization of debt issuance costs	8.7		—		—		—		8.7
Gain on early extinguishment of debt	—		—		—		—		—
Foreign currency losses (gains), net	—		0.6		9.3		—		9.9
Miscellaneous, net	194.4		(115.1)		(79.2)		—		0.1
Other expense (income), net	258.7		(113.8)		(63.1)		—		81.8
(Loss) income from continuing operations before income taxes	(293.7)		137.4		110.2		—		(46.1)
(Benefit from) provision for income taxes	—		3.2		2.3		—		5.5
(Loss) income from continuing operations, net of taxes	(293.7)		134.2		107.9		—		(51.6)

Equity in income (loss) of subsidiaries	243.9		92.5		—		(336.4)		—
Net (loss) income	$	(49.8)	$	226.7	$	107.9	$	(336.4)	$	(51.6)
Other comprehensive income (loss)	2.9		3.9		(2.5)		(1.4)		2.9
Total comprehensive (loss) income	$	(46.9)	$	230.6	$	105.4	$	(337.8)	$	(48.7)



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended September 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	95.7	$	148.9	$	232.4	$	0.1	$	477.1
Cost of sales	45.6		92.6		96.0		0.1		234.3
Gross profit	50.1		56.3		136.4		—		242.8
Selling, general and administrative expenses	84.4		47.7		119.3		—		251.4
Acquisition and integration costs	0.8		—		0.1		—		0.9
Restructuring charges and other, net	(8.4)		2.7		5.0		—		(0.7)
Impairment charges	(23.4)		22.0		1.4		—		—
Gain on divested assets	(1.1)		—		—		—		(1.1)
Operating (loss) income	(2.2)		(16.1)		10.6		—		(7.7)
Other (income) expense:
Intercompany interest, net	(0.5)		0.7		(0.2)		—		—
Interest expense	67.3		—		1.4		—		68.7
Amortization of debt issuance costs	7.8		—		—		—		7.8
Gain on early extinguishment of debt, net	(31.2)		—		—		—		(31.2)
Foreign currency losses (gains), net	1.0		(0.7)		(10.1)		—		(9.8)
Miscellaneous, net	(1.8)		(55.4)		54.6		—		(2.6)
Other expense (income), net	42.6		(55.4)		45.7		—		32.9
(Loss) income from continuing operations before income taxes	(44.8)		39.3		(35.1)		—		(40.6)
(Benefit from) provision for income taxes	(6.3)		17.8		(9.2)		—		2.3
Loss (income) from continuing operations, net of taxes	(38.5)		21.5		(25.9)		—		(42.9)

Equity in income (loss) of subsidiaries	30.0		(10.0)		—		(20.0)		—
Net (loss) income	$	(8.5)	$	11.5	$	(25.9)	$	(20.0)	$	(42.9)
Other comprehensive income (loss)	5.0		(7.1)		1.6		5.5		5.0
Total comprehensive (loss) income	$	(3.5)	$	4.4	$	(24.3)	$	(14.5)	$	(37.9)



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Nine Months Ended September 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	311.6	$	411.6	$	740.3	$	—	$	1,463.5
Cost of sales	155.4		182.8		270.5		—		608.7
Gross profit	156.2		228.8		469.8		—		854.8
Selling, general and administrative expenses	262.8		178.9		350.0		—		791.7
Acquisition, integration and divestiture costs	1.7		—		0.1		—		1.8
Restructuring charges and other, net	13.5		2.5		6.8		—		22.8

(Gain) loss on divested assets	(1.7)		—		—		—		(1.7)
Operating (loss) income	(120.1)		47.4		112.9		—		40.2
Other (income) expense:
Intercompany interest, net	(3.9)		1.9		2.0		—		—
Interest expense	178.4		—		5.5		—		183.9
Amortization of debt issuance costs	30.7		—		—		—		30.7

Foreign currency losses, net	(0.2)		(0.3)		12.0		—		11.5
Miscellaneous, net	231.1		(126.9)		(101.4)		—		2.8
Other expense (income), net	436.1		(125.3)		(81.9)		—		228.9
(Loss) income from operations before income taxes	(556.2)		172.7		194.8		—		(188.7)
Provision for (benefit from) for income taxes	—		4.6		19.3		—		23.9
(Loss) income from operations, net of taxes	(556.2)		168.1		175.5		—		(212.6)

Equity in income (loss) of subsidiaries	353.9		102.2		—		(456.1)		—
Net (loss) income	$	(202.3)	$	270.3	$	175.5	$	(456.1)	$	(212.6)
Other comprehensive (loss) income	4.5		8.1		—		(8.1)		4.5
Total comprehensive (loss) income	$	(197.8)	$	278.4	$	175.5	$	(464.2)	$	(208.1)


Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Nine Months Ended September 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	305.9	$	339.6	$	632.2	$	—	$	1,277.7
Cost of sales	158.5		190.5		251.7		—		600.7
Gross profit	147.4		149.1		380.5		—		677.0
Selling, general and administrative expenses	247.6		163.8		321.8		—		733.2
Acquisition, integration and divestiture costs	4.0		—		0.2		—		4.2
Restructuring charges and other, net	32.3		7.0		5.5		—		44.8
Impairment charges	120.7		22.0		1.4		—		144.1
Loss on divested assets	(0.5)		—		—		—		(0.5)
Operating (loss) income	(256.7)		(43.7)		51.6		—		(248.8)
Other (income) expenses:
Intercompany interest, net	(3.5)		1.8		1.7		—		—
Interest expense	173.0		—		5.0		—		178.0
Amortization of debt issuance costs	17.8		—		—		—		17.8
Gain on early extinguishment of debt, net	(43.1)		—		—		—		(43.1)
Foreign currency losses, net	1.6		1.7		5.8		—		9.1
Miscellaneous, net	(0.9)		(71.5)		86.3		—		13.9
Other expense (income), net	144.9		(68.0)		98.8		—		175.7
Loss from operations before income taxes	(401.6)		24.3		(47.2)		—		(424.5)
Benefit from income taxes	(58.4)		19.2		(5.0)		—		(44.2)
(Loss) income from operations, net of taxes	(343.2)		5.1		(42.2)		—		(380.3)

Equity in (loss) income of subsidiaries	0.7		(36.9)		—		36.2		—
Net (loss) income	$	(342.5)	$	(31.8)	$	(42.2)	$	36.2	$	(380.3)
Other comprehensive (loss) income	16.6		7.3		4.0		(11.3)		16.6
Total comprehensive (loss) income	$	(325.9)	$	(24.5)	$	(38.2)	$	24.9	$	(363.7)

Condensed Consolidating Statements of Cash Flows


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Nine Months Ended September 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash provided by (used in) operating activities	$	(418.6)	$	57.7	$	274.2	$	—	$	(86.7)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities	(1.9)		(0.8)		(1.5)		—		(4.2)



CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	(4.5)		(5.6)		(2.4)		—		(12.5)
Borrowings on term loans	305.0		—		—		—		305.0

Repayments on term loans	(186.7)		—		—		—		(186.7)
Net (repayments) borrowings under the revolving credit facilities	(2.7)		—		—		—		(2.7)


Payment of financing costs	(17.9)		—		—		—		(17.9)
Tax withholdings related to net share settlements of restricted stock and RSUs	(2.4)		—		—		—		(2.4)
Other financing activities	(0.2)		(0.1)		—		—		(0.3)
Net cash provided by (used in) financing activities	90.6		(5.7)		(2.4)		—		82.5
Effect of exchange rate changes on cash, cash equivalents and restricted cash	349.5		(57.8)		(294.1)		—		(2.4)
Net increase (decrease) in cash, cash equivalents and restricted cash	19.6		(6.6)		(23.8)		—		(10.8)
Cash, cash equivalents and restricted cash at beginning of period	$	6.5	$	7.8	$	88.2	$	—	$	102.5
Cash, cash equivalents and restricted cash at end of period	$	26.1	$	1.2	$	64.4	$	—	$	91.7


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Nine Months Ended September 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(260.0)	$	6.6	$	(3.5)	$	—	$	(256.9)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities	(6.0)		(0.5)		(0.9)		—		(7.4)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	2.5		(3.8)		0.6		—		(0.7)
Borrowings on term loans	880.0		—		—		—		880.0
Repayments on Term Loans	(354.7)		—		—		—		(354.7)
Net (repayments) borrowings under the revolving credit facilities	19.5		—		—		—		19.5
Payments of financing costs	(109.4)		—		1.1		—		(108.3)
Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		—		—		—		(1.6)
Other financing activities	(0.1)		(0.1)		(0.1)		—		(0.3)
Net cash provided by (used in) financing activities	436.2		(3.9)		1.6		—		433.9
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0.4		2.0		(2.8)		—		(0.4)
Net increase (decrease) in cash, cash equivalents and restricted cash	170.6		4.2		(5.6)		—		169.2
Cash, cash equivalents and restricted cash at beginning of period	$	1.0	$	6.4	97.2		$	—	104.5
Cash, cash equivalents and restricted cash at end of period	$	171.6	$	10.6	$	91.6	$	—	$	273.7

DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Liquidity position	$ 121.9
Cash and cash equivalents	73.3	$ 97.1
Outstanding checks	4.6
2016 Revolving Credit Agreement
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Remaining borrowing capacity	53.2
Amount outstanding	316.2
Foreign Subsidiaries
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Cash and cash equivalents	$ 67.1

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

RESTRUCTURING CHARGES - Narrative (Details) - RGGA Program - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring costs recognized to date	$ 96.8	$ 68.8
Employee severance, other personnel benefits and other costs
Restructuring Cost and Reserve [Line Items]
Restructuring costs recognized to date	73.3	$ 50.5
Lease and other restructuring-related charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs recognized to date	$ 23.5

RESTRUCTURING CHARGES - Restructuring and Related Charges Activity (Details) $ in Millions	9 Months Ended
	Sep. 30, 2021 USD ($)
Total Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges incurred during period	$ 22.8
RGGA Program
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	68.8
Charges incurred during period	28.0
Charges incurred through end of period	96.8
RGGA Program \| Total Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	50.5
Charges incurred during period	22.8
Charges incurred through end of period	73.3
RGGA Program \| Employee Severance and Other Personnel Benefits
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	48.6
Charges incurred during period	3.5
Charges incurred through end of period	52.1
RGGA Program \| Other Costs
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	1.9
Charges incurred during period	19.3
Charges incurred through end of period	21.2
RGGA Program \| Leases
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	12.6
Charges incurred during period	3.9
Charges incurred through end of period	16.5
RGGA Program \| Other Related Charges
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	5.7
Charges incurred during period	1.3
Charges incurred through end of period	$ 7.0

RESTRUCTURING CHARGES - Restructuring and Related Charges by Segment (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
RGGA Program
Restructuring Cost and Reserve [Line Items]
Charges incurred during period	$ 28.0
Cumulative charges incurred	96.8	$ 68.8
Total Restructuring Charges
Restructuring Cost and Reserve [Line Items]
Charges incurred during period	22.8
Total Restructuring Charges \| RGGA Program
Restructuring Cost and Reserve [Line Items]
Charges incurred during period	22.8
Cumulative charges incurred	73.3	$ 50.5
Total Restructuring Charges \| RGGA Program \| Operating segments
Restructuring Cost and Reserve [Line Items]
Charges incurred during period	22.8
Cumulative charges incurred	73.3
Total Restructuring Charges \| RGGA Program \| Operating segments \| Revlon
Restructuring Cost and Reserve [Line Items]
Charges incurred during period	6.5
Cumulative charges incurred	27.2
Total Restructuring Charges \| RGGA Program \| Operating segments \| Elizabeth Arden
Restructuring Cost and Reserve [Line Items]
Charges incurred during period	8.0
Cumulative charges incurred	17.4
Total Restructuring Charges \| RGGA Program \| Operating segments \| Portfolio
Restructuring Cost and Reserve [Line Items]
Charges incurred during period	3.9
Cumulative charges incurred	17.5
Total Restructuring Charges \| RGGA Program \| Operating segments \| Fragrance
Restructuring Cost and Reserve [Line Items]
Charges incurred during period	4.4
Cumulative charges incurred	$ 11.2

RESTRUCTURING CHARGES - Restructuring Reserve (Details) $ in Millions	9 Months Ended
	Sep. 30, 2021 USD ($)
Total Restructuring Charges
Restructuring Reserve [Roll Forward]
Liability Balance at period start	$ 13.8
Expense, Net	22.8
Cash Utilized, Net	(33.1)
Liability Balance at period end	3.5
RGGA:
Restructuring Reserve [Roll Forward]
Expense, Net	28.0
RGGA: \| Total Restructuring Charges
Restructuring Reserve [Roll Forward]
Liability Balance at period start	12.6
Expense, Net	22.8
Cash Utilized, Net	(32.8)
Liability Balance at period end	2.6
RGGA: \| Employee severance and other personnel benefits
Restructuring Reserve [Roll Forward]
Liability Balance at period start	12.6
Expense, Net	3.5
Cash Utilized, Net	(13.5)
Liability Balance at period end	2.6
RGGA: \| Other Costs
Restructuring Reserve [Roll Forward]
Liability Balance at period start	0.0
Expense, Net	19.3
Cash Utilized, Net	(19.3)
Liability Balance at period end	0.0
Other restructuring initiatives: \| Total Restructuring Charges
Restructuring Reserve [Roll Forward]
Liability Balance at period start	1.2
Expense, Net	0.0
Cash Utilized, Net	(0.3)
Liability Balance at period end	0.9
Other restructuring initiatives: \| Employee severance and other personnel benefits
Restructuring Reserve [Roll Forward]
Liability Balance at period start	1.2
Expense, Net	0.0
Cash Utilized, Net	(0.3)
Liability Balance at period end	$ 0.9

INVENTORIES (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Finished goods	$ 329.0	$ 356.7
Raw materials and supplies	116.3	97.1
Work-in-process	16.2	8.8
Inventories	$ 461.5	$ 462.6

PROPERTY, PLANT AND EQUIPMENT - Property, Plant and Equipment (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Right-of-Use assets	$ 75.6	$ 87.0
Property, plant and equipment and Right-of-Use assets, net	305.9	352.0
Land and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	10.9	11.4
Building and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	44.7	48.3
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	86.8	98.7
Office furniture, fixtures and capitalized software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	63.6	76.2
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	18.7	21.3
Construction-in-progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	$ 5.6	$ 9.1

PROPERTY, PLANT AND EQUIPMENT - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 16.5	$ 18.3	$ 50.7	$ 59.3
Property, plant and equipment, accumulated depreciation	$ 559.9		$ 559.9		$ 528.9

GOODWILL AND INTANGIBLE ASSETS, NET - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment charge	$ 0	$ 0	$ 0	$ 111,000,000
Finite-lived intangible assets impairment	0	0	0	0
Indefinite-lived intangible assets impairment	0	0	0	33,100,000
Amortization expense	$ 9,100,000	$ 8,300,000	$ 26,100,000	$ 25,000,000

GOODWILL AND INTANGIBLE ASSETS, NET - Changes in Goodwill by Segment (Details) $ in Millions	9 Months Ended
	Sep. 30, 2021 USD ($)
Goodwill [Roll Forward]
Beginning Balance	$ 563.7
Ending Balance	563.1
Operating segments
Goodwill [Roll Forward]
Beginning Balance	563.7
Foreign currency translation adjustment	(0.6)
Ending Balance	563.1
Cumulative goodwill impairment charges	(166.2)
Operating segments \| Revlon
Goodwill [Roll Forward]
Beginning Balance	265.4
Foreign currency translation adjustment	(0.2)
Ending Balance	265.2
Operating segments \| Portfolio
Goodwill [Roll Forward]
Beginning Balance	87.9
Foreign currency translation adjustment	(0.2)
Ending Balance	87.7
Operating segments \| Elizabeth Arden
Goodwill [Roll Forward]
Beginning Balance	89.5
Foreign currency translation adjustment	(0.1)
Ending Balance	89.4
Operating segments \| Fragrance
Goodwill [Roll Forward]
Beginning Balance	120.9
Foreign currency translation adjustment	(0.1)
Ending Balance	$ 120.8

GOODWILL AND INTANGIBLE ASSETS, NET - Summary of Intangible Assets (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 574.5	$ 578.6
Accumulated Amortization	(285.7)	(263.7)
Impairment	0.0	0.0
Net Carrying Amount	288.8	314.9
Indefinite-lived Intangible Assets [Line Items]
Gross Carrying Amount	145.8	149.0
Impairment	(33.1)	(33.1)
Net Carrying Amount	112.7	115.9
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Gross Carrying Amount	720.3	727.6
Accumulated Amortization	(285.7)	(263.7)
Impairment	(33.1)	(33.1)
Net Carrying Amount	401.5	430.8
Trade names
Indefinite-lived Intangible Assets [Line Items]
Gross Carrying Amount	145.8	149.0
Impairment	(33.1)	(33.1)
Net Carrying Amount	112.7	115.9
Trademarks and licenses
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	271.1	272.8
Accumulated Amortization	(139.2)	(128.6)
Impairment	0.0	0.0
Net Carrying Amount	$ 131.9	$ 144.2
Weighted-Average Useful Life (in Years)	12 years	12 years
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (139.2)	$ (128.6)
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	247.4	249.9
Accumulated Amortization	(119.5)	(110.7)
Impairment	0.0	0.0
Net Carrying Amount	$ 127.9	$ 139.2
Weighted-Average Useful Life (in Years)	10 years	11 years
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (119.5)	$ (110.7)
Patents and internally-developed intellectual property
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	23.7	23.6
Accumulated Amortization	(16.9)	(15.6)
Impairment	0.0	0.0
Net Carrying Amount	$ 6.8	$ 8.0
Weighted-Average Useful Life (in Years)	4 years	5 years
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (16.9)	$ (15.6)
Distribution rights
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	31.0	31.0
Accumulated Amortization	(8.8)	(7.5)
Impairment	0.0	0.0
Net Carrying Amount	$ 22.2	$ 23.5
Weighted-Average Useful Life (in Years)	13 years	14 years
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (8.8)	$ (7.5)
Other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1.3	1.3
Accumulated Amortization	(1.3)	(1.3)
Impairment	0.0	0.0
Net Carrying Amount	$ 0.0	$ 0.0
Weighted-Average Useful Life (in Years)	0 years	0 years
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (1.3)	$ (1.3)

GOODWILL AND INTANGIBLE ASSETS, NET - Estimated Future Amortization Expense (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
2021	$ 8.3
2022	32.6
2023	30.8
2024	27.5
2025	26.3
Thereafter	163.3
Net Carrying Amount	$ 288.8	$ 314.9

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES - Components of Accrued Expenses and Other (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Schedule of Accrued Liabilities [Line Items]
Advertising, marketing and promotional costs	$ 99.0	$ 96.3
Sales returns and allowances	74.9	95.5
Taxes	54.2	41.8
Compensation and related benefits	44.4	50.1
Interest	24.0	29.6
Freight and distribution costs	17.6	9.5
Professional services and insurance	14.7	18.6
Short-term lease liability	14.3	16.6
Restructuring reserve	3.5	13.8
Software	2.2	3.1
Other	51.7	46.0
Total	400.5	420.9
Revlon Consumer Products Corporation
Schedule of Accrued Liabilities [Line Items]
Taxes	57.3	44.8
Total	$ 403.7	$ 423.2

DEBT - Components of Long-term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Long-term debt	$ 3,466.1	$ 3,322.5
Less current portion	(163.8)	(217.5)
Long-term debt	3,302.3	3,105.0
Short-term borrowings	$ 0.6	$ 2.5
Weighted-average interest rate (as a percent)	11.40%	11.70%
Amended 2016 Revolving Credit Facility (Tranche A) due 2024
Debt Instrument [Line Items]
Long-term debt	$ 134.5	$ 136.7
SISO Term Loan Facility due 2024
Debt Instrument [Line Items]
Long-term debt	125.8	0.0
2021 Foreign Asset-Based Term Facility due 2024
Debt Instrument [Line Items]
Long-term debt	70.7	0.0
2020 ABL FILO Term Loans due 2023
Debt Instrument [Line Items]
Long-term debt	50.0	50.0
2020 Troubled-debt-restructuring: future interest
Debt Instrument [Line Items]
Long-term debt	46.2	57.8
2020 BrandCo Term Loan Facility due 2025
Debt Instrument [Line Items]
Long-term debt	1,742.9	1,719.8
2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025
Debt Instrument [Line Items]
Long-term debt	869.2	874.8
2018 Foreign Asset-Based Term Facility due 2021
Debt Instrument [Line Items]
Long-term debt	$ 0.0	57.7
6.25% Senior Notes due 2024
Debt Instrument [Line Items]
Stated interest rate (as a percent)	6.25%
Long-term debt	$ 426.5	425.4
Spanish Government Loan due 2025
Debt Instrument [Line Items]
Long-term debt	$ 0.3	$ 0.3

DEBT - Narrative (Details)					3 Months Ended		9 Months Ended
DEBT - Narrative (Details)	May 07, 2021 USD ($)	May 06, 2021 USD ($)	Mar. 08, 2021 USD ($)	Mar. 02, 2021 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Mar. 07, 2021 USD ($)	Dec. 31, 2020 USD ($)
Debt Instrument [Line Items]
Selling, general and administrative expenses					$ 256,100,000	$ 253,400,000	$ 796,000,000.0	$ 739,100,000
Amortization of debt issuance costs					8,700,000	7,800,000	30,700,000	17,800,000
Proceeds from long-term lines of credit								19,500,000
Held in escrow					18,400,000	5,400,000	18,400,000	5,400,000
Revlon Consumer Products Corporation
Debt Instrument [Line Items]
Selling, general and administrative expenses					254,500,000	251,400,000	791,700,000	733,200,000
Amortization of debt issuance costs					8,700,000	7,800,000	30,700,000	17,800,000
Proceeds from long-term lines of credit								19,500,000
Held in escrow					18,400,000	$ 5,400,000	18,400,000	$ 5,400,000
2016 Revolving Credit Agreement \| Revolving credit facility \| Revlon Consumer Products Corporation
Debt Instrument [Line Items]
Covenant springing maturity, number of days prior to the maturity date	91 days
Minimum excess available reserve requirement, fixed charge coverage ratio greater than 1.0		$ 20,000,000
Minimum excess available reserve requirement, fixed charge coverage ratio less than 1.00x		30,000,000
Springing minimum fixed charge coverage ratio based on excess availability triggering event	1.00
Springing minimum fixed charge cover ratio triggering event, excess availability threshold	$ 27,500,000
Springing cash dominion requirement triggering event, excess availability threshold	45,000,000
Tranche A Revolving Credit Facility \| Revolving credit facility \| Revlon Consumer Products Corporation
Debt Instrument [Line Items]
Maximum borrowing capacity	270,000,000	$ 300,000,000	$ 300,000,000		270,000,000.0		270,000,000.0
Selling, general and administrative expenses							800,000
Amortization of debt issuance costs							4,700,000
Deferred financing cots incurred	$ 2,100,000		4,200,000
Unamortized deferred financing costs			$ 5,100,000
Increase in interest margin			0.50%
Tranche A Revolving Credit Facility \| Revolving credit facility \| Revlon Consumer Products Corporation \| Minimum
Debt Instrument [Line Items]
Basis spread on variable interest rate			2.50%
Tranche A Revolving Credit Facility \| Revolving credit facility \| Revlon Consumer Products Corporation \| Maximum
Debt Instrument [Line Items]
Basis spread on variable interest rate			3.00%
Tranche A Revolving Credit Facility \| Revolving credit facility \| Revlon Consumer Products Corporation \| LIBOR
Debt Instrument [Line Items]
Basis spread on variable interest rate	3.75%
Variable rate floor	0.50%	1.75%
Tranche A Revolving Credit Facility \| Revolving credit facility \| Revlon Consumer Products Corporation \| LIBOR \| Minimum
Debt Instrument [Line Items]
Basis spread on variable interest rate		2.50%
Tranche A Revolving Credit Facility \| Revolving credit facility \| Revlon Consumer Products Corporation \| LIBOR \| Maximum
Debt Instrument [Line Items]
Basis spread on variable interest rate		3.00%
SISO Term Loan Facility \| Revolving credit facility \| Revlon Consumer Products Corporation
Debt Instrument [Line Items]
Deferred financing cots incurred			$ 4,300,000
SISO Term Loan Facility \| Secured debt \| Revlon Consumer Products Corporation
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 130,000,000	$ 100,000,000	100,000,000		130,000,000.0		130,000,000.0
Selling, general and administrative expenses							400,000
Amortization of debt issuance costs							1,400,000
Deferred financing cots incurred	$ 900,000
Unamortized deferred financing costs		$ 4,000,000
Proceeds from long-term lines of credit			$ 100,000,000
SISO Term Loan Facility \| Secured debt \| Revlon Consumer Products Corporation \| LIBOR
Debt Instrument [Line Items]
Basis spread on variable interest rate			5.75%
Variable rate floor			1.75%
Amended 2016 Revolving Credit Facility due 2021, Tranche A \| Revolving credit facility \| Revlon Consumer Products Corporation
Debt Instrument [Line Items]
Maximum borrowing capacity									$ 400,000,000
Unamortized deferred financing costs									$ 800,000
2021 Foreign Asset-Based Term Facility \| Secured debt \| Revlon Consumer Products Corporation
Debt Instrument [Line Items]
Maximum borrowing capacity				$ 75,000,000
Amortization of debt issuance costs					0		1,000,000
Deferred financing cots incurred				3,200,000
Held in escrow				$ 7,500,000	$ 13,800,000		$ 13,800,000
Borrowing base calculation, percentage of eligible accounts receivable				80.00%
Borrowing base calculation, percentage of eligible inventory				65.00%
Borrowing base calculation, percentage of eligible real property				45.00%
Prepayment premium, first year after the closing date				3.00%
Prepayment premium, second year after the closing date				2.00%
Prepayment premium, third year after the closing date and thereafter				1.00%
Covenant, minimum cash and cash equivalents				$ 3,500,000
Covenant, minimum cash and cash equivalents, business days prior to month end				10 days
2021 Foreign Asset-Based Term Facility \| Secured debt \| Revlon Consumer Products Corporation \| LIBOR
Debt Instrument [Line Items]
Basis spread on variable interest rate				8.50%
Variable rate floor				1.50%
5.75% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)					5.75%		5.75%
5.75% Senior Notes \| Revlon Consumer Products Corporation
Debt Instrument [Line Items]
Stated interest rate (as a percent)					5.75%		5.75%			5.75%
2020 Troubled-debt-restructuring: future interest
Debt Instrument [Line Items]
Future interest payments included in restructured debt										$ 57,800,000
Future interest amortization					$ 3,700,000		$ 11,600,000

DEBT - Covenants (Details) - USD ($)	Sep. 30, 2021	May 07, 2021	May 06, 2021	Mar. 08, 2021
6.25% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	6.25%
Revlon Consumer Products Corporation \| 6.25% Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	6.25%
Revlon Consumer Products Corporation \| 2020 ABL FILO Term Loans
Debt Instrument [Line Items]
Commitment	$ 50,000,000.0
Borrowing Base	40,600,000
Aggregate principal amount outstanding	50,000,000.0
Availability	0
Reserve for shortfall of the borrowing base	9,400,000
Revlon Consumer Products Corporation \| Revolving credit facility \| Tranche A Revolving Credit Facility
Debt Instrument [Line Items]
Commitment	270,000,000.0	$ 270,000,000	$ 300,000,000	$ 300,000,000
Borrowing Base	189,400,000
Aggregate principal amount outstanding	136,200,000
Availability	53,200,000
Revlon Consumer Products Corporation \| Secured debt \| SISO Term Loan Facility
Debt Instrument [Line Items]
Commitment	130,000,000.0	$ 130,000,000	$ 100,000,000	$ 100,000,000
Borrowing Base	130,000,000.0
Aggregate principal amount outstanding	130,000,000.0
Availability	$ 0

DEBT - Foreign Subsidiaries (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Cash and cash equivalents	$ 73.3	$ 97.1
Foreign Subsidiaries
Debt Instrument [Line Items]
Cash and cash equivalents	$ 67.1

FAIR VALUE MEASUREMENTS - Schedule of Fair Values of Financial Liabilities (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Financial assets required to be measured at fair value	$ 0	$ 0
Financial liabilities required to be measured at fair value	0	0
Liabilities:
Long-term debt, including current portion, Fair Value	2,531,200,000	2,168,900,000
Long-term debt, including current portion, Carrying Value	3,466,100,000	3,322,500,000
Level 1
Liabilities:
Long-term debt, including current portion, Fair Value	0	0
Level 2
Liabilities:
Long-term debt, including current portion, Fair Value	2,531,200,000	2,168,900,000
Level 3
Liabilities:
Long-term debt, including current portion, Fair Value	$ 0	$ 0

Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.

FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Standby letters of credit which support products corporations workers compensation, general liability and automobile insurance programs
Fair Value Measurements Of Financial Instruments [Line Items]
Standby and trade letters of credit for various corporate purposes	$ 6.6	$ 5.3
Sublimit, letters of credit
Fair Value Measurements Of Financial Instruments [Line Items]
Standby and trade letters of credit for various corporate purposes	$ 9.1	$ 7.8

PENSION AND POST-RETIREMENT BENEFITS - Components of Net Periodic Benefit Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Net periodic benefit costs:
Total net periodic benefit costs	$ 1.3	$ 1.5	$ 3.6	$ 4.2	$ 4.0
Pension Plans
Net periodic benefit costs:
Service cost	0.4	0.5	1.1	1.3
Interest cost	2.3	3.8	6.9	11.2
Expected return on plan assets	(4.9)	(5.7)	(14.8)	(17.1)
Amortization of actuarial loss	3.3	2.7	9.9	8.3
Total net periodic benefit costs prior to allocation	1.1	1.3	3.1	3.7
Portion allocated to Revlon Holdings	0.0	0.0	(0.1)	(0.1)
Total net periodic benefit costs	1.1	1.3	3.0	3.6
Other Post-Retirement Benefit Plans
Net periodic benefit costs:
Service cost	0.0	0.0	0.0	0.0
Interest cost	0.0	0.1	0.1	0.3
Expected return on plan assets	0.0	0.0	0.0	0.0
Amortization of actuarial loss	0.2	0.1	0.5	0.3
Total net periodic benefit costs prior to allocation	0.2	0.2	0.6	0.6
Portion allocated to Revlon Holdings	0.0	0.0	0.0	0.0
Total net periodic benefit costs	$ 0.2	$ 0.2	$ 0.6	$ 0.6

PENSION AND POST-RETIREMENT BENEFITS - Narrative (Details) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($) plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost	$ 1.3	$ 1.5	$ 3.6	$ 4.2		$ 4.0
Minimum
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Aggregate employer contributions during 2021	21.0		21.0
Maximum
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Aggregate employer contributions during 2021	24.0		24.0
Forecast
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost					$ 5.0
Pension Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost	1.1	1.3	3.0	3.6
Employer contributions	3.1		19.9
Pension Plans \| Qualified Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions, expected deferral in 2020, CARES Act						$ 11.8
Number of qualified defined benefit plans \| plan						2
Other Post-Retirement Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost	0.2	$ 0.2	0.6	$ 0.6
Employer contributions	$ 0.2		$ 0.6

PENSION AND POST-RETIREMENT BENEFITS - Classification of Net Periodic Pension (Income) Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Total net periodic benefit costs	$ 1.3	$ 1.5	$ 3.6	$ 4.2	$ 4.0
Selling, general and administrative expense
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Total net periodic benefit costs	0.4	0.5	1.1	1.3
Miscellaneous, net
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Total net periodic benefit costs	$ 0.9	$ 1.0	$ 2.5	$ 2.9

STOCK COMPENSATION PLAN - Narrative (Details)		3 Months Ended					9 Months Ended		12 Months Ended	25 Months Ended	33 Months Ended
STOCK COMPENSATION PLAN - Narrative (Details)	Jun. 03, 2021 shares	Sep. 30, 2021 USD ($) shares	Jun. 30, 2021 shares	Mar. 31, 2021 shares	Jun. 30, 2020 shares	Mar. 31, 2020 shares	Sep. 30, 2021 USD ($) shares	Sep. 30, 2020 USD ($) shares	Dec. 31, 2019 USD ($) installment	Sep. 30, 2021 USD ($) shares	Sep. 30, 2021 USD ($) shares	Dec. 31, 2020 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation amortization \| $							$ 10,400,000	$ 8,600,000
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated cost \| $										$ 2,000,000
Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional shares reserved (in shares) \| shares	2,000,000
Shares reserved for issuance (in shares) \| shares		8,565,000					8,565,000			8,565,000	8,565,000
Shares remaining available for grants (in shares) \| shares		2,700,000					2,700,000			2,700,000	2,700,000
Revlon 2019 Transaction Incentive Program \| Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated cost \| $							$ 1,800,000
Revlon 2019 Transaction Incentive Program \| Time-Based Restricted Stock Units (RSU) Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares) \| shares			78,000
Revlon 2019 Transaction Incentive Program \| Time-Based Restricted Stock Units (RSU) Awards \| First Tranche
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage							50.00%
Revlon 2019 Transaction Incentive Program \| Time-Based Restricted Stock Units (RSU) Awards \| Second Tranche
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage							50.00%
Revlon 2019 Transaction Incentive Program, Tier 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash-based awards \| $									$ 6,800,000
Number of installments \| installment									2
Cash-based awards granted, net of forfeitures \| $											$ 1,400,000
Revlon 2019 Transaction Incentive Program, Tier 1 \| Acquisition, Integration and Divestiture Costs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash-based awards granted, amortization expense \| $		$ 400,000					$ 1,500,000				$ 4,500,000
Revlon 2019 Transaction Incentive Program, Tier 1 \| Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated vesting, number of awards (in shares) \| shares		355					6,540			47,743
Accelerated cost \| $		$ 0					$ 200,000
Revlon 2019 Transaction Incentive Program, Tier 1 \| Time-Based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted and outstanding (in shares) \| shares		121,891					121,891			121,891	121,891
Revlon 2019 Transaction Incentive Program, Tier 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash-based awards \| $									$ 2,500,000
Number of installments \| installment									1
LTIP Plan \| Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares) \| shares					0	1,300,000		0
Accelerated vesting, number of awards (in shares) \| shares		887					8,121			57,763
LTIP Plan \| Time-Based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares) \| shares		15,000	35,000	1,500,000
LTIP Plan \| Time-Based RSUs \| First Tranche
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage							50.00%
LTIP Plan \| Time-Based RSUs \| Second Tranche
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage							25.00%
LTIP Plan \| Time-Based RSUs \| Third Tranche
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage							25.00%
LTIP Plan \| Performance-Based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation amortization \| $		$ 500,000					$ 1,000,000
Deferred stock-based compensation \| $		$ 11,300,000					$ 11,300,000			$ 11,300,000	$ 11,300,000
LTIP Plan \| Time-Based Restricted Stock Units (RSU) Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted and outstanding (in shares) \| shares		1,811,200					1,811,200			1,811,200	1,811,200	732,200
Awards granted (in shares) \| shares							1,559,000
Total LTIP and TIP RSU's \| Time-Based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation amortization \| $		$ 3,400,000					$ 9,000,000
Deferred stock-based compensation \| $		$ 15,000,000					$ 15,000,000			$ 15,000,000	$ 15,000,000
Total LTIP and TIP RSU's \| Time-Based Restricted Stock Units (RSU) Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted and outstanding (in shares) \| shares		1,933,100					1,933,100			1,933,100	1,933,100	791,000.0

STOCK COMPENSATION PLAN - Activity Related to Time-based and Performance-based RSUs and the Grant Date Fair Value (Details) - $ / shares	3 Months Ended				9 Months Ended		25 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021
Revlon 2019 Transaction Incentive Program \| Time-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Awards granted (in shares)		78,000
Revlon 2019 Transaction Incentive Program \| 2019 \| Time-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					58,800
Awards granted (in shares)					80,100
Awards vested (in shares)					(8,900)
Awards forfeited/canceled (in shares)					(8,100)
Outstanding, end of period (in shares)	121,900				121,900		121,900
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in dollars per share)					$ 15.95
Awards granted, weighted average grant date fair value (in dollars per share)					13.11
Awards vested, weighted average grant date fair value (in dollars per share)					15.30
Awards forfeited/canceled, weighted average grant date fair value (in dollars per share)					15.11
Awards outstanding, weighted average grant date fair value (in dollars per share)	$ 14.09				$ 14.09		$ 14.09
Revlon 2019 Transaction Incentive Program, Tier 1 \| Restricted Stock Units
Weighted Average Grant Date Fair Value Per RSU
Accelerated vesting, number of awards (in shares)	355				6,540		47,743
LTIP Plan \| Time-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					732,200
Awards granted (in shares)					1,559,000
Awards vested (in shares)					(340,000.0)
Awards forfeited/canceled (in shares)					(140,000.0)
Outstanding, end of period (in shares)	1,811,200				1,811,200		1,811,200
LTIP Plan \| Performance-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					934,100
Awards granted (in shares)					0
Awards vested (in shares)					(38,500)
Awards forfeited/canceled (in shares)					(289,500)
Outstanding, end of period (in shares)	606,100				606,100		606,100
LTIP Plan \| Restricted Stock Units
Restricted Stock Units
Awards granted (in shares)			0	1,300,000		0
Weighted Average Grant Date Fair Value Per RSU
Accelerated vesting, number of awards (in shares)	887				8,121		57,763
LTIP Plan \| 2021 \| Time-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Awards granted (in shares)					1,559,000
Awards forfeited/canceled (in shares)					(81,200)
Outstanding, end of period (in shares)	1,477,800				1,477,800		1,477,800
Weighted Average Grant Date Fair Value Per RSU
Awards granted, weighted average grant date fair value (in dollars per share)					$ 10.77
Awards forfeited/canceled, weighted average grant date fair value (in dollars per share)					10.75
Awards outstanding, weighted average grant date fair value (in dollars per share)	$ 10.77				$ 10.77		$ 10.77
LTIP Plan \| 2021 \| Performance-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Awards granted (in shares)					0
Awards forfeited/canceled (in shares)					0
Outstanding, end of period (in shares)	0				0		0
Weighted Average Grant Date Fair Value Per RSU
Awards granted, weighted average grant date fair value (in dollars per share)					$ 0
Awards forfeited/canceled, weighted average grant date fair value (in dollars per share)					0
Awards outstanding, weighted average grant date fair value (in dollars per share)	$ 0				$ 0		$ 0
LTIP Plan \| 2020 \| Time-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					496,500
Awards granted (in shares)					0
Awards vested (in shares)					(182,700)
Awards forfeited/canceled (in shares)					(52,100)
Outstanding, end of period (in shares)	261,700				261,700		261,700
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in dollars per share)					$ 14.96
Awards granted, weighted average grant date fair value (in dollars per share)					0
Awards vested, weighted average grant date fair value (in dollars per share)					14.96
Awards forfeited/canceled, weighted average grant date fair value (in dollars per share)					14.96
Awards outstanding, weighted average grant date fair value (in dollars per share)	$ 14.96				$ 14.96		$ 14.96
LTIP Plan \| 2020 \| Performance-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					462,900
Awards granted (in shares)					0
Awards vested (in shares)					0
Awards forfeited/canceled (in shares)					(73,500)
Outstanding, end of period (in shares)	389,400				389,400		389,400
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in dollars per share)					$ 14.96
Awards granted, weighted average grant date fair value (in dollars per share)					0
Awards vested, weighted average grant date fair value (in dollars per share)					0
Awards forfeited/canceled, weighted average grant date fair value (in dollars per share)					14.96
Awards outstanding, weighted average grant date fair value (in dollars per share)	$ 14.96				$ 14.96		$ 14.96
LTIP Plan \| 2019 \| Time-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					169,300
Awards granted (in shares)					0
Awards vested (in shares)					(91,400)
Awards forfeited/canceled (in shares)					(6,200)
Outstanding, end of period (in shares)	71,700				71,700		71,700
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in dollars per share)					$ 22.55
Awards granted, weighted average grant date fair value (in dollars per share)					0
Awards vested, weighted average grant date fair value (in dollars per share)					22.53
Awards forfeited/canceled, weighted average grant date fair value (in dollars per share)					22.55
Awards outstanding, weighted average grant date fair value (in dollars per share)	$ 22.57				$ 22.57		$ 22.57
LTIP Plan \| 2019 \| Performance-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					255,300
Awards granted (in shares)					0
Awards vested (in shares)					0
Awards forfeited/canceled (in shares)					(38,600)
Outstanding, end of period (in shares)	216,700				216,700		216,700
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in dollars per share)					$ 22.55
Awards granted, weighted average grant date fair value (in dollars per share)					0
Awards vested, weighted average grant date fair value (in dollars per share)					0
Awards forfeited/canceled, weighted average grant date fair value (in dollars per share)					22.55
Awards outstanding, weighted average grant date fair value (in dollars per share)	$ 22.55				$ 22.55		$ 22.55
LTIP Plan \| 2018 \| Time-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					66,400
Awards granted (in shares)					0
Awards vested (in shares)					(65,900)
Awards forfeited/canceled (in shares)					(500)
Outstanding, end of period (in shares)	0				0		0
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in dollars per share)					$ 19.40
Awards granted, weighted average grant date fair value (in dollars per share)					0
Awards vested, weighted average grant date fair value (in dollars per share)					19.42
Awards forfeited/canceled, weighted average grant date fair value (in dollars per share)					16.80
Awards outstanding, weighted average grant date fair value (in dollars per share)	$ 0				$ 0		$ 0
LTIP Plan \| 2018 \| Performance-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					215,900
Awards granted (in shares)					0
Awards vested (in shares)					(38,500)
Awards forfeited/canceled (in shares)					(177,400)
Outstanding, end of period (in shares)	0				0		0
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in dollars per share)					$ 19.42
Awards granted, weighted average grant date fair value (in dollars per share)					0
Awards vested, weighted average grant date fair value (in dollars per share)					19.44
Awards forfeited/canceled, weighted average grant date fair value (in dollars per share)					19.42
Awards outstanding, weighted average grant date fair value (in dollars per share)	$ 0				$ 0		$ 0
Total LTIP and TIP RSU's \| Time-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					791,000.0
Outstanding, end of period (in shares)	1,933,100				1,933,100		1,933,100
Total LTIP and TIP RSU's \| Performance-Based Restricted Stock Units (RSU) Awards
Restricted Stock Units
Outstanding, beginning of period (in shares)					934,100
Outstanding, end of period (in shares)	606,100				606,100		606,100

INCOME TAXES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
INCOME TAXES (Details) - USD ($) $ in Millions	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Line Items]
Provision for (benefit from) income taxes	$ 5.4	$ 1.9	$ 23.8	$ (45.2)
Increase (decrease) in provision (benefit) from income taxes	3.5		69.0
Revlon Consumer Products Corporation
Income Tax Disclosure [Line Items]
Provision for (benefit from) income taxes	5.5	$ 2.3	23.9	$ (44.2)
Increase (decrease) in provision (benefit) from income taxes	$ 3.2		$ 68.1

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

ACCUMULATED OTHER COMPREHENSIVE LOSS - Roll-forward of Accumulated Other Comprehensive Loss (Details) - USD ($)

3 Months Ended

9 Months Ended

Sep. 30, 2021

Jun. 30, 2021

Mar. 31, 2021

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Sep. 30, 2021

Sep. 30, 2020

Foreign currency translation adjustment, net of tax

$ (2,020,000,000)

$ (1,958,700,000)

$ (1,862,000,000)

$ (1,548,500,000)

$ (1,435,800,000)

$ (1,221,200,000)

$ (1,862,000,000)

$ (1,221,200,000)

(600,000)

2,200,000

(6,000,000.0)

7,300,000

^[1],[2]

3,500,000

2,800,000

10,500,000

9,300,000

2,900,000

^[3]

3,000,000.0

^[3]

(1,400,000)

^[3]

5,000,000.0

^[3]

14,300,000

^[3]

(2,700,000)

^[3]

4,500,000

16,600,000

Foreign currency translation adjustment, tax expense (benefit)

(2,066,300,000)

(2,020,000,000)

(1,958,700,000)

(1,582,900,000)

(1,548,500,000)

(1,435,800,000)

(2,066,300,000)

(1,582,900,000)

Amortization of pension related costs, tax expense (benefit)

500,000

(700,000)

Accumulated Other Comprehensive (Loss) Income

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

(276,300,000)

(279,300,000)

(277,900,000)

(235,800,000)

(250,100,000)

(247,400,000)

(277,900,000)

(247,400,000)

^[3]

2,900,000

3,000,000.0

(1,400,000)

5,000,000.0

14,300,000

(2,700,000)

Foreign Currency Translation

(273,400,000)

$ (276,300,000)

(279,300,000)

$ (230,800,000)

$ (235,800,000)

$ (250,100,000)

(273,400,000)

$ (230,800,000)

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

Foreign currency translation adjustment, net of tax

(17,100,000)

(6,000,000.0)

(6,000,000.0)

Actuarial (Loss) Gain on Post-retirement Benefits

(23,100,000)

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

(260,500,000)

10,500,000

10,500,000

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

(250,000,000.0)

Other

$ (300,000)

(300,000)

$ (300,000)

[1]	Net of tax expense of nil and $0.5 million for the three months ended September 30, 2021 and 2020, respectively, and net of tax benefit of nil and $0.7 million for the nine months ended September 30, 2021 and 2020, respectively.
[2]	This amount is included in the computation of net periodic benefit costs (income). See Note 10, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).
[3]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the nine months ended September 30, 2021 and 2020, respectively.

SEGMENT DATA AND RELATED INFORMATION - Narrative (Details)	9 Months Ended
	Sep. 30, 2021 reporting_unit brand_team country
Segment Reporting Information [Line Items]
Number of reporting units \| reporting_unit	4
Number of global brand teams \| brand_team	4
International
Segment Reporting Information [Line Items]
Number of countries in which entity operates \| country	25

SEGMENT DATA AND RELATED INFORMATION - Net Sales and Segment Profit (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Net sales	$ 521.1	$ 477.1	$ 1,463.5	$ 1,277.7
Segment profit	34.1	(9.7)	35.9	(254.7)
Depreciation and amortization			96.8	108.3
Non-Operating items:
Acquisition, integration and divestiture costs	0.6	0.9	1.8	4.2
Loss (gain) on divested assets	0.1	(1.1)	(1.7)	(0.5)
Impairment charges	0.0	0.0	0.0	144.1
Operating income (loss)	34.1	(9.7)	35.9	(254.7)
Interest Expense	63.1	68.7	183.9	178.0
Amortization of debt issuance costs	8.7	7.8	30.7	17.8
Gain (loss) on early extinguishment of debt, net	0.0	(31.2)	0.0	(43.1)
Foreign currency losses (gains), net	9.9	(9.8)	11.5	9.1
Miscellaneous, net	0.1	(2.6)	2.8	13.9
(Loss) income from operations before income taxes	(47.7)	(42.6)	(193.0)	(430.4)
Operating segments
Segment Reporting Information [Line Items]
Net sales	521.1	477.1	1,463.5	1,277.7
Segment profit	82.4	54.5	184.5	128.3
Non-Operating items:
Operating income (loss)	82.4	54.5	184.5	128.3
Segment reconciling items
Segment Reporting Information [Line Items]
Depreciation and amortization	31.2	35.1	96.8	108.3
Non-cash stock compensation expense	3.9	5.1	10.4	8.6
Non-Operating items:
Restructuring and related charges	10.8	4.5	28.0	61.2
Acquisition, integration and divestiture costs	0.6	0.9	1.8	4.2
Loss (gain) on divested assets	0.1	(1.1)	(1.7)	(0.5)
Financial control remediation and sustainability actions and related charges	0.0	0.7	0.4	8.5
Excessive coupon redemptions	0.0	0.0	0.0	4.2
COVID-19 charges	(0.1)	9.7	6.1	35.1
Capital structure and related charges	1.8	9.3	6.8	9.3
Impairment charges	0.0	0.0	0.0	144.1
Revlon
Segment Reporting Information [Line Items]
Net sales	173.0	166.0	521.8	482.8
Revlon \| Operating segments
Segment Reporting Information [Line Items]
Net sales	173.0	166.0	521.8	482.8
Segment profit	16.1	13.5	45.3	41.4
Non-Operating items:
Operating income (loss)	16.1	13.5	45.3	41.4
Elizabeth Arden
Segment Reporting Information [Line Items]
Net sales	122.8	106.3	359.7	282.4
Elizabeth Arden \| Operating segments
Segment Reporting Information [Line Items]
Net sales	122.8	106.3	359.7	282.4
Segment profit	21.3	3.4	42.1	18.4
Non-Operating items:
Operating income (loss)	21.3	3.4	42.1	18.4
Portfolio
Segment Reporting Information [Line Items]
Net sales	112.7	99.6	307.4	298.1
Portfolio \| Operating segments
Segment Reporting Information [Line Items]
Net sales	112.7	99.6	307.4	298.1
Segment profit	22.1	12.2	46.3	33.9
Non-Operating items:
Operating income (loss)	22.1	12.2	46.3	33.9
Fragrance
Segment Reporting Information [Line Items]
Net sales	112.6	105.2	274.6	214.4
Fragrance \| Operating segments
Segment Reporting Information [Line Items]
Net sales	112.6	105.2	274.6	214.4
Segment profit	22.9	25.4	50.8	34.6
Non-Operating items:
Operating income (loss)	22.9	25.4	50.8	34.6
Revlon Consumer Products Corporation
Segment Reporting Information [Line Items]
Net sales	521.1	477.1	1,463.5	1,277.7
Segment profit	35.7	(7.7)	40.2	(248.8)
Depreciation and amortization	31.2	35.1	96.8	108.3
Non-cash stock compensation expense	3.9	5.1	10.4	8.6
Non-Operating items:
Acquisition, integration and divestiture costs	0.6	0.9	1.8	4.2
Loss (gain) on divested assets	0.1	(1.1)	(1.7)	(0.5)
Impairment charges	0.0	0.0	0.0	144.1
Operating income (loss)	35.7	(7.7)	40.2	(248.8)
Interest Expense	63.1	68.7	183.9	178.0
Amortization of debt issuance costs	8.7	7.8	30.7	17.8
Gain (loss) on early extinguishment of debt, net	0.0	(31.2)	0.0	(43.1)
Foreign currency losses (gains), net	9.9	(9.8)	11.5	9.1
Miscellaneous, net	0.1	(2.6)	2.8	13.9
(Loss) income from operations before income taxes	(46.1)	(40.6)	(188.7)	(424.5)
Revlon Consumer Products Corporation \| Operating segments
Segment Reporting Information [Line Items]
Net sales	521.1	477.1	1,463.5	1,277.7
Segment profit	84.0	56.5	188.8	134.2
Non-Operating items:
Operating income (loss)	84.0	56.5	188.8	134.2
Revlon Consumer Products Corporation \| Segment reconciling items
Non-Operating items:
Restructuring and related charges	10.8	4.5	28.0	61.2
Acquisition, integration and divestiture costs	0.6	0.9	1.8	4.2
Loss (gain) on divested assets	0.1	(1.1)	(1.7)	(0.5)
Financial control remediation and sustainability actions and related charges	0.0	0.7	0.4	8.5
Excessive coupon redemptions	0.0	0.0	0.0	4.2
COVID-19 charges	(0.1)	9.7	6.1	35.1
Capital structure and related charges	1.8	9.3	6.8	9.3
Impairment charges	0.0	0.0	0.0	144.1
Revlon Consumer Products Corporation \| Revlon \| Operating segments
Segment Reporting Information [Line Items]
Net sales	173.0	166.0	521.8	482.8
Segment profit	16.6	14.2	46.8	43.6
Non-Operating items:
Operating income (loss)	16.6	14.2	46.8	43.6
Revlon Consumer Products Corporation \| Elizabeth Arden \| Operating segments
Segment Reporting Information [Line Items]
Net sales	122.8	106.3	359.7	282.4
Segment profit	21.7	3.8	43.1	19.7
Non-Operating items:
Operating income (loss)	21.7	3.8	43.1	19.7
Revlon Consumer Products Corporation \| Portfolio \| Operating segments
Segment Reporting Information [Line Items]
Net sales	112.7	99.6	307.4	298.1
Segment profit	22.5	12.6	47.3	35.3
Non-Operating items:
Operating income (loss)	22.5	12.6	47.3	35.3
Revlon Consumer Products Corporation \| Fragrance \| Operating segments
Segment Reporting Information [Line Items]
Net sales	112.6	105.2	274.6	214.4
Segment profit	23.2	25.9	51.6	35.6
Non-Operating items:
Operating income (loss)	$ 23.2	$ 25.9	$ 51.6	$ 35.6

SEGMENT DATA AND RELATED INFORMATION - Schedule of Net Sales and Long-Lived Assets by Geographic Area (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 521.1	$ 477.1	$ 1,463.5	$ 1,277.7
Long-lived assets	1,365.7		1,365.7		$ 1,455.6
North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	277.4	256.0	747.5	666.4
EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	123.4	118.3	345.9	308.1
Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	65.0	58.5	216.2	178.8
Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	24.9	18.6	66.6	53.0
Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	30.4	25.7	87.3	71.4
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 1,137.7		$ 1,137.7		$ 1,194.9
Percentage of long lived assets by geographic location	83.00%		83.00%		82.00%
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 228.0		$ 228.0		$ 260.7
Percentage of long lived assets by geographic location	17.00%		17.00%		18.00%
Revlon
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 173.0	166.0	$ 521.8	482.8
Revlon \| North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	88.4	86.4	270.9	265.6
Revlon \| EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	43.8	41.4	125.4	105.2
Revlon \| Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	9.1	12.1	31.7	33.6
Revlon \| Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	14.2	11.3	40.7	35.3
Revlon \| Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	17.5	14.8	53.1	43.1
Elizabeth Arden
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	122.8	106.3	359.7	282.4
Elizabeth Arden \| North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	32.3	30.5	80.9	66.9
Elizabeth Arden \| EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	30.4	25.3	85.9	64.9
Elizabeth Arden \| Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	52.0	43.3	171.8	135.5
Elizabeth Arden \| Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	2.5	2.5	5.8	3.5
Elizabeth Arden \| Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	5.6	4.7	15.3	11.6
Portfolio
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	112.7	99.6	307.4	298.1
Portfolio \| North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	75.2	59.9	201.9	182.8
Portfolio \| EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	28.7	32.8	80.6	93.6
Portfolio \| Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	0.4	0.4	2.3	1.6
Portfolio \| Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	4.8	3.3	12.2	11.6
Portfolio \| Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	3.6	3.2	10.4	8.5
Fragrance
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	112.6	105.2	274.6	214.4
Fragrance \| North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	81.5	79.2	193.8	151.1
Fragrance \| EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	20.5	18.8	54.0	44.4
Fragrance \| Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	3.5	2.7	10.4	8.1
Fragrance \| Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	3.4	1.5	7.9	2.6
Fragrance \| Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 3.7	$ 3.0	$ 8.5	$ 8.2

SEGMENT DATA AND RELATED INFORMATION - Schedule of Net Sales by Classes of Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue from External Customer [Line Items]
Net sales	$ 521.1	$ 477.1	$ 1,463.5	$ 1,277.7
Color cosmetics
Revenue from External Customer [Line Items]
Net sales	$ 124.8	$ 104.7	$ 368.5	$ 305.3
Percentage of net sales by classes of similar products	24.00%	22.00%	25.00%	24.00%
Fragrance
Revenue from External Customer [Line Items]
Net sales	$ 160.1	$ 141.6	$ 395.4	$ 300.5
Percentage of net sales by classes of similar products	31.00%	30.00%	27.00%	24.00%
Hair care
Revenue from External Customer [Line Items]
Net sales	$ 124.2	$ 115.9	$ 351.6	$ 338.0
Percentage of net sales by classes of similar products	24.00%	24.00%	24.00%	26.00%
Beauty care
Revenue from External Customer [Line Items]
Net sales	$ 45.6	$ 50.4	$ 124.8	$ 141.9
Percentage of net sales by classes of similar products	9.00%	11.00%	9.00%	11.00%
Skin care
Revenue from External Customer [Line Items]
Net sales	$ 66.4	$ 64.5	$ 223.2	$ 192.0
Percentage of net sales by classes of similar products	12.00%	13.00%	15.00%	15.00%

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Condensed Income Statements, Captions [Line Items]

REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE - Components of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator:
Net loss	$ (53.1)	$ (67.7)	$ (96.0)	$ (44.5)	$ (126.8)	$ (213.9)	$ (216.8)	$ (385.2)
Denominator:
Weighted-average common shares outstanding - Basic (in shares)	54,025,861			53,476,354			53,899,732	53,371,986
Effect of dilutive restricted stock and RSUs (in shares)	0			0			0	0
Weighted-average common shares outstanding - Diluted (in shares)	54,025,861			53,476,354			53,899,732	53,371,986
Basic and Diluted (loss) earnings per common share:
Basic net loss per common share (in dollars per share)	$ (0.98)			$ (0.83)			$ (4.02)	$ (7.22)
Diluted net loss per common share (in dollars per share)	$ (0.98)			$ (0.83)			$ (4.02)	$ (7.22)
Restricted Stock and Restricted Stock Units
Basic and Diluted (loss) earnings per common share:
Unvested restricted stock and RSUs under the Stock Plan (in shares)	759,994			0			581,856	0

CONTINGENCIES (Details) $ in Millions	Feb. 16, 2021 USD ($)
Pending litigation
Gain Contingencies [Line Items]
Damages sought	$ 504

RELATED PARTY TRANSACTIONS (Details) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended		12 Months Ended
RELATED PARTY TRANSACTIONS (Details) - USD ($)	Oct. 31, 2013	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2009	Jan. 31, 2007	Mar. 31, 2006
Related Party Transaction [Line Items]
Reimbursement Agreements termination notice period			90 days
Conversion ratio, outstanding principal amount per share of common stock issued (in dollars per share)						$ 5.21
Number of days demand registration may be postponed			30 days
Products Corporation
Related Party Transaction [Line Items]
Percentage of voting capital stock			66.00%
Registration Rights Agreement \| 2003 Equity Rights Offering
Related Party Transaction [Line Items]
Equity right offering value	$ 50,000,000
Registration Rights Agreement \| 2006 Equity Rights Offering
Related Party Transaction [Line Items]
Equity right offering value								$ 110,000,000
Registration Rights Agreement \| 2007 Equity Rights Offering
Related Party Transaction [Line Items]
Equity right offering value							$ 100,000,000
Class A Common Stock
Related Party Transaction [Line Items]
Shares converted in Offering	3,125,000					9,336,905
Percentage ownership of outstanding common stock		86.10%	86.10%
MacAndrews & Forbes \| Reimbursements
Related Party Transaction [Line Items]
Payments to related party		$ 1,300,000			$ 5,300,000
Related party income			$ 600,000	$ 200,000
Receivable from related party		100,000	100,000		100,000
Majority Shareholder \| Related party expense, other advertising coupon redemption and raw material supply
Related Party Transaction [Line Items]
Payments to related party			200,000	800,000
Related party expenses			8,700,000	$ 28,200,000
Payable to related party		300,000	300,000		300,000
Majority Shareholder \| Related party expense, coupon redemption services
Related Party Transaction [Line Items]
Payable to related party		$ 1,600,000	$ 1,600,000		$ 600,000

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION - Narrative (Details) - 6.25% Senior Notes	Sep. 30, 2021
Condensed Financial Statements, Captions [Line Items]
Stated interest rate (as a percent)	6.25%
Revlon Consumer Products Corporation
Condensed Financial Statements, Captions [Line Items]
Stated interest rate (as a percent)	6.25%

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION - Balance Sheet (Details) - USD ($) $ in Millions	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Cash and cash equivalents	$ 73.3			$ 97.1
Trade receivables, less allowances for doubtful accounts	391.3			352.3
Inventories, net	461.5			462.6
Property, plant and equipment, net	305.9			352.0
Deferred income taxes	23.7			25.7
Goodwill	563.1			563.7
Intangible assets, net	401.5			430.8
Other assets	95.2			109.1
Total assets	2,448.2			2,527.7
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	0.6			2.5
Current portion of long-term debt	163.8			217.5
Accounts payable	245.6			203.3
Accrued expenses and other current liabilities	400.5			420.9
Long-term debt	3,302.3			3,105.0
Stockholder’s (deficiency) equity	(2,066.3)	$ (2,020.0)	$ (1,958.7)	(1,862.0)	$ (1,582.9)	$ (1,548.5)	$ (1,435.8)	$ (1,221.2)
Total liabilities and stockholder’s (deficiency) equity	2,448.2			2,527.7
Revlon Consumer Products Corporation
ASSETS
Cash and cash equivalents	73.3			97.1
Trade receivables, less allowances for doubtful accounts	391.3			352.3
Inventories, net	461.5			462.6
Prepaid expenses and other	305.4			300.5
Intercompany receivables	0.0			0.0
Investment in subsidiaries	0.0			0.0
Property, plant and equipment, net	305.9			352.0
Deferred income taxes	32.4			34.1
Goodwill	563.1			563.7
Intangible assets, net	401.5			430.8
Other assets	95.2			109.1
Total assets	2,629.6			2,702.2
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	0.6			2.5
Current portion of long-term debt	163.8			217.5
Accounts payable	245.6			203.3
Accrued expenses and other current liabilities	403.7			423.2
Intercompany payables	0.0			0.0
Long-term debt	3,302.3			3,105.0
Other long-term liabilities	414.3			453.7
Total liabilities	4,530.3			4,405.2
Stockholder’s (deficiency) equity	(1,900.7)	$ (1,855.9)	$ (1,796.2)	(1,703.0)	$ (1,444.5)	$ (1,411.7)	$ (1,301.9)	$ (1,089.4)
Total liabilities and stockholder’s (deficiency) equity	2,629.6			2,702.2
Revlon Consumer Products Corporation \| Eliminations
ASSETS
Cash and cash equivalents	0.0			0.0
Trade receivables, less allowances for doubtful accounts	0.0			0.0
Inventories, net	0.0			0.0
Prepaid expenses and other	0.0			0.0
Intercompany receivables	(8,836.4)			(7,755.9)
Investment in subsidiaries	(1,025.7)			(1,655.9)
Property, plant and equipment, net	0.0			0.0
Deferred income taxes	0.0			0.0
Goodwill	0.0			0.0
Intangible assets, net	0.0			0.0
Other assets	0.0			0.0
Total assets	(9,862.1)			(9,411.8)
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	0.0			0.0
Current portion of long-term debt	0.0			0.0
Accounts payable	0.0			0.0
Accrued expenses and other current liabilities	0.0			0.0
Intercompany payables	(8,836.2)			(7,755.7)
Long-term debt	0.0			0.0
Other long-term liabilities	0.0			0.0
Total liabilities	(8,836.2)			(7,755.7)
Stockholder’s (deficiency) equity	(1,025.9)			(1,656.1)
Total liabilities and stockholder’s (deficiency) equity	(9,862.1)			(9,411.8)
Revlon Consumer Products Corporation \| Products Corporation \| Reportable Legal Entities
ASSETS
Cash and cash equivalents	5.6			5.5
Trade receivables, less allowances for doubtful accounts	88.0			86.0
Inventories, net	121.5			121.3
Prepaid expenses and other	215.4			220.6
Intercompany receivables	4,098.4			3,592.2
Investment in subsidiaries	1,231.7			1,653.6
Property, plant and equipment, net	159.8			178.5
Deferred income taxes	0.0			0.0
Goodwill	404.9			48.9
Intangible assets, net	9.4			10.0
Other assets	60.5			67.9
Total assets	6,395.2			5,984.5
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	0.0			0.0
Current portion of long-term debt	163.7			159.2
Accounts payable	95.1			72.5
Accrued expenses and other current liabilities	149.4			144.1
Intercompany payables	4,390.2			3,897.1
Long-term debt	3,229.5			3,104.7
Other long-term liabilities	272.5			377.3
Total liabilities	8,300.4			7,754.9
Stockholder’s (deficiency) equity	(1,905.2)			(1,770.4)
Total liabilities and stockholder’s (deficiency) equity	6,395.2			5,984.5
Revlon Consumer Products Corporation \| Guarantor Subsidiaries \| Reportable Legal Entities
ASSETS
Cash and cash equivalents	3.2			2.5
Trade receivables, less allowances for doubtful accounts	119.3			95.7
Inventories, net	154.8			147.7
Prepaid expenses and other	26.2			24.6
Intercompany receivables	4,011.3			3,549.6
Investment in subsidiaries	(206.0)			2.3
Property, plant and equipment, net	62.8			72.1
Deferred income taxes	12.2			10.6
Goodwill	30.0			264.0
Intangible assets, net	174.6			187.8
Other assets	8.4			9.3
Total assets	4,396.8			4,366.2
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	0.0			0.0
Current portion of long-term debt	0.0			0.0
Accounts payable	55.3			48.0
Accrued expenses and other current liabilities	75.3			61.7
Intercompany payables	3,552.4			3,162.0
Long-term debt	0.0			0.0
Other long-term liabilities	109.5			33.8
Total liabilities	3,792.5			3,305.5
Stockholder’s (deficiency) equity	604.3			1,060.7
Total liabilities and stockholder’s (deficiency) equity	4,396.8			4,366.2
Revlon Consumer Products Corporation \| Non-Guarantor Subsidiaries \| Reportable Legal Entities
ASSETS
Cash and cash equivalents	64.5			89.1
Trade receivables, less allowances for doubtful accounts	184.0			170.6
Inventories, net	185.2			193.6
Prepaid expenses and other	63.8			55.3
Intercompany receivables	726.7			614.1
Investment in subsidiaries	0.0			0.0
Property, plant and equipment, net	83.3			101.4
Deferred income taxes	20.2			23.5
Goodwill	128.2			250.8
Intangible assets, net	217.5			233.0
Other assets	26.3			31.9
Total assets	1,699.7			1,763.3
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	0.6			2.5
Current portion of long-term debt	0.1			58.3
Accounts payable	95.2			82.8
Accrued expenses and other current liabilities	179.0			217.4
Intercompany payables	893.6			696.6
Long-term debt	72.8			0.3
Other long-term liabilities	32.3			42.6
Total liabilities	1,273.6			1,100.5
Stockholder’s (deficiency) equity	426.1			662.8
Total liabilities and stockholder’s (deficiency) equity	$ 1,699.7			$ 1,763.3

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION - Statement of Operations and Comprehensive Income (Details) - USD ($)
$ in Millions

3 Months Ended

9 Months Ended

Sep. 30, 2021

Jun. 30, 2021

Mar. 31, 2021

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Sep. 30, 2021

Sep. 30, 2020

$ 521.1

$ 477.1

$ 1,463.5

$ 1,277.7

221.2

234.3

608.7

600.7

299.9

242.8

854.8

677.0

256.1

253.4

796.0

739.1

0.6

0.9

1.8

4.2

9.0

(0.7)

22.8

44.8

0.0

144.1

0.1

(1.1)

(1.7)

(0.5)

34.1

(9.7)

35.9

(254.7)

63.1

68.7

183.9

178.0

8.7

7.8

30.7

17.8

0.0

(31.2)

0.0

(43.1)

9.9

(9.8)

11.5

9.1

0.1

(2.6)

2.8

13.9

81.8

32.9

228.9

175.7

(47.7)

(42.6)

(193.0)

(430.4)

5.4

1.9

23.8

(45.2)

(53.1)

$ (67.7)

$ (96.0)

(44.5)

$ (126.8)

$ (213.9)

(216.8)

(385.2)

2.9

^[1]

3.0

^[1]

(1.4)

^[1]

5.0

^[1]

14.3

^[1]

(2.7)

^[1]

4.5

16.6

(50.2)

(39.5)

(212.3)

(368.6)

Condensed Income Statements, Captions [Line Items]

521.1

477.1

1,463.5

1,277.7

221.2

234.3

608.7

600.7

299.9

242.8

854.8

677.0

254.5

251.4

791.7

733.2

0.6

0.9

1.8

4.2

9.0

(0.7)

22.8

44.8

0.0

144.1

0.1

(1.1)

(1.7)

(0.5)

35.7

(7.7)

40.2

(248.8)

0.0

63.1

68.7

183.9

178.0

8.7

7.8

30.7

17.8

0.0

(31.2)

0.0

(43.1)

9.9

(9.8)

11.5

9.1

0.1

(2.6)

2.8

13.9

81.8

32.9

228.9

175.7

(46.1)

(40.6)

(188.7)

(424.5)

(Loss) income from continuing operations, net of taxes

5.5

2.3

23.9

(44.2)

(51.6)

(42.9)

(212.6)

(380.3)

0.0

(51.6)

(66.1)

(94.9)

(42.9)

(125.2)

(212.2)

(212.6)

(380.3)

2.9

^[2]

$ 3.0

^[2]

$ (1.4)

^[2]

5.0

^[2]

$ 14.3

^[2]

$ (2.7)

^[2]

4.5

16.6

Revlon Consumer Products Corporation | Eliminations

(48.7)

(37.9)

(208.1)

(363.7)

Condensed Income Statements, Captions [Line Items]

0.0

0.1

0.0

0.0

0.1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

(Loss) income from continuing operations, net of taxes

0.0

0.0

(336.4)

(20.0)

(456.1)

36.2

(336.4)

(20.0)

(456.1)

36.2

(1.4)

5.5

(8.1)

(11.3)

Revlon Consumer Products Corporation | Products Corporation | Reportable Legal Entities

(337.8)

(14.5)

(464.2)

24.9

Condensed Income Statements, Captions [Line Items]

103.1

95.7

311.6

305.9

56.7

45.6

155.4

158.5

46.4

50.1

156.2

147.4

74.0

84.4

262.8

247.6

0.6

0.8

1.7

4.0

6.7

(8.4)

13.5

32.3

0.0

(23.4)

120.7

0.1

(1.1)

(1.7)

(0.5)

(35.0)

(2.2)

(120.1)

(256.7)

(3.1)

(0.5)

(3.9)

(3.5)

58.7

67.3

178.4

173.0

8.7

7.8

30.7

17.8

0.0

(31.2)

(43.1)

0.0

1.0

(0.2)

1.6

194.4

(1.8)

231.1

(0.9)

258.7

42.6

436.1

144.9

(293.7)

(44.8)

(556.2)

(401.6)

(Loss) income from continuing operations, net of taxes

0.0

(6.3)

0.0

(58.4)

(293.7)

(38.5)

(556.2)

(343.2)

243.9

30.0

353.9

0.7

(49.8)

(8.5)

(202.3)

(342.5)

2.9

5.0

4.5

16.6

Revlon Consumer Products Corporation | Guarantor Subsidiaries | Reportable Legal Entities

(46.9)

(3.5)

(197.8)

(325.9)

Condensed Income Statements, Captions [Line Items]

162.2

148.9

411.6

339.6

72.4

92.6

182.8

190.5

89.8

56.3

228.8

149.1

65.9

47.7

178.9

163.8

0.0

0.3

2.7

2.5

7.0

0.0

22.0

0.0

23.6

(16.1)

47.4

(43.7)

0.7

1.9

1.8

0.0

0.0

0.0

0.6

(0.7)

(0.3)

1.7

(115.1)

(55.4)

(126.9)

(71.5)

(113.8)

(55.4)

(125.3)

(68.0)

137.4

39.3

172.7

24.3

(Loss) income from continuing operations, net of taxes

3.2

17.8

4.6

19.2

134.2

21.5

168.1

5.1

92.5

(10.0)

102.2

(36.9)

226.7

11.5

270.3

(31.8)

3.9

(7.1)

8.1

7.3

Revlon Consumer Products Corporation | Non-Guarantor Subsidiaries | Reportable Legal Entities

230.6

4.4

278.4

(24.5)

Condensed Income Statements, Captions [Line Items]

255.8

232.4

740.3

632.2

92.1

96.0

270.5

251.7

163.7

136.4

469.8

380.5

114.6

119.3

350.0

321.8

0.0

0.1

0.2

2.0

5.0

6.8

5.5

0.0

1.4

0.0

47.1

10.6

112.9

51.6

2.4

(0.2)

2.0

1.7

4.4

1.4

5.5

5.0

0.0

0.0

9.3

(10.1)

12.0

5.8

(79.2)

54.6

(101.4)

86.3

(63.1)

45.7

(81.9)

98.8

110.2

(35.1)

194.8

(47.2)

(Loss) income from continuing operations, net of taxes

2.3

(9.2)

19.3

(5.0)

107.9

(25.9)

175.5

(42.2)

0.0

107.9

(25.9)

175.5

(42.2)

(2.5)

1.6

0.0

4.0

$ 105.4

$ (24.3)

$ 175.5

$ (38.2)

[1]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the nine months ended September 30, 2021 and 2020, respectively.
[2]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the nine months ended September 30, 2021 and 2020, respectively.

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION - Statement of Cash Flow (Details) - USD ($)

3 Months Ended

9 Months Ended

Sep. 30, 2021

Sep. 30, 2020

Sep. 30, 2021

Sep. 30, 2020

Net cash provided by (used in) operating activities

$ (86,700,000)

$ (256,900,000)

Net cash (used in) provided by investing activities

(4,200,000)

(7,400,000)

Net decrease in short-term borrowings and overdraft

(12,500,000)

(700,000)

305,000,000.0

880,000,000.0

^[1]

(186,700,000)

(354,700,000)

(2,700,000)

19,500,000

Tax withholdings related to net share settlements of restricted stock and RSUs

(17,900,000)

(108,300,000)

$ (9,700)

$ (6,400)

(2,400,000)

(1,600,000)

Net cash provided by (used in) financing activities

(300,000)

82,500,000

433,900,000

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(2,400,000)

(400,000)

Net increase (decrease) in cash, cash equivalents and restricted cash

(10,800,000)

169,200,000

Cash, cash equivalents and restricted cash at beginning of period

^[2]

102,500,000

104,500,000

Cash, cash equivalents and restricted cash at end of period

^[2]

91,700,000

273,700,000

91,700,000

273,700,000

Net cash provided by (used in) operating activities

(86,700,000)

(256,900,000)

Net cash (used in) provided by investing activities

(4,200,000)

(7,400,000)

Net decrease in short-term borrowings and overdraft

(12,500,000)

(700,000)

305,000,000.0

880,000,000.0

^[3]

(186,700,000)

(354,700,000)

(2,700,000)

19,500,000

Tax withholdings related to net share settlements of restricted stock and RSUs

(17,900,000)

(108,300,000)

(2,400,000)

(1,600,000)

Net cash provided by (used in) financing activities

(300,000)

82,500,000

433,900,000

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(2,400,000)

(400,000)

Net increase (decrease) in cash, cash equivalents and restricted cash

(10,800,000)

169,200,000

Cash, cash equivalents and restricted cash at beginning of period

^[4]

102,500,000

104,500,000

Cash, cash equivalents and restricted cash at end of period

^[4]

91,700,000

273,700,000

91,700,000

273,700,000

Revlon Consumer Products Corporation | Reportable Legal Entities | Products Corporation

Net cash provided by (used in) operating activities

(418,600,000)

(260,000,000.0)

Net cash (used in) provided by investing activities

(1,900,000)

(6,000,000.0)

Net decrease in short-term borrowings and overdraft

(4,500,000)

2,500,000

305,000,000.0

880,000,000.0

(186,700,000)

(354,700,000)

(2,700,000)

19,500,000

Tax withholdings related to net share settlements of restricted stock and RSUs

(17,900,000)

(109,400,000)

(2,400,000)

(1,600,000)

Net cash provided by (used in) financing activities

(200,000)

(100,000)

90,600,000

436,200,000

Effect of exchange rate changes on cash, cash equivalents and restricted cash

349,500,000

400,000

Net increase (decrease) in cash, cash equivalents and restricted cash

19,600,000

170,600,000

Cash, cash equivalents and restricted cash at beginning of period

6,500,000

1,000,000.0

Cash, cash equivalents and restricted cash at end of period

26,100,000

171,600,000

26,100,000

171,600,000

Revlon Consumer Products Corporation | Reportable Legal Entities | Guarantor Subsidiaries

Net cash provided by (used in) operating activities

57,700,000

6,600,000

Net cash (used in) provided by investing activities

(800,000)

(500,000)

Net decrease in short-term borrowings and overdraft

(5,600,000)

(3,800,000)

Tax withholdings related to net share settlements of restricted stock and RSUs

Net cash provided by (used in) financing activities

(100,000)

(5,700,000)

(3,900,000)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(57,800,000)

2,000,000.0

Net increase (decrease) in cash, cash equivalents and restricted cash

(6,600,000)

4,200,000

Cash, cash equivalents and restricted cash at beginning of period

7,800,000

6,400,000

Cash, cash equivalents and restricted cash at end of period

1,200,000

10,600,000

1,200,000

10,600,000

Revlon Consumer Products Corporation | Reportable Legal Entities | Non-Guarantor Subsidiaries

Net cash provided by (used in) operating activities

274,200,000

(3,500,000)

Net cash (used in) provided by investing activities

(1,500,000)

(900,000)

Net decrease in short-term borrowings and overdraft

(2,400,000)

600,000

Tax withholdings related to net share settlements of restricted stock and RSUs

1,100,000

Net cash provided by (used in) financing activities

(100,000)

(2,400,000)

1,600,000

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(294,100,000)

(2,800,000)

Net increase (decrease) in cash, cash equivalents and restricted cash

(23,800,000)

(5,600,000)

Cash, cash equivalents and restricted cash at beginning of period

88,200,000

97,200,000

Cash, cash equivalents and restricted cash at end of period

64,400,000

91,600,000

64,400,000

91,600,000

Revlon Consumer Products Corporation | Eliminations

Net cash provided by (used in) operating activities

Net cash (used in) provided by investing activities

Net decrease in short-term borrowings and overdraft

Tax withholdings related to net share settlements of restricted stock and RSUs